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  Abstract	  
Drug-resistance occurs in about 30% of patients with epilepsy and is 
associated with increased mortality and morbidity and cognitive decline. 
Furthermore, present AEDs treat the symptom (seizures) but do not modify the 
disease or associated cognitive comorbidities and do not prevent the 
development of epilepsy following brain injury. Transient receptor potential 
melastanin 7 (TRPM7) is a ubiquitous, stress-activated channel, that plays 
essential roles in cell viability and Mg2+ homeostasis, and opening of the 
channel depolarises neurons. Inhibiting TRPM7 channels is neuroprotective in 
brain ischemia. Conditions that activate the channel, such as low intracellular 
Mg2+ concentrations, oxidative stress, and decreased intracellular pH occur 
during seizure activity.  
This thesis aimed to assess the role of blocking TRPM7 channel in preventing: 
1) seizure occurrence, 2) seizure induced cell death, 3) the development of 
epilepsy after brain damage induced by status epilepticus (SE) and 4) cognitive 
comorbidity in epilepsy.  
The low Mg2+ and pentylenetetrazol (PTZ) in vitro seizure models were used in 
entorhinal-hippocampal slices to assess the effect of TRPM7 inhibitors 
carvacrol and Waxiencin A (a recent more specific inhibitor) on seizure-like 
activity. The perforant path stimulation (PPS) model of epilepsy was used to 
investigate the effect of carvacrol on status epilepticus (SE), chronic epilepsy 
and memory dysfunction in epilepsy in vivo.  
TRPM7 inhibitors abolished (carvacrol) or significantly reduced (Waxiencin A) 
seizure-like activity in vitro indicating that TRPM7 channels contribute to 
seizure generation. Status epilepticus resulted in cell loss in CA1 area and hilus 
in the PPS model of epilepsy, and this was rescued by treatment with 
carvacrol, suggesting that TRPM7 channels contribute to status epilepticus 
induced cell death. Blocking TRPM7 channels in vivo prevented the occurrence 
of recurrent SE and early seizures following induced SE but did not affect 
chronic seizures. Lastly, TRPM7 channel inhibition by carvacrol significantly 
prevented memory impairment as measured by rewarded T-maze alternation in 
chronic epilepsy. 
These findings suggest that in vitro seizure-like activity and the sequelae of 
status epilepticus and chronic epilepsy such as neuronal death and memory 
dysfunction can be effectively treated by blocking TRPM7 channels.  
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Chapter 1. Introduction   
1. 	  	  	  	  	  	  Overview	  
Epilepsy affects over 50 million people worldwide and is the commonest 
serious neurological disorder, (Neligan et al., 2012) and second in terms of 
disease burden after stroke. Epilepsy is associated with a high mortality and 
morbidity, amongst which are psychiatric comorbidity and cognitive decline. 
Seizure-induced cell loss may contribute to the latter. Moreover, epilepsy 
significantly affects patients’ quality of life. The disease can occur at any age, 
however, higher prevalence is reported in young children and in the elderly. 
The lowest incidence was reported between ages of 20 and 40; the incidence 
then rises significantly after 50 years (Rugg-Gunn and Smalls, 2013). In 
respect to seizure origin, epilepsy is broadly divided into generalised and partial 
(focal) epilepsy. Although there are many drugs available that control the 
symptoms - seizures - none of the presently available drugs modify the course 
of the disease (Walker et al., 2002). Idiopathic generalised epilepsy syndromes 
which compromise about 92% of all generalised epilepsies have better 
treatment outcome, the majority of patients recover fully , whereas  patients 
with symptomatic focal epilepsy respond poorly to treatment and temporal lobe 
epilepsy was the most drug resistant (Semah et al., 1998). Up to 60% of all 
active epilepsies in the general population comprise partial epilepsies and 
nearly 60-70% of these are of temporal lobe origin (Frampton, 2015; Téllez-
Zenteno et al., 2011). Identifying new targets for better seizure control, 
preventing epileptogenesis and neuronal loss are questions that need to be 
urgently addressed. This thesis is concerned with disease modification in 
temporal lobe epilepsy following status epilepticus.  
TRPM7 channels and epilepsy 
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2. Temporal	  lobe	  epilepsy	  
Temporal lobe epilepsy (TLE) is divided into mesial and neocortical TLE, 
however, spread from one to another is common. Among partial epilepsies 
mesial temporal lobe epilepsy (MTLE) comprises the majority and is the most 
drug-resistant type. Cognitive involvement is present in majority of cases, 
ranging from mood changes, memory impairment to psychosis. 
 Seizures in TLE can be simple partial or complex partial. The former can 
manifest as aura without objective signs. Typical MTLE complex partial 
seizures evolve slowly and last longer than other partial seizures (2-10 min). 
They have three stages: aura, blank spells (motor arrest) and automatism. 
Postictal confusion and headache are common (Rugg-Gunn and Smalls, 
2013). While the commonest causes of neocortical TLE are malformations of 
cortical development and tumours such as glioma, cavernous angioma, 
hamartoma etc., (Tassi et al., 2009), the most common pathology found in 
patients with MTLE is hippocampal sclerosis.  
2.1 Psychiatric	  comorbidity	  and	  cognitive	  	  	  decline	  
in	  epilepsy	  
Epilepsy is associated with an increased prevalence of mental health disorders. 
Psychiatric comorbidity varies between 19 and 80% in different patient groups 
and epilepsy syndromes; it is most common in TLE (80%) (Swinkels et al., 
2005). Increased rates of major depression, anxiety and suicidal ideation were 
reported in patients with epilepsy (Agrawal and Govender, 2011). Furthermore, 
memory difficulties have been frequently reported by patients. Abnormal mood 
such as depressed affect, aggressive behaviour as well as manic symptoms 
(grandiose delusions, religiosity) occur often post-ictally (Nadkarni et al., 2007). 
Several potential risk factors that can contribute to the development of 
psychiatric problems in epilepsy have been identified, including seizure type, 
TRPM7 channels and epilepsy 
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age of onset, duration, laterality and others iatrogenic factors (eg antiepileptic 
drugs, surgery) (Agrawal and Govender, 2011). 
The prevalence of psychosis in epilepsy is also high and occurs more 
commonly in TLE (Devinsky, 2003). Ictal psychosis is rare and comprises 
visual or auditory hallucinations together with affective changes, whereas 
postictal psychosis has clinical features similar to schizophrenia-like psychoses 
and is present in 2-9% of epilepsy patients (Elliott et al., 2009; Nadkarni et al., 
2007). This is characterised by hallucinations, delusions, and gross 
abnormalities of behaviour lasting up to seven days after a seizure (Nadkarni et 
al., 2007). 
Chronic interictal psychosis also occurs more commonly in TLE (Elliott et al., 
2009). The interictal psychosis resembles primary schizophrenia; persecutory 
auditory hallucinations are common and religiosity also can occur (Nadkarni et 
al. 2007; Elliott et al. 2009). Short recurrent or sometimes continuous 
subclinical electrographic activity during psychotic symptoms has been 
reported. Therefore, it is unclear whether the psychosis is caused by such 
activity or is a result of functional change provoked by such activity (Elliott et 
al., 2009). 
Patients with epilepsy ranked cognitive and memory problem as being their 
primary concern (Fisher et al., 2000; Thompson and Corcoran, 1992). This is 
particularly worse in TLE.  Short term memory loss is well known in epilepsy. 
The memory impairment correlates positively with the degree of brain damage 
in humans demonstrated with histology (Rausch and Babb, 1993;  Pauli et al., 
2006) and atrophy observed in MRI (Lencz et al., 1992).  Moreover, age of 
onset, seizure frequency and lifetime number of seizures have also been 
shown to play a role (Butler and Zeman, 2008). The site of seizure focus 
determines the type of memory loss i.e. left TLE causes predominantly verbal 
memory loss, whereas non-verbal memory impairment is more prominent in 
right TLE (Hermann et al., 1997; Gleissner et al., 1998; Baxendale et al., 1998). 
TRPM7 channels and epilepsy 
Chapter 1.  Introduction 
 
 
 19	  
However, memory problems reported by patients are often undetectable by 
objective memory tests, which do not always correlate with the severity of 
subjective complains. Three other distinct types of memory impairment have 
been described in epilepsy:  
• transient epileptic amnesia, which is itself the primary manifestation of 
seizures, is a form of TLE. 
• accelerated long-term forgetting, when memory for recently learned 
information vanish over days to weeks 
• remote memory impairment, which is a loss of memory for events of the 
distant past   (Butler and Zeman, 2008). 
2.2 Pathogenesis of epilepsy 
Epilepsy syndromes are divided into two broad categories: idiopathic and 
symptomatic. Different factors contribute to the aetiology of various epilepsy 
types. Genetic components possibly play a role in all epilepsy syndromes 
(Ottman et al., 1996). A strong genetic contribution has been shown in 
idiopathic generalised epilepsies (Johnson et al. 2001), whereas the aetiology 
of acquired partial epilepsies (amongst the commonest epilepsy syndromes) is 
often attributed to a brain insult. The development of epilepsy following brain 
damage is termed epileptogenesis. Any major brain disorder or injuries that 
disrupt neuronal connectivity may initiate epileptogenesis (Theodore and 
Porter, 1995). 
A cascade of structural and functional changes occurring in the brain following 
brain insults such as head trauma, cerebrovascular disease, brain tumours, 
neurosurgical procedures, neurodegenerative conditions, status epilepticus 
(SE), febrile convulsions may lead to the development of epilepsy in 
susceptible individuals (Walker et al. 2002; Löscher, 2012). About 40% of 
epilepsy result from such insults (Barker-Haliski et al., 2015). Seizures 
TRPM7 channels and epilepsy 
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themselves can then further cause morphological and functional changes 
contributing to progression in some epilepsy syndromes (Walker et al., 2002).  
The latent period between insult and development of epilepsy can vary from 
days to over 10 years; such a long latent period could be explained by a 
second hit hypothesis in which the initial insult leads to a lowering of seizure 
threshold and a second, later insult is necessary for the development of 
epilepsy (Walker et al., 2002).This time interval offers a potential opportunity for 
the prevention of epileptogenesis and subsequent unprovoked seizures 
(Löscher, 2012).  
Pathways of epileptogenesis are not well understood, however, there is 
growing evidence for the involvement of certain mechanisms. Structural and 
cellular changes that have been implicated in epileptogenesis include axonal 
regeneration within hippocampal dentate gyrus with sprouting of excitatory 
fibres, dendritic remodelling, neurogenesis, gliosis, and neuronal cell death. 
Moreover, synaptic modifications, and alterations in neuronal excitability 
secondary to acquired channelopathies have been described. Synaptic 
alterations include downregulation of GABAergic signalling, and upregulation of 
N-methyl-D-aspartate (NMDA) receptors (Pitkänen and Lukasiuk, 2009). All 
these changes lead to increased excitability of neurons and neuronal networks. 
Hippocampal sclerosis is the commonest pathology in TLE, which is the most 
common type of drug-resistant epilepsy in adults (Manford et al., 1992). This 
thesis is solely concerned with a TLE model of epilepsy and status epilepticus 
induced hippocampal damage, and so I will first review here hippocampal 
structure and pathology. Examples will be related primarily to TLE animal 
model, in particular the perforant path stimulation (PPS) model. 
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2.3 Hippocampal	  formation	  
2.3.1 Overview	  
The hippocampus, located in the medial temporal lobe, forms a part of the 
limbic system (Figure 1.1). It is a phylogenically preserved structure that 
captivated by its physical appearance anatomist from the time of ancient Egypt 
and the current name derived from the Latin for seahorse: hippocampus. The 
hippocampus (hippocampus proper), and nearby structures - entorhinal cortex, 
subiculum, presubiculum, parasubiculum and the dentate gyrus (DG) constitute 
the hippocampal formation. (Spiers, 2012). The hippocampal formation plays a 
central role in short term memory and spatial navigation. It is the most 
vulnerable structure to seizures, as well as the most common site of drug-
resistant seizures.   
2.3.2 Cellular	  anatomy	  of	  the	  hippocampus	  
The primary excitatory cells of the hippocampus are pyramidal cells - multipolar 
neurons: their dendrites extend in both directions from the cell body, forming 
apical and basal dendrites (Figure 1.3) (Shepherd, 2004). The pyramidal cell 
layer of the hippocampus proper has three main ‘Cornu Ammonis’ (CA) 
subfields: CA1, CA2 and CA3. CA translates as ‘Amun’s horns’, named after 
the ancient Egyptian god whose symbol was a ram’s horn. Unlike the neocortex 
where pyramidal cells form multiple layers, in CA regions pyramidal cells are 
aligned in a densely packed single cell layer (Spiers, 2012). These regions 
receive different inputs: CA3 receives projections from the axons of dentate 
granule cells - mossy fibers. CA2 is a small area between CA1 and CA3:  the 
cell bodies resemble CA3 cells however do not receive mossy fiber input. CA2 
region is also distinct in that it is more resistant to epileptic cell death 
(Shepherd, 2004).  
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                Figure 1.1. Hippocampal formation and parahippocampal region.  
The image is the illustration of right hemisphere horizontal section of a rat brain. Principal 
hippocampal and parahippocampal areas are shown with colour code for the individual 
subregion: the dentate gyrus (DG), CA1–CA3, the subiculum (Sub), the medial entorhinal cortex 
(MEC), presubiculum (PrS) and parasubiculum (PaS). The figure was taken from (Moser et al., 
2014).  
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Dentate gyrus does not have pyramidal cells, but consists of densely packed 
small granule cells (Spiers, 2012). The dentate gyrus has three layers: the 
molecular layer (outer and inner), the main granule cell layer (principal cell 
bodies), and diffuse polymorphic cell layer – hilus. The Molecular layer is 
relatively acellular, contains mainly the dendrites of the granule cells and the 
perforant path fibers projecting from the entorhinal cortex. Also, a small number 
of interneurons are present in the molecular layer as well as variety of extrinsic 
input fibers. The granule cell layer is the principal cell layer, densely packed 
with granule cells (excitatory cells). Basket cells, the most studied inhibitory 
interneurons in dentate gyrus, are located typically just within the granule cell 
layer at the border with the polymorphic layer. In the polymorphic cell layer, the 
principal cell type is the mossy cells (excitatory cells). In addition, this layer 
contains two main interneurons types (Figure 1.2): 1) A long-spined multipolar 
hilar perforant path-associated cell (HIPP cells), their axons extend into outer 
molecular layer i.e., the perforant path zone (Amaral et al., 2007). They receive 
input from granule cells, contributing to feedback inhibition (Savanthrapadian et 
al., 2014). HIPP cells are atypical interneurons. 2) Multipolar cells with thin, 
aspiny dendrites, hilar commissural-associational pathway related cells (HICAP 
cells) (Amaral et al., 2007). HICAP and basket cells receive input from 
commissural associational path, the perforant path in molecular layer and the 
granule cells; they mediate feedback and feedforward inhibition 
(Savanthrapadian et al., 2014). Axons of HICAP cells extend through the 
granule cell layer and branch profusely in the inner molecular layer (Amaral et 
al., 2007).  
Mossy fibers originating from dentate granule cells form abundant synaptic 
connections collaterals with hilar interneurons that project back to the granule 
cells (Moser et al., 2014). Granule cells do not make direct excitatory 
connections between each other. 
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Figure 1.2 Schematic illustration of principal GABAergic interneuron microcircuit in 
dentate gyrus  
(Ramaswamy, 2015).  Grey lines indicate layer borders:  oml, outer molecular layer; iml, inner 
molecular layer; gcl, granule cell layer.  Axons, soma and dendrites of the cells indicated by 
distinct colour: axons) green –HICAP cell, orange – basket cells (BC), blue- HIPP cells; soma) 
purple –HICAP, pink –BC, green - HIPP interneurons; dendrites) maroon –HICAP, red –BC, 
black –HIPP cells. Arrows depict unidirectional inhibitory synaptic connections between 
interneurons; the connection probability shown in %. The figure was taken from (Ramaswamy, 
2015). 
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2.3.3 Intra	  and	  Extra	  Hippocampal	  connections	  	  
The unidirectional excitatory hippocampal pathway connecting its part to each 
other was termed trisynaptic circuit (Figure 1.3). Glutamate is the main 
neurotransmitters in these pathways. The entorhinal cortex (EC) is the starting 
point of the circuit, as it is where the majority of the sensory input enters the 
hippocampus: it has a central role in connecting other brain regions with the 
hippocampus (Shepherd, 2004). 
The entorhinal cortex forms two pathways to connect with the hippocampus 
(Spiers, 2012). The perforant pathway starts from layer II (stellate cells) of the 
entorhinal cortex, passes through subiculum (perforates) and projects to the 
molecular layer of the DG and stratum lacunosum-moleculare of the CA3 and 
CA2 areas (Shepherd, 2004; Moser et al., 2014). Neurons from layer III of the 
entorhinal cortex project to CA1 via subiculum bypassing dentate gyrus and 
CA3 forming the temporoammonic pathway (Spiers, 2012). Dentate gyrus 
granule cells send input to CA3 proximal dendrites via mossy fibers; projections 
from CA3 to CA1 are called Schaffer collaterals. Commissural fibers from the 
contralateral hippocampus form connections from one hippocampus to the 
other.  
The hippocampus sends output to the entorhinal cortex via subiculum. 
Pathways from the CA1 and the subiculum end in the layer V of the entorhinal 
cortex from where the output passes to the neocortex and other brain regions 
(Moser et al., 2014). 
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Figure 1.3 Intra and Extra Hippocampal connections.  
A – Illustrates the position of the hippocampus in the brain. B – Hippocampal formation and four 
main intra and extra hippocampal connections. Enthorhinal cortex (EC) sends projections via two 
pathways, perforant path (PP) from layer II to DG and CA2/CA3 and temporoammonic (TA) 
pathway from layer III to the subiculum and CA1. Mossy fibers (MF) project from DG selectively 
to CA3. Projections from CA3 to CA1 form Schaffer collaterals (SC). Pathways from CA1 and 
subiculum project to layers V of EC. C – pyramidal CA1 and CA3 cells, * -st. lucidum identified in 
CA3, but not in CA1. Information adopted the following sources (Spiers, 2012; Ojo et al., 2013; 
Moser et al., 2014) 
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2.3.4 Lamellar	  structure	  
According to the original hypothesis of the laminar hippocampal organisation 
excitatory activity travels from the entorhinal cortex and through the 
hippocampus via a trisynaptic circuit lying within a series of parallel 
hippocampal slices or lamellae (Andersen et al., 1971). In this way, it was 
envisaged that temporal lobe interactions between the entorhinal cortex and 
the hippocampus were organized topographically, and that lamellae might 
operate independently, permitting a relatively simple structure to mediate 
complex behaviours. Each specific layer of the entorhinal cortex projects fibers 
to a restricted segment of the hippocampus (Sloviter and Lømo, 2012). 
 
3. 	  Cell	  death	  in	  status	  epilepticus	  	  
3.1 Status	  Epilepticus	  
Status epilepticus (SE) is an extreme manifestation of epilepsy or an 
expression of an acute life-threatening brain disorder such as anoxic brain 
damage, encephalitis, or trauma. SE is conventionally defined as a single 
clinical seizure lasting > 30 minute or repetitive seizures lasting < 30 minutes 
without full recovery of consciousness between seizures (International League 
Against Epilepsy, 1993). However, due to the high risk of brain damage from 
prolonged seizures and risk to life, a practical definition was suggested:  SE is 
defined as continuous clinical and/or electrographic seizure activity or recurrent 
seizure activity without recovery between seizures lasting over 5 minute 
(Brophy et al., 2012) and requires immediate treatment. The majority of 
generalized tonic-clonic seizure (GTCS) typically last less than 2-3 minutes 
(Trinka et al., 2012). SE is one of the most common emergencies in neurology; 
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the annual incidence of SE is 10-41 per 100,000. Mortality rates associated 
with SE can reach 20%. Over 50% of patients presenting with SE have no 
history of previous seizures or epilepsy (Trinka et al., 2012). SE is broadly 
divided into two types, convulsive and non-convulsive SE. SE can lead to 
irreversible damage to neurons and alterations in synaptic network. 
Underlying mechanisms that lead to prolonged seizures or SE are not well 
understood. It has been suggested that SE could be a result of misbalance in 
excitation and inhibition i.e. increase in excitatory and exhaustion of inhibitory 
processes. Modulation of γ-aminobutyric acid (GABA) receptor function through 
various mechanisms that decreases GABA function has been suggested in a 
number of studies. Alterations in other inhibitory pathways have also been 
proposed (Walker, 2009). The trisynaptic excitatory circuit in the hippocampus 
that creates a closed loop could be responsible for the development and 
persistence of self-sustained SE (Andersen et al., 1966). 
Prolonged seizures can damage neuronal cells, leading to cell loss. Cell death 
following status epilepticus (SE) is observed in human epilepsies as well as 
animal models. One of the challenging questions however is whether cell death 
contributes to epileptogenesis or is an antiepileptogenetic process (Walker, 
2007). Nevertheless, it has been shown that cell damage is involved in other 
pathological processes associated with epilepsy such as cognitive impairment 
and neurological deficit (Walker et al., 2002) affecting patients’ quality of life. 
Below I will review patterns and mechanisms of cell death in TLE model.  
3.2 Patterns	  of	  cell	  death	  
3.2.1 Cell	  loss	  areas	  
In ‘classical’ hippocampal sclerosis selective loss of pyramidal neurons in CA1 and 
dentate hilus region was reported, however, cell loss sometimes can only be 
confined to hilar region (Matthew et al., 2006). The hilus is the most vulnerable area 
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to cell death in TLE; cell death initially occurs in this area and the damage is more 
extensive. Loss of both excitatory mossy cells and inhibitory interneurons in this 
area was observed in TLE in humans and animal models (Schwarcz and Witter, 
2002). In perforant path stimulation (PPS) model, hilar cells, CA1 and CA3 were 
the most damaged areas whereas CA2 and dentate granule cells were relatively 
spared (Sloviter, 1983). However, other studies also suggested that CA1 and CA4 
(or CA3c) were the most vulnerable to cell death, whereas CA3 and dentate gyrus 
cells were less affected and a big variation was seen in CA2 (Pauli et al., 2006). 
Damage to the same areas was seen during autopsy of humans with TLE and from 
surgical specimens obtained from patients with TLE (Thom, 2014). With 2 hour 
continuous perforant path stimulation lesions (clear, round spaces) were also 
observed in extrahippocampal areas: the subiculum, lateral septum, dorso-lateral 
thalamus and amygdala. However, with intermittent 24 h stimulation damage was 
confined to hippocampus only (Sloviter, 1983). High vulnerability of hilar cells to 
damage was proposed to be due to highly convergent input from granule cells and 
release of high concentrations of excitatory neurotransmitters from large mossy 
fiber terminals (Sloviter and Damiano, 1981). 
Both loss of principal neurons and interneurons can be observed in hippocampal 
sclerosis. The pattern of loss and cell types that are most vulnerable may differ 
among epilepsy models, species and brain areas (Houser, 2014). Loss of 
GABAergic interneurons expressing neuropeptide Y and somatostatin that are 
abundant in the hilar region were observed in hippocampal sclerosis. However, it 
was speculated that these neurons are not specifically targeted and are lost in the 
proportion to the overall cell loss (Matthew et al., 2006). Nevertheless, loss of 
somatatin-containing neurons in hilar region is the most consistent and very well 
established finding in epileptic brains; this was observed in almost all animal 
epilepsy models as well as in human TLE. Similarly, in stratum oriens of CA1 
region somatastatin cells are also commonly affected cells. Loss of pavalbumin 
expressing neurons in hilar dentate has also been described in several animal 
epilepsy models, both basket cells and axo-axonic cells were affected. However, in 
the same animals the loss of parvalbumin-expressing neurons in the dentate gyrus 
was generally less severe than that of somatostatin interneurons (Houser, 2014). 
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Granule cells are resistant to cell damage relative to other excitatory cell types 
(Matthew et al., 2006).  
3.2.2 Laterality	  of	  cell	  loss	  in	  relation	  to	  the	  damage	  site	  	  
Some studies have shown similar damage ipsi- and contralateral to the insult 
(Gorter et al., 2003), others have shown more severe damage on the ipsilateral 
side (Sloviter, 1983) and some others suggested complete sparing of the 
contralateral side (Kienzler et al., 2006). Sloviter et al. suggested that PPS on a 
side of the brain evoking unilateral seizures caused only ipsilateral damage 
(with low-frequency stimulation 2-2.5 Hz), whereas higher frequency stimulation 
(20 Hz) that caused bilateral discharges led to damage in both hippocampi 
(Sloviter, 1983). In contrast, a study in mice showed no damage in contralateral 
hippocampus with 20 Hz stimulation (Kienzler et al., 2006). Gorter et al. 
reported that in PPS laterality of the damage was linked to the severity of the 
disease; progressive epilepsy was associated with similar damage bilaterally 
whereas in non-progressive disease  cell reduction on the side contralateral to 
the damage was less pronounced (Gorter et al., 2003). Evidence from human 
magnetic resonance imaging (MRI) studies has also shown that on the side of 
the seizure focus hippocampal as well as temporal lobe shrinkage was 
significant compared to the contralateral side (Lencz et al., 1992). The 
ipsilateral hippocampal damage caused by PPS was also explained by limited 
anatomical connection between the two hippocampi and temporal lobes 
(Sloviter et al. 1983).   
3.3 Duration	  of	  SE	  and	  cell	  death	  
The degree of cell damage also depends on the duration of status epilepticus. 
Longer initial stimulation in animal models as well as longer self-sustaining 
status epilepticus (SSSE), i.e. periodic epileptiform discharges (1-2 Hz) after 
stimulation, correlated positively with more severe hilar cell loss (Gorter et al., 
2003; Norwood et al., 2011). A study published by Norwood et al. showed that 
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35 min stimulation did not lead to hippocampal cell damage, whereas 40 min 
stimulation led to hilar cell loss but preserved CA3 area. Longer duration of 
stimulation, 60 min and more resulted in an additional cell loss in CA3 area. 
This challenges the hypothesis that an individual brief seizure can cause 
neuronal damage, as up to 40 min stimulation did not lead to neuronal loss in 
the hippocampus (Norwood 2011). Cell death is also determined by the 
severity of the initial stimulation in animal models.  
The highest degree of cell death was observed in the first 1-2 days following 
SE and continued until one week but no further cell death was seen after that. 
TUNEL staining of the hippocampus that identifies apoptotic and necrotic 
neurons, showed significant increase in necrotic neurons at day 1 after induced 
SE and with a peak at 1 week followed by a sharp decrease necrotic cell death 
afterwards. This highlights the need to stop SE early in the disease course. 
Therefore, neuroprotective drugs can be useful in the first week following SE 
and might not be effective in the chronic phase (Gorter et al., 2003). 
3.4 Mechanisms	  of	  cell	  death	  
Neuronal death in epilepsy is related to excessive neuronal firing such as 
occurs in status epilepticus (Pitkänen et al., 2002). Seizure related brain 
damage was associated with pre-synaptic release of excitatory 
neurotransmitters; this leads to the post-synaptic changes causing dendritic 
swelling and cell death. These changes were also seen in epileptic brain tissue 
removed during surgery from patients with pharmacoresistant epilepsy 
(Sloviter, 1983).  
Excessive neuronal firing requires increased energy substrates to maintain 
ionic balance (Kovac et al., 2012). Energy depletion leads to excess glutamate 
release which in turn causes Ca2+ influx into cells, as well as release of Ca2+ 
from intracellular stores. This triggers a Ca2+-dependent cascade of intracellular 
processes that results in the production of free radicals (Walker et al., 2002). 
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Free radical species generating oxidative stress contribute to mitochondrial 
dysfunction and cell death (Menon et al., 2012). 
3.5 Consequences	  of	  cell	  death	  and	  development	  
of	  chronic	  epilepsy	  
Prolonged seizures or SE that cause cell death in animal models promote 
epileptogenesis, leading to the conception that cell death is an epileptogenetic 
process. Although some studies have suggested that neuronal loss is not 
necessary for the development of chronic epilepsy lack of neuronal loss is not 
easy to prove. Conventionally, the link between cell loss and epileptogenesis 
was explained by recapitulation of the development hypothesis - when input 
from dying cells is lost this induces axonal sprouting and synaptic 
reorganisation in the hippocampus, termed mossy fiber sprouting (Dingledine et 
al., 2014).    
Mossy fiber sprouting is one of the most prominent changes observed in the 
hippocampus during epileptogenesis in mesial TLE and involves axonal 
regeneration in the dentate gyrus (Pun et al., 2012). The entorhinal cortex and 
perforant path as the main source of excitatory input to the hippocampus, have 
been implicated in mesial TLE. Dentate granule cells play a role of a 
gatekeeper in this pathway, modifying input to the hippocampus (Scimemi et 
al., 2006). Due to sprouting of granule cell mossy fibre axons into the dentate 
molecular layer, this function of the DG is impaired during epileptogenesis, 
leading to recurrent excitatory circuits. Moreover, neurogenesis also occurs in 
the hippocampus during epileptogenesis and newly born granule cells form 
anomalous basal dendrites and are ectopically placed in the dentate gyrus 
(Pun et al., 2012). Increased release probability of glutamate by N-methyl-D-
aspartate (NMDA) receptors leading to increased neurotransmission at the 
perforant path to dentate granule cell is a common mechanism that enhances 
the epileptogenic process. Increased cross talk between medial and lateral 
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perforant path was found in epileptic tissue, which also increases excitability 
and reduces the specificity of perforant path which in turn impairs hippocampal 
function. These processes may contribute to lowering of the seizure threshold 
(Scimemi et al., 2006). 
A new hypothesis of cell death related epileptogenesis, a neuronal death 
pathway, has been suggested. According to this hypothesis epileptogenesis 
after cell death occurs due to activation of the biochemical pathways leading to 
programmed neurodegeneration, rather than due to neuronal loss itself. 
Various cell death pathways have been described. Therefore, even cell death 
per se is not the factor that is leading to epileptogenesis; the cell death pathway 
activates molecular mechanisms that may be leading to it. Interestingly, 
preventing cell death does not necessarily prevent seizure occurrence or their 
severity (Dingledine et al., 2014).  
Brain inflammation is one such pathways that can be triggered by brain injury 
and excitotoxicity and can contribute to epileptogenesis. A plethora of evidence 
suggests the key role of brain inflammation in the pathology of various types of 
drug resistant epilepsies, and that inflammation can change seizure threshold 
significantly in susceptible brain regions. Activation of the interleukin-1 
Receptor/Toll-like receptor, the Transforming Growth Factor (TGF)-β signalling 
and the Cyclooxygenase-2 (COX-2) pathway are the main inflammatory 
pathways described in epileptic brain. These molecules are involved in 
processes associated with epileptogenesis such as neurodegeneration, 
neurogenesis, synaptic plasticity and regulation of blood brain barrier 
permeability. Immune responses in the brain to injury or excitotoxicity are 
mediated mainly via microglia and astrocytes. However, neurons are also 
involved in immune responses, for instance, via release of prostaglandins. 
Chronic inflammatory processes that present in the brain during 
epileptogenesis mediated by cytokines and chemokines; astrogliosis and 
microglia activation, leukocytosis from blood are involved in particular in brain 
injury models. Inflammatory processes were observed in chronic epilepsy as 
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well as during the period before development of spontaneous seizures 
suggesting contribution of inflammation to seizure generation and the 
development of epilepsy. However, their direct role in the development of 
epilepsy is yet unclear (Vezzani et al., 2013).  
3.6 Chronic	  seizures	  and	  cell	  death	  
Another unanswered question in epilepsy research is whether chronic epilepsy 
i.e. recurrent spontaneous seizures induce cell death or not. Some studies 
have suggested occurrence of neuronal loss in chronic epilepsy. However, 
these studies were done in the kindling model where seizure stage five with 
secondary generalisation occur, therefore it was suggested that cell death may 
be due to secondary hypoxic cell death (Gorter et al., 2003). There is some 
evidence to suggest that cell death depends on the type of seizures. For 
example, it was suggested that short seizures such as absence seizures 
lasting 5-10 second do not cause cell loss (Dingledine et al., 2014). However, 
case reports have described the development of hippocampal sclerosis after 
several GTCS or partial seizures (Briellmann et al., 2001; Worrell et al., 2002). 
However, in one of these cases the patient sustained a minor head injury prior 
to the onset of GTSC seizures, in the other case acute thrombosis of an 
ipsilateral parietal venous angioma preceded new-onset partial seizures. 
Undoubtedly, prolonged and repetitive seizures that define SE cause extensive 
cell death. Cell death in a model of SE has been described to relate to initial SE 
and not to seizure frequency in chronic phase if seizures are short (<2 min) 
(Gorter et al., 2003). Neuropathological analysis of hippocampal specimen from 
patients who underwent temporal lobe resection showed no correlation 
between the degree of cell loss and the disease duration (Pauli et al., 2006) 
suggesting that chronic seizure do not cause significant cell damage.  
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4. Antiepileptic	  drugs	  (AEDs)	  	  
To prevent or stop seizures, AEDs act on targets involved in seizure generation 
and propagation. The most common targets are: 
• Modulation of voltage-gated ion channels. By targeting these channels 
inhibition of neuronal firing, synchronization and seizure spread can be 
achieved. 
• Enhancement of synaptic inhibition  
• Inhibition of synaptic excitation  
• Modulation of neurotransmitter release via presynaptic mechanisms 
(Porter et al., 2012). 
However, the mechanism of action of each AED is unique and drugs acting on 
the same target can vary in their clinical efficacy. Multiple targets for certain 
drugs also recognised. Moreover, for some AEDs mechanism of action is not 
completely understood (Porter et al., 2012). The main target of current AEDs 
are described below (see Table 1.1 and Table 1.2): 
Voltage-gated sodium channels. Agents acting on sodium channels 
comprise the majority of AEDs. Drugs modulating voltage-gated sodium 
channel inhibit high frequency repetitive spike firing without altering 
physiological activity. They do not directly affect synaptic inhibition or excitation. 
Interictal discharges are short and therefore sodium channel blocking agents 
do not change their frequency. These agents are particularly effective against 
generalised tonic-clonic and partial seizures.  
Voltage-gated calcium channels. Some AEDs inhibit high voltage activated 
(HVA) calcium channels (P/Q type). HVA calcium channels open with strong 
membrane depolarisation and are responsible for calcium entry and hence 
neurotransmitter release. Drugs targeting these types of calcium channels are 
effective in some epilepsy syndromes however do not have effect in absence 
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seizures. Whereas a drug (Ethosuximide) that acts on low voltage activated 
type calcium channels (T-type) in thalamic neurons is effective in absence 
epilepsy. T-type calcium channels are involved in the pathology of absences 
(Rogawski and Löscher, 2004). 
Potassium. Opening of potassium channels hyperpolarise membrane potential 
and reduce cell excitability. An AED that acts on potassium channels, 
Retigabine, positively modulates Kv7 potassium channels (Kv7.2 to Kv7.5) in the 
nervous system. KV.7 brain potassium channels mediate M-current, that 
increases when the membrane potential in neurons close to action potential 
threshold. Kv7 limits further neuronal firing after an action potential and 
therefore serve as a “brake” on epileptic firing (Rogawski and Löscher, 2004).  
GABA. GABAA receptors localized at the postsynaptic membrane of inhibitory 
synapses transmit fast neuronal inhibition, whereas GABAA located 
extrasynaptically mediate tonic (long-term) inhibition. Benzodiazepines 
enhance synaptic inhibition via modulating synaptic GABAA receptors 
containing the γ2 subunit that leads to increase of the GABA-induced chloride 
channel opening frequency. However, Barbiturates (phenobarbital) do not 
increase the channel opening frequency but increase the channel open time. 
Inhibition of GABA transporter GAT-1 is the main mechanism of action of 
Tiagabine; this suppresses the translocation of extracellular GABA into the 
intracellular medium, therefore increases extracellular GABA levels that may 
activate extrasynaptic GABA receptors. This leads to enhancement of tonic 
GABA inhibition (Wyllie, 2015). 
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Table 1.1. Main targets of AEDs.  
 
!
Targets Drugs Approved indications in epilepsy 
Modulation of ion channels 
N+ channel blockers Phenytoin 
Carbamazepine 
 
Oxcarbazepine 
Eslicarbazepine 
Lacosamide  
Zonisamide 
Retigabine 
 
Lamotrigine  
 
Ethosuximade 
PGCS 
 
 
Partial seizures 
 
 
 
 
 
PGCS, Lennox–Gastaut synd 
 
Absence seizurse 
 
Ca2+ channel blockers Lacosamide  
Zonisamide 
Ethosuximade  
 
K+ channel 
potentiation 
Retigabine  
HCN channels Lamotrigine  
Increase GABA-ergic inhibition 
GABA potentiation Benzodiazepines 
 
 
Vigabatrin 
 
 
Tiagabin 
 
Convulsive disorders, status 
epilepticus 
Infantile spasms, complex 
partial seizures 
Partial seizures 
 
Decrease in glutamergic inhibition 
AMPA inhibitor Perampanel Partial seizures 
     Modulation of neurotransmitter release via presynaptic mechanisms 
α2δ subunit 
(accessory subunit of 
Ca channel 
 
Gabapentine/Pregabalin PGCS 
SV2A modulation  Levetiracetam PGCS, partial seizures, 
GTCS, JME 
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 Table 1.2. AEDs with multiple mechanism of action  
 
The following sources were used (Rogawski and Löscher, 2004; Löscher et al., 2013; Wyllie, 
2015). 
 
Glutamate. Although glutamate is the main excitatory neurotransmitter in the 
brain drugs blocking glutamate receptors have not been very effective in 
seizure reduction (Rogawski and Löscher, 2004). Although NMDA receptors 
involved in seizure activity, inhibition of these receptors does not stop 
epileptiform activity in seizure models. However, inhibition of AMPA receptors 
had antiseizure effect in animal seizure models. Perampanel is the only potent 
selective antagonist of AMPA receptors; it does not affect NMDA receptors or 
other ion channels (Wyllie, 2015). 
!
 
Targets 
                   
              Drugs with Multiple mechanisms of action 
  Valproate 
 
Felbamate 
 
Topiramate 
 
Phenobarbital 
     
N+ channel 
blockers 
 
+ 
 
+ 
 
+ 
 
Ca2+ 
channel 
blockers 
T-type HVA HVA HVA 
K+ channel 
enhancing +  +  
GABA 
potentiation  + +  + + 
Glutamate                  
inhibitor NMDA NMDA AMPA/KA AMPA/KA 
Approved 
indication 
in epilepsy 
PGCS, 
absence 
seizures 
 
PGCS, Lennox–
Gastaut syndrome 
 
PGCS, Lennox–
Gastaut syndrome 
 
PGCS 
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About 30% of patient with new onset epilepsy are resistant to treatment with 
current AEDs and approximately 50% of patients will have at least one adverse 
effect with the first line agents. According to long-term studies 14% of patients 
with new onset childhood epilepsy will go on to develop drug-resistance while 
remaining on treatment after several years (Schmidt and Schachter, 2014).  
However, the majority of currently used antiepileptic drugs (AEDs) have similar 
mechanisms and targets (Loscher 2011). Moreover, current anticonvulsant 
drugs are symptomatic that is they reduce the occurrence of seizures but do 
not modify disease (e.g. cure the epilepsy) or prevent epileptogenesis (Walker 
et al., 2002). Patients who are seizure free on antiepileptic medication are at 
high risk of recurrent seizures after discontinuation of the treatment (Wyllie et 
al., 2012). 
Identifying new drug targets for the prevention of disease development i.e. 
disease modifying treatment is therefore an important step in the treatment of 
epilepsy. Novel anti-epileptogenic approaches could also target early stage of 
neuronal network reorganisation and thus prevent development of intractable 
post-insult epilepsy. Drug development in epilepsy should also aim to prevent 
neuronal damage and death. This could reduce cognitive decline and other co-
morbidities caused by neuronal loss (Walker et al., 2002).  
 
5. TRP	  channels	  
Transient receptor potential (TRP) ion channels are a superfamily of cation 
channels with polymodal (activated by various types of stimulus, whether 
thermal, mechanical or chemical) activation properties (Ramsey et al., 2006). 
TRP channel subunits consist of six transmembrane domains that assemble to 
form non-selective cationic channels. These channels are permeable to Ca2+ 
and monovalent cations. Calcium enters the cell at hyperpolarized membrane 
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potentials (Clapham et al., 2001).TRP channels facilitate the influx of cations 
through the membrane into cells against their electrochemical gradients. This 
raises intracellular concentrations of Ca2+ and Na+ leading to depolarisation of 
the cell (Ramsey et al., 2006).The channel subfamily shares a common 
property of activation or modulation by phosphatidylinositol signal transduction 
pathways (Clapham et al., 2001). 
TRP channels are widely expressed in the body and have various functions. 
Some TRP channels have been identified in the CNS, however, they are 
abundantly expressed in variety of sensory receptors cells such as those 
mediating vision, pheromone sensation, thermal sensation, taste, touch and 
cell volume regulation. TRP channels have critical roles in sensing and 
transmission of a broad variety of external or internal stimuli, including 
mechanical stress, painful stimuli, etc. (Yin and Kuebler, 2010). They are also 
involved in repletion of intracellular calcium stores, receptor-mediated excitation 
and modulation of the cell cycle (Clapham et al., 2001). Involvement of these 
channels in cellular guidance mediation and chemotaxis has also been 
suggested (Ramsey et al., 2006). There are seven main subfamilies in the TRP 
channel family: the TRPC (Canonical), the TRPV (Vanilloid), the TRPM 
(Melastatin), the TRPP (Polycystin), the TRPML (Mucolipin), the TRPA 
(Ankyrin) and the TRPN (NOMP) family (Nilius and Voets, 2005). TRPN 
subfamily has only been found in Drosophila and zebrafish to date. Eight 
channels (TRPM1-8) have been identified in the TRPM group. The name of the 
subfamily has derived from the founding member of the subfamily - melastanin 
(TRPM1) (Fleig and Penner, 2004). 
5.1 TRPM7	  channel	  
TRPM7 (previously known as LTRPC7 - long TRP channel 7) is a ubiquitously 
expressed ligand-gated cation channel. The TRPM7 channel gene is located 
on chromosome 15 and consists of 39 exons (Paravicini et al., 2012). It is a 
unique channel which possesses both channel and kinase properties. Due to 
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the presence of a protein kinase domain at C-termini the channel is referred to 
as a chanzyme. This domain also exists as an independent enzyme (Montell, 
2005). TRPM7 channel kinase is classified as an atypical alpha protein kinase 
(Harteneck 2005). The specific function of the channel and whether the kinase 
domain is important for channel activity is unclear. TRPM6 is a chanzyme with 
biophysical properties similar to those of TRPM7, however, TRPM6 has a 
limited expression profile: epiltelial cells of the renal convoluted tubule and the 
intestine (Chubanov et al., 2005).  
TRPM7 is a constitutively active channel, suppressed by physiological 
concentrations of intracellular Mg2+ (McNulty and Fonfria, 2005). TRMP7 is a 
non-selective divalent permeable channel, however, it has a high affinity for 
Ca2+ and Mg2+. In physiological conditions (-40 to -80 mV) inward currents are 
only conducted by divalent cations, however, in the absence of extracellular 
divalents (both Mg2+ and Ca2+), the channel conducts monovalent cations, such 
as Na+. The TRPM7 channel is permeable to many essential as well as toxic 
divalent metals with the following permeability sequence: Zn2+ ≈ Ni2+>> Ba2+> 
Co2+> Mg2+≥ Mn2+≥ Sr2+≥ Cd2+ ≥ Ca2+, while trivalent ions such as La3+ and 
Gd3+ are not measurably permeable (Monteilh-Zoller et al., 2003). Entry of toxic 
metal ions like Zn2+ and Ni2+ through TRPM7 during severe metabolic stress 
conditions such as hypoxia or hypoglycaemia may contribute to the 
accumulation and toxicity of these metals (Montell, 2005; Nadler et al., 2001). 
 
5.1.1 Structure	  of	  TRPM7	  and	  Physiological	  role	  
TRPM7 channels consist of six transmembrane segments flanked by 
cytoplasmic N-terminal and C-terminal tails (Figure 1.4). The N-termini contain 
four stretches of amino acids having similar sequence. The C-terminal 
sequences of the TRPM family vary in length and structure. The C-terminal 
regions of TRPM6 and TRPM7 contain a kinase domain with similar 
TRPM7 channels and epilepsy 
Chapter 1.  Introduction 
 
 
 42	  
biochemical properties (Fleig and Penner, 2004). Although in physiological 
ionic conditions TRPM7 has a small inward current at voltages ranging from -
100 to -40 mV, decreased extracellular pH dramatically increases the inward 
current. The effect of protons on TRPM7 currents is concentration-dependent 
(Jiang et al., 2005).  
The exact function of TRMP7 channel and its regulatory role are not yet 
completely understood. However, it is one of the essential channels in cell 
viability. A global deletion mutation was lethal in mice (Sun et al., 2009). 
Moreover, TRPM7 has a central role in Mg2+ homeostasis. It is one of a few 
identified Mg2+ transporters in vertebrates (Schmitz et al., 2007). 
The channel has also been implicated in many cellular processes such as 
synaptic transmission, cell cycle, normal growth and development, regulation of 
vascular smooth muscle cells and proliferation of retinoblastoma cells (Cook et 
al., 2009).  
Various mutations have different effects on the function of TRPM7 channel. A 
deletion mutation in DT-40 cell line affected cell viability (Nadler et al., 2001). 
Some mutations only led to growth arrest without disrupting Mg2+ homeostasis 
(Jin et al., 2008) whereas others impaired cell Mg2+ homeostasis too (Schmitz 
et al., 2003). Extracellular Mg2+ supplementation in some mutations affecting 
Mg2+ homeostasis and cell growth have rescued cell viability and proliferation 
(Jin et al., 2008). Moreover, TRPM7 channel deficiency resulted in severe 
abnormalities of skeletal development in mutant zebrafish (Elizondo et al., 
2005). 
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Figure 1.4. Structure of TRPM7 channel.  
(A) The diagram illustrates putative membrane topology of a TRPM7 channel. TRPM7 channel 
contains six transmembrane segments and a pore-forming loop between S5 and S.  KD-kinase 
domain, MHR- the N-terminal region that contain four major homology regions (MHR) (stretches 
of amino acids that share some sequence similarity), CC- coiled coli region. TRPM7 channel 
conducts both monovalent ions, such as, Na+ and divalent ions, such as, Ca2+ and Mg2+ and 
other trace metal ions; permeability sequence for divalent shown. (B) Representative current-
voltage (I-V) curve shows that at negative membrane potential TRPM7 conducts small inward 
current, the potential reverses at 0mV and at positive membrane potential it conducts strong 
outward current in the presence of normal external concentrations of Ca2+ and Mg2+. The 
information adopted from (Monteilh-Zoller et al., 2003; Fleig and Penner, 2004; Park et al 2014). 
Figure (B) taken from (Fleig and Penner, 2004). 
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5.1.2 The	  kinase	  domain	  
Annexin 1, which is a member of Ca2+ and lipid binding proteins, is a 
physiological substrate for the TRPM7 kinase domain. Phosphorylation of 
annexin 1 by TRPM7 might be involved in physiological functions of the 
channel (Chubanov et al., 2005). The kinase domain possesses 
autophosphorylation property and it can phosphorylate prototypic kinase 
substrates, such as myelic basic protein and histone H3, and annexin 1. This 
activity of the kinase depends on adenosine triphosphate (ATP) and requires 
magnesium (Harteneck, 2005).  
The role of the kinase domain in activation of TRPM7 channel is somewhat 
controversial. It was initially suggested that the kinase is important for the 
channel's function (Runnels et al., 2001). Kinases in general have been known 
for having a role in ion channel regulation. TRPM7 is unique in that it has its 
own kinase domain. Additionally, the kinase presents at the sixth 
transmembrane segment that appears to be involved in the gating of ion 
channels (Runnels et al., 2001). A single point mutation in the kinase domain 
has been shown to impair Mg-nucleotide dependent inhibition of the channel 
(Demeuse et al., 2006). However, this mutation did not abolish Mg2+ dependent 
inhibition although slightly reduced the efficacy. Surprisingly, a mutation leading 
to complete deletion of the kinase domain restored nucleotide dependent 
inhibition of the channel (Demeuse et al. 2006). The authors suggested that 
this could be due to exposure of a previously blocked binding site of Mg2+ 
nucleotides. However, Schimtz and collegues suggested that although the 
channels kinase domain by itself is not essential for the activation of TRPM7, it 
acts by an unknown coupling mechanism to regulate channel gating and Mg2+ 
uptake (Schmitz et al., 2003). A recent study in kinase-inactive mutant mice 
has also suggested that kinase domain is not important for channel activity 
(Kaitsuka et al., 2014). 
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5.1.3 Activation	  and	  inhibition	  mechanisms	  
TRPM7 channels are activated by oxidative stress, low extracellular Mg2+ 
concentration and reduction of intracellular pH (Chokshi et al., 2012).  ATP, a 
functional kinase domain and autophosphorylation of the channel are all 
necessary for the activation of the channel (McNulty and Fonfria, 2005). The 
data available in the literature to date regarding various aspects of the 
channel’s modulation is controversial. Nevertheless, there is strong evidence to 
suggest that the channel is inhibited by free intracellular Mg2+; physiological 
concentrations (4-6mM) inhibit the channel activity whereas low Mg2+ 
concentrations (0-2mM) activate the channel. Some data suggest that Mg*ATP 
more potently inhibits the channel than free Mg2+ although it has been 
proposed that intracellular Mg2+ but not ATP is important for the suppression of 
the channel by Mg*ATP (Kozak and Cahalan, 2003). 
Magnesium nucleotides. Physiological concentrations of Mg*ATP suppress 
the channel and strongly increase the inhibitory effect of free Mg2+. Likewise, 
Mg*ADP had a similar but smaller effect. Almost all magnesium nucleotides 
were shown to inhibit TRPM7 current and have stronger effect than free Mg2+ 
alone. The following rank in potency of nucleotides has been suggested: TP > 
TTP > CTP ≥ GTP ≥ UTP > ITP ≈ free Mg2+ alone (Demeuse et al., 2006). The 
presence of two binding sites on the channel that in combination modulate 
TRPM7 channel activity has been suggested; they provide synergic inhibition 
by both Mg2+ and Mg-nucleotides. The Mg2+ binding site is extrinsic and the 
nucleotide binding site is intrinsic to the TRPM7 kinase domain (Demeuse et 
al., 2006). However, it has shown that inhibition of the TRPM7 channel by 
Mg*ATP is lost when using a strong Mg2+ chelator, HEDTA, suggesting that the 
Mg2+ nucleotide effect can be explained by free Mg2+ alone (Kozak and 
Cahalan, 2003).Due to sensitivity to physiological Mg*ATP levels, TRPM7 is 
implicated in regulation of divalent exchange across the plasma membrane to 
adjust to the metabolic state of the cell (Nadler et al., 2001). 
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Adenosine triphosphate. The role of ATP on TRPM7 channel’s activity is not 
conclusive based on current research data. The activation of the channel by 
ATP via the kinase domain was described by Runnels and colleagues (Runnels 
et al., 2001). However, another study has suggested the opposite effect: the 
channel was inhibited by addition of ATP to the internal solution (Nadler et al., 
2001).Nevertheless, the role of ATP is apparent in TRPM7 inhibition: Mg2+ 
*ATP has stronger blocking effect on the channel than Mg2+ alone. 3 mM of 
free Mg2+ is required to completely block the channel, whereas 6 mM of 
Mg*ATP that contains 670 µM to 800 µM free Mg2+ is sufficient to inhibit the 
channel. This indicates the importance of ATP in inhibiting the channel at lower 
Mg2+ concentrations.   
Phosphatidylinositol 4,5-bisphosphate (PIP2), Cyclic adenosine 
monophosphate (cAMP). TRPM7 can be positively regulated by G-protein 
coupled receptors, through adenosine 3,5 -monophosphate (cAMP) and protein 
kinase A (PKA) pathway (Harteneck, 2005). The protein kinase domain 
mediates the effects of cAMP on the channel activity. Elevation of cAMP 
concentrations promoted TRPM7-dependent currents, and this effect was 
inhibited by loss of function mutations of TRPM7 kinase (Montell, 2005). 
TRPM7 upregulation via the PKA pathway also requires a functional TRPM7 
kinase domain (Demeuse et al. 2006).  
Numerous studies demonstrated that phosphatidylinositol 4,5-bisphosphate 
(PIP2), which is a component of cell membrane and the substrate of PLC, is a 
key regulator of TRPM7. PIP2 has inhibitory effect on TRPM7 channel. 
Activation of PLC results in the hydrolysis of localized PIP2, leading to 
inactivation of the TRPM7 channel (Runnel et al. 2002). Therefore, the 
channels activity depends on the activity of PLC and subsequently upon the 
concentration of PIP2. TRPM7 channel is activated when PIP2 concentrations 
are depleted, whereas activity of phophoinositide kinases inhibits the channels 
by restoring PIP2 concentrations (Harteneck, 2005). Tyrosine kinase receptors 
also block the channel via activation of PLC (Runnels et al., 2002). Mg2+ 
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mediated activation of PLC associated with the chanzyme was assumed to 
reduce PIP2 concentration. Indeed, Mg2+ - activated PLCs have been 
described in certain cell types (Montell, 2005). 
Activation by stretch, swelling and Oxidative stress. A study showed that 
TRPM7 channels are activated by stretch and swelling and thus they can be 
involved in volume regulation in human epithelial cells. A further study has 
demonstrated that shear stress induced activation is directly mediated by 
mechano-stress receptors (Numata et al., 2007). A study in hippocampal slices 
has reported that TRPM7 channels are activated under oxidative stress 
conditions (Lipski et al., 2006). 
β-adrenergic stimulation induced TRPM7 activation, whereas muscarinic 
stimulation suppressed the activity (Harteneck, 2005). 
 
5.1.1 TRPM7	  in	  the	  brain	  pathology	  
TRPM7 channels are widely expressed in the nervous system (Jiang et al., 
2003; Tian et al., 2007) however their function in the brain is unknown. Jiang et 
al. demonstrated that the channel was inhibited by increased intracellular Mg2+ 
but not affected by cell swelling or a different range of intracellular Ca2+ 
concentrations. Tyrosine kinase inhibitors had inhibitory effect on TRPM7 
channels in microglia (Jiang et al., 2003). Several studies have demonstrated 
an essential role of TRPM7 in anoxia induced death of cortical neurons (Aarts 
et al., 2003; Nicotera and Bano, 2003; Sun et al., 2009). Cardiac arrest led to 
neuronal death of CA1 hippocampal area, followed by memory and cognition 
dysfunction. Suppression of TRPM7 in CA1 by viral shRNA against TRPM7 into 
the rodent hippocampus prevented this cell death in rats. This silencing 
resulted in neuronal resistance to ischemic death, preserved neuronal function 
and prevented ischemia-induced deficits in LTP and preserved performance in 
memory tasks. TRPM7 suppression did not affect neuronal excitability, 
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plasticity and had no adverse effect on animal survival, neuronal and dendritic 
morphology. TRPM7 suppression following brain injury inhibited Ca2+ influx and 
neuronal recovery was enhanced (Sun et al., 2009).These effects can also be 
explained by a decrease in TRPM7-mediated Ca2+ or Zn2+ influx (Zierler et al., 
2011).  
Hypoxia-ischemia induced delayed cell death in the brain is a feature of stoke 
and neurodegenerative disorders (Sun et al. 2009). Therefore, TRPM7 has 
been linked to neurological pathology such as brain ischemia, trauma, and 
neurodegeneration due to oxidative stress induced cell death. Moreover, 
TRPM7 could play a role in traumatic brain injury due to facilitation of cation 
influx and involvement in Mg2+ homeostasis. In addition, the channel kinase 
may have role in posttraumatic inflammatory processes (Cook et al., 2009). 
5.1.2 TRPM7	  channels	  and	  epilepsy	  
As described above opening of TRPM7 channels is induced by a decrease in 
intracellular Mg2+ and extracellular Ca2+ concentrations, oxidative stress and 
decreased extracellular pH (Kozak and Cahalan, 2003; Monteilh-Zoller et al., 
2003; Jiang et al. 2005; Lipski et al. 2006). These changes occur during seizure 
activity. Thus, TRPM7 activation, and Ca2+ and Na+ influx into cell may play a 
role in neuronal depolarisation contributing to seizure activity. Moreover, Ca2+ 
influx as well as entry of trace metals through the channel may induce seizure-
dependent neuronal death. Elevated intracellular Ca2+ is one of the main 
factors leading to neuronal cell death in neurological disorders. 
TRPM7 may also play a role in epilepsy and other neurological disorders linked 
to Zn2+ induced neurotoxicity. It has been shown that neurotoxicity of Zn2+ is 
mediated via it is entry to cells through TRPM7 channel (Inoue et al., 2010). 
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5.1.3 TRPM7	  channel	  antagonists	  
The inhibitory effect of the following agents on TRPM7 channels have been 
described: 2-aminoethyl-diphenylborinate (2-APB), lanthanum (La3+), 
gadolinium (Gd3+), SKF-96365, spermine, carvacrol, and 5-lipoxygenase 
inhibitors. None of these agents is specific for TRPM7 channel and they affect 
other ion channels, e.g. calcium release activated channels (CRAC) or other 
TRP channel family members, and/or lack sufficient efficacy (Zierler et al., 
2011).  
La3+, Gd3+, and SKF-96365 block TRPM7 channel but also inhibit other Ca2+ 
permeable channels, including CRAC. SKF-96365 also blocks other TRP 
channels, such as TRPC.   
The polyamine spermine distinguishes between CRAC and TRPM7 channels, 
blocking only monovalent TRPM7 currents at micromolar concentrations. 
However, spermine also inhibits conductance of monovalents such as Na+, K+, 
NMDG+ (Kucherenko and Lang, 2010).  
The 5-lipoxygenase inhibitors: nordihydroguaiaretic acid, AA861, and 
MK886 have also been shown to affect TRPM7 channels in the micromolar 
range independently of lipoxygenase activity; however, they also affect K+ and 
Cl-  channels (Zierler 2011).  
Nafamostat mesilate (NM) is a synthetic serine protease inhibitor. NM blocks 
TRPM7 currents in inverse relationship to the concentration of extracellular 
divalent cations: in the absence of extracellular divalent cations (Ca2+ and 
Mg2+) it blocks TRPM7 current, however, in physiological concentrations of 
extracellular divalents NM activates the channel (Chen et al., 2010). NM 
reversibly blocks acid-sensing ion channels (Ugawa et al., 2007). 
Carvacrol inhibited mammalian TRPM7 channels in HEK cells and in CA3/CA1 
cells in hippocampal cultures. However, carvacrol activated thermo TRP 
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channels, TRPV3 and TRPA1 (Parnas et al., 2009). Carvacrol also inhibited 
drosophila TRPL channels which is considered mammalian TRPC channel 
analogue. TRPC are non-selective Ca2+ permeable cation channels although 
the selectivity ratio PCa/PNa varies significantly between different members of 
the family (Pedersen et al., 2005). Chen et al. has also shown the inhibition of 
TRPM7 current in HEK cells by carvacrol (Chen et al., 2015).  
2-Aminoethoxydiphenyl borate (2-APB) produces dual effect on TRPM7 
activity but not on TRPM6 or TRPM6/7. Concentrations <1 mM of 2-APB 
inhibited TRPM7 currents, however higher concentrations increased TRPM7 
channel activation. Overall, micromolar concentrations of 2-APB enhanced 
TRPM6 however inhibited TRPM7 activity, whereas at millimolar 
concentrations, 2-APB increased both TRPM7 and TRPM6/7 currents (Li et al., 
2006). 2-APB also affects variety of other TRP channels. It activates TRPV1, 
TRPV2, and TRPV3 channels (Hu et al., 2004) and also affects CRAC 
channels (Peinelt et al., 2008).  
A recent study identified a potentially specific inhibitor of the TRPM7 channel – 
Waixencin A which is a marine-derived natural product. Waixencin A is 
xenicane diterpenoid produced from the Hawaiian soft coral Sarcothelia 
edmondsonia. It demonstrated high potency and selective inhibition for the 
TRPM7 channel (Zierler et al. 2011). The compound did not have inhibitory 
effect on close homologue, TRPM6 channel and had insignificant effect on 
TRPM2 and TRPM4 channels. Waixencin A did not affect CRAC.  
For the purpose of the current research to study the effect of TRPM7 channels 
in epilepsy carvacrol was selected as a blocking agent. We were unable to 
obtain Waxiencin A initially. Due to difficulties and delays in obtaining 
Waxiencin A I started my initial experiments with carvacrol. Moreover, because 
this study aims to test the effect of TRPM7 blocking both in vitro and in vivo, I 
aimed to use a compound that is also safe to apply in vivo. Although Waxiencin 
A is the only potentially selective blocker of TRPM7 channel, it is a new 
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compound that has not been tested in vivo yet and is available only in small 
quantities for research. Whereas carvacrol is a naturally occurring compound 
with a simple structure that is unlikely to have many adverse effects on 
animals. Moreover, carvacrol has already been used in in vivo studies and was 
well tolerated without known toxic effects. In addition, to our knowledge to date 
it does not affect pathways that can modulate cell excitability. Nafamostat 
mesilate was not chosen because it has opposite effects on TRPM7 channels 
depending on extracellular divalent concentrations. 
 
                Table 1.3. TRPM7 channel antagonists  
CRAC - calcium release activated channels, + indicates that the compound has inhibitory 
effect on the target. 
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6. In	  vitro	  seizure	  models	  
Studying various of epileptic processes to understand their mechanisms on 
animal brain slices is a valuable tool. The effects of various drugs can be 
studied easily without confounders such as liver metabolism and the blood 
brain barrier. Moreover, brain cells in slices behave similarly to brain cells in 
vivo and different brain regions can be studied in isolation (Mosfeldt Laursen, 
1984). A number of in vitro models have been used to induce epileptiform 
activity. Widely used in vitro models are low Mg2+, 4-Aminopyridine (4-AP), and 
Pentylenetetrazol (PTZ) models.  Low Ca2+ and high K+ models have also been 
used to induce epileptiform activity in vitro; both these conditions present during 
seizure activity in humans (Pitkänen et al., 2005). Elevated K+ levels could be 
responsible for propagation of epileptic activity (Mosfeldt Laursen, 1984). High 
K+ levels successfully generated epileptiform activity in vitro (Pitkänen et al., 
2005). Moreover, to elicit epileptform events in other seizure models higher K+ 
concentration used  4-AP is a potassium channel blocker, which induces 
epileptiform activity by reducing K+ efflux from cells (Yamaguchi and Rogawski, 
1992). For the current study two in vitro models were selected, low Mg2+ and 
PTZ. These are distinct in that one relies on enhancement of excitatory 
pathways (low Mg2+) and the other inhibition of inhibitory pathways (PTZ) to 
generate seizure-like activity.      
Low Mg2+ model is a well-established and widely used in vitro model of 
epilepsy. Artificial cerebrospinal fluid ACSF containing low Mg2+ is used to 
unblock NMDA receptors. The low Mg2+ in vitro model is a powerful tool to 
study prolonged seizure activity in brain tissue; acute or cultured brain slices 
(Pitkänen et al., 2005). Seizure-like event can be induced in brain slices from 
all epilepsy-sensitive regions and in particular hippocampus (Dreier and 
Heinemann, 1991). Furthermore, epileptogenesis induced in this model is 
resistant to most current AEDs and therefore serves as a good model of drug 
resistant epilepsy (Dreier et al., 1998). In low Mg2+ conditions NMDA block will 
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be released and GABAA will be supressed. Moreover, release of glutamate 
from presynaptic neurons inhibited in normal Mg2+ concentrations, therefore 
reduced extracellular Mg2+ will trigger glutamate release (Baaij et al., 2015). 
Pentylenetetrazol (PTZ) is a convulsant agent that is frequently used to study 
seizure activity. PTZ blocks inhibitory neurotransmitters, in particular GABA 
which results in depolarisation of neurones. PTZ acts via binding to picrotoxin-
binding site of the post-synaptic GABAA receptor (Rozsa et al., 2008). PTZ 
model have been widely used in vivo and to a less extend in vitro to study 
epilepsy. Intraperitoneal injections of PTZ in animals leads to tonic-clonic 
seizures (Brito et al., 2006). Addition of PTZ to normal ACSF generates 
prolonged interictal –like activity in vitro. 
7. In	  vivo	  epilepsy	  models	  
Animal models have a fundamental role in identifying new and testing existing 
AEDs. One of the problems in improvement of drug discovery for epilepsy is 
possibly the use of the same seizure models for decades such as maximal 
electroshock seizures (MES) or PTZ administration. These models are effective 
only in identifying drugs with similar characteristics to existing AEDs and have 
failed to identify compounds that work through different mechanisms. The 
majority of animal models used in epilepsy research represent seizure models 
rather than epilepsy models. Hence models such as MES, whereby acute 
seizure are induced in non-epileptic animals, are not representative of an 
epilepsy model which should have spontaneous recurrent seizures. True 
models of epilepsy that are more closely related to human epilepsy are those 
animal mutants or transgenic animals with spontaneously recurrent seizures, 
and chemically or electrically induced epileptogenesis resulting in spontaneous 
recurrent seizures (Löscher, 2011). 
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Table 1.4. In vivo epilepsy and seizure models  
MES – maximal electroshock model, GAERS - genetic absence epilepsy in rats from 
Strasbourg, DBA - dilute brown agouti coat color, GEPRs - Genetically epilepsy-prone rats. 
Information in the table adopted from several sources (Seyfried and Glaser, 1985; Pitkänen 
et al., 2005) Löscher, 2011; De Sarro et al., 2015). 
 
Model Type of epilepsy or seizure modeled 
Acquired electrically induced models 
MES 
 
6 Hz psychomotor 
Acute (induced) generalize tonic-clonic seizures 
 
Acute (induced) partial seizures 
 
Electrical kindling 
 
Chronic (induced) limbic seizures or chronic TLE 
 
PPS 
 
Amygdala 
stimulation 
 
TLE, SE 
 
TLE, SE 
Acquired chemiconvulsant induced models 
Chemical kindling 
 
Chronic (induced) limbic seizures or chronic TLE 
Kainic acid 
 
Pilocarpine 
TLE, SE 
 
TLE, SE 
 
PTZ 
 
generalized tonic-clonic seizures and absence seizures   
 
Tetanus toxin 
 
Partial epilepsies 
Genetic models 
GAERS Absence epilepsy  
DBA/2 mice 
 
reflex generalized tonic–clonic seizures 
GEPRs reflex generalized tonic–clonic seizures 
 
tottering 
 
Absence epilepsy, partial epilepsy 
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Epilepsy models are divided into generalised and partial epilepsy models as 
well as into genetic models and induction of epilepsy in normal animals. The 
table compares some epilepsy in vivo models (see Table 1.4). 
Generalised epilepsy syndromes primarily studied in transgenic animals 
whereas partial epilepsies are induced in normal animals by chemical 
compounds or by electrical stimulation of certain brain areas (Löscher, 2011). 
An ideal model to study epilepsy and disease modification should have high 
incidence of seizure development after an insult, and similarities with human 
epilepsy such as cell death as well as cognitive comorbidities. Also, epilepsy 
must develop after similar insult as in humans, for example SE, stroke, tumour, 
and trauma (Barker Halski 2015). For the purpose of this study I was interested 
in chronic TLE and status epilepticus model. Some of the most commonly used 
models of epilepsy, in particular TLE models will be briefly reviewed below. 
7.1 Chemoconvulsant	  models	  
Kainic acid model is one of the widely used and studied models of epilepsy. 
Kainic acid is an analog of L-glutamate and a potent agonist of kainate 
glutamate receptors (Lévesque and Avoli, 2013). It has a strong convulsive 
effect. Kainic acid model has been used in particular to model TLE and has 
many electrographic and neuropathological similarities with human TLE. Kainic 
acid can be administered intracerebrally or intraperitoneally to induce SE, either 
a single dose or in multiple small doses. This causes damage to CA1, CA3, 
dentate hilus and the damage is typically bilateral. It is a robust model, 
however, animals of different strain, sex, weight and age exhibit variable 
sensitivity to kainic acid (Reddy and Kuruba, 2013). The latent period from 
administration of Kainic acid in the hippocampus and subsequent SE to the 
development of spontaneous seizures can vary between 5 days to one month 
(Lévesque and Avoli, 2013). 
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Pilocapine model is another well established TLE model. Pilocarpine 
hydrochloride is an agonist of muscarinic acetylcholine receptors expressed 
widely in the hippocampus (Rubio et al., 2010). Activation of M1 muscarinic 
receptors initiates seizures (Kow et al., 2014). Seizures originate in the 
hippocampus initially, and then propagate to the amygdala with later spread to 
neocortex. Although SE in this model is initiated by hyperactivation of 
cholinergic receptors, but glutamine receptor activation proposed to play role to 
maintain the activity. Therefore, neuronal cell death and spontaneous seizures 
also linked to glutamate release (Reddy and Kuruba, 2013). Pilocarpine also 
can be administered both inracerebrally and systemically (Kow et al., 2014). 
Pilocaprine leads to similar neuronal damage as kainic acid however wider 
spread to neocortex is seen (Reddy and Kuruba, 2013). Animals develop 
spontaneous seizures a few weeks following induction of SE. (Kow et al., 
2014). 
The major limitation of these models is the direct neurotoxic effect, hence 
chemoconvulsant induced damage is difficult to distinguish from seizure 
induced damage (Reddy and Kuruba, 2013). Pilocarpine leads to severe 
seizures, with extensive brain damage and mortality is high compared to kainic 
acid model. Furthermore, systemic acetylcholine activation following pilocarpine 
administration leads to side effects such as hypersalivation, lacrimation which 
causes distress to animals. 
7.2 Electrically	  induced	  seizurure	  models	  
Electroshock model produces tonic-clonic seizures and severity of seizures 
depend on the intensity of the stimulation. 2 ms duration high electric currents 
(25 -150 mA) and frequency of 50 Hz has been used to induce seizures. Such 
electroshock stimulation activates extensive brain area and leads to 
generalized neuronal firing. Repetitive low intensity daily stimulation however 
induces limbic kindling which leads to predominantly granule hippocampal 
cells, as well as neocortex and piriform cortex discharges (Rubio et al., 2010).  
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Electrical kindling model has been extensively used to study TLE. Spontaneous 
seizures develop with prolonged kindling. It involves induction of focal seizures 
by electrical stimulation with progressive change in response to subsequent 
daily stimulation. Stimulation is delivered through implanted electrode with high 
frequency stimulation (~60 Hz) with intensity of ~400 µA. Eventually, over a 
long period of time animals develop spontaneous seizures. The main 
disadvantage of this model is it is very labour intensive. In addition, it does not 
share similarities with human TLE as compared to the models described above. 
Although some studies report damage to the hippocampus with high number of 
repetitions these results were inconsistent (Pitkänen et al., 2005). Moreover, 
epilepsy in kindling model is no induced by initial damage as in human TLE.  
For the purpose of this study the perforant path stimulation model was chosen 
as it does not rely upon an exogenous convulsant that may lead to drug 
specific actions.  
 
7.2.1 Perforant	  path	  stimulation	  
The perforant path stimulation (PPS) model is a well-established and reliable 
model of acquired chronic epilepsy (in particular MTLE) and status epilepticus. 
This model is very close to human epilepsy and very robust (Vicedomini and 
Nadler, 1987). PPS has been used with some variations. 24 hour or 2 hour 
repetitive stimulation in either anaesthetised or unanaesthetised rats was used 
initially (Sloviter, 1983; Olney et al., 1983; Walker et al., 1999; Norwood et al., 
2011). A more widely used protocol involves continued stimulation of 
hippocampal afferent pathways for two hour in the unanaesthetised rat. 
Repetitive stimulation is delivered through electrodes implanted in the angular 
bundle or fimbria of the brain. Following stimulation animals develop SE 
(Vicedomini and Nadler, 1987). PPS induces granule cell population firing and 
ictal-like activity. Population spikes represent activation of axons that terminate 
on hilar neurons and the pyramidal CA3 cells (Walker et al., 1999). Post 
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stimulation recurrent inhibitory activity in the granule cell layer was inhibited 
(Sloviter, 1983).  
The PPS model enables an analysis of the biochemical and physiological 
properties of seizures, status epilepticus, and neuronal cell death. PPS causes 
excitatory hippocampal damage similar to kainic acid induced epilepsy. One 
major advantage, however, is that the PPS model avoids direct neurotoxic 
effects of chemoconvulsants. The model also enables easy monitoring of EEG 
and behaviour. Furthermore, PPS reproduces the behavioural, electrographic 
and neuropathologic changes typical for human SE (Vicedomini & Nadler 
1987). Structural changes in the PPS model resemble hippocampal damage in 
humans caused by SE. Most prominent neuronal damage is seen in the 
dentate hilus, CA1 and CA3 hippocampal regions with relative preservation of 
CA2 and the dentate granule cells (Walker et al. 1999). Damage to other 
parahippocampal structures was also seen (Sloviter, 1983). PPS is an ideal 
model to study epilepsy and disease modification.  One of the main drawbacks 
of PPS is however the necessity of electrode implantation which makes the 
model complicated and time-consuming compared to chemiconvulsant models 
(Reddy and Kuruba, 2013). 
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8. Aim	  
The current research aimed to investigate the role of TRPM7 channels in 
epilepsy. In particular, I aimed to test the effects of inhibiting the channel on 
seizure activity, and also neuronal death, epileptigenesis and cognitive deficits 
following status epilepticus. There is no study so far that investigated the role 
TRPM7 in epilepsy. 
9. Hypotheses	  
1. TRPM7 channels contribute to seizure generation and blocking the channel 
stops seizure activity  
2. TRPM7 channels contribute to seizure related neuronal death in epilepsy 
and blocking TRPM7 channels would have a neuroprotective effect following 
status epilepticus and will prevent cognitive decline and the development of 
epilepsy (epileptognesis). 
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Chapter 2. General methods  
 
1. Animals	  
Animals were housed in the Institute of Neurology, UCL animal facility under 
controlled conditions; at a temperature of 22 0C, maintained on a 12/12 hour 
dark/light cycle with free access to food and water. All animal care and 
procedures were carried out with local ethical approval and adhered to the UK 
Home Office Animal (Scientific Procedures) Act, 1986. 
 
2. In	  vitro	  electrophysiology	  experiments	  	  
Male Sprague-Dawley rats aged 3-3.5 weeks were used to prepare acute brain 
slices for the in vitro electrophysiological recordings.  
2.1 Preparing	  brain	  slices	  
All compounds for preparing solutions were purchased from Sigma Aldrich, UK. 
To obtain acute brain slices, the rats were culled with isoflurane overdose and 
then decapitated. Following decapitation, the brain was rapidly removed and 
placed in  
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Figure 2.1. Preparation of horizontal brain slices. 
A - the areas of brain that were removed a) distal third of the frontal brain , b) cerebellum c) and 
a part of apical fronto-parietal cortex. B – Both hemispheres were glued on the specimen holder 
facing down with fronto-parietal cortex part. Arrows show the part that was glued to the surface 
 
 
 
 
 
a b c 
A B 
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ice-cold (2-4°C) slicing solution (75 mM sucrose, 2.5 mM KCl, 87 mM NaCl, 
1.25 mM NaH2PO4, 7 mM MgCl2*H2O, 5.5 mM D-glucose, 2.6 mM NaHCO3, 
0.5 mM CaCl2, osmolality 315 mOsm/kg) to minimise metabolic activity. All 
procedures for slice preparation were then performed in ice-cold slicing 
solution. 
The cerebellum and distal third of the frontal brain were removed and the 
hemispheres were separated with a scalpel (see Figure 2.1). Then both 
hemispheres were glued onto the centre of the specimen holder with cyano-
acrylic glue. Horizontal brain slices comprising the hippocampal formation, 
dentate gyrus and entorhinal cortex were prepared on the vibratome (Leica 
VT1200S, Leica mycrosystems, Nussloch, Germany). A slice thickness of 
350µm, speed of slicing 0.09 mm/s and amplitude 0.75mV were selected. 
Then, about 3-4 slices from the same area of each hemisphere were selected 
and transferred into storage solution (119 mM NaCl, 2.5 mM KCl, 1.3 mM 
MgSO4*7H2O, 0.9 mM NaH2PO4, 14 mM D-glucose, 1 mM CaCl2, 1.7 mM 
MgCl2 2.6 mM NaHCO3, osmolality 296 mOsm/kg). Slices were incubated in a 
bath at the temperature of 33°C for 30 min to allow recovery from the damage 
that resulted from the dissection procedure and to adjust to the new artificial 
environment. Following the recovery time, slices were kept at room temperature 
for about 45 min before starting experiments. All solutions were bubbled with 
95% O2/5%CO2 gas to maintain pH 7.4-7.35 and to oxygenate the tissue.  
2.2 Micropipette	  preparation	  
Recording electrodes were prepared from Borosilicate standard wall capillaries 
with filament and flame polished ends by pulling on a horizontal puller (DMZ 
universal puller, Zeitz Instruments, Germany). The puller settings were adjusted 
to achieve a pipette resistance of 1-2MΩ in artificial cerebrospinal fluid (ACSF).  
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2.3 Low	  Mg2+	  and	  PTZ	  seizure	  models	  
The effect of TRPM7 antagonists on in vitro epileptiform activity was tested in 
two seizure models. I first used low Mg2+ model to test the effect of TRPM7 
channel blocker on seizure-like activity. As low magnesium condition is ideal for 
opening TRPM7 channels this was chosen as the first step to test the 
involvement of TRPM7 channels in seizure generation via blocking the channel. 
I then used PTZ seizure model to see if the results obtained could be 
extrapolated to another model that was not dependent on magnesium 
concentrations, i.e. whether TRPM7 channels are activated during seizure 
activity regardless of magnesium concentrations. Acute combined 
hippocampal-enthorhinal cortex slices were used. 
Acute brain slices from a total of 28 rats were used for low magnesium 
experiments. To induce epileptiform activity ACSF solution was prepared (126 
mM NaCl, 5 mM KCl, 0.9 mM NaH2PO4, 14 mM D-glucose, 2.5 mM CaCl2, 2.6 
mM NaHCO3, osmolality 296 mOsm/kg) without adding Mg2+ and potassium 
concentration was increased to 5 mM. An individual slice was transferred to this 
solution and kept for ~30 min to initiate epileptiform activity. 
In total 38 rats were used to prepare acute brain slices for the PTZ induced 
seizure experiments. To a normal ACSF solution 2 mM of PTZ was added and 
potassium was increased to 5-6 mM to induce epileptiform activity. An 
individual slice was kept in the solution for about 30 min to initiate epileptiform 
activity. 
2.3.1 Electrophysiology	  
For the electrophysiology experiments, acute brain slices must be provided with 
adequate oxygen, appropriate pH, osmolality and temperature. Moreover, good 
visual control and mechanical access to slices is also important. For this 
reason a submersion superfusion chamber was used, in which a slice rests on 
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a submerged net to permit slice perfusion from below and above. The 
submersion recording chamber was continuously perfused with 
ACSF/95%O2/5%CO2 at the rate of ~4 ml/min and temperature was controlled 
to be maintained at ~33°C.  
An individual combined hippocampal - entorhinal cortex slice was placed in the 
recording chamber. Low Mg2+ or PTZ induced epileptiform discharges were 
recorded from CA1 region of the hippocampus (see Figure 2.2). The recording 
electrode was filled with the perfusion solution (low Mg2+ or PTZ added ACSF).  
Recordings were initiated if regular stable epileptiform discharges were present 
for about 10 min. Recordings were obtained using a Multi-Clamp 700B or 
Axopatch 200B amplifier (Molecular Devices), and were low-pass filtered at 4 
kHz. WinEDR (Strathclyde Electrophysiology Software) was used for data 
acquisition. Sampling rate was 0.1 ms (i.e. 10 kHz). 
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Figure 2.2. Seizure-like activity recording.  
A) Schematic illustrations of a combined hippocampal-entorhinal cortex slice and electrode 
positioning for seizure-like activity recording: R - recording electrode filled with appropriate aCSF 
solution (Low Mg2+ or PTZ containing) and positioned in CA1 area. EC – entorhinal cortex B) An 
example of PTZ induced seizure-like burst recorded from CA1  
 
0.5 s  
0.1 
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2.4 Evoked	  field	  EPSP	  experiments	  
Evoked extracellular field excitatory postsynaptic potentials (fEPSPs) were 
recorded from CA1 region of the hippocampus. Ex vivo combined hippocampal-
enthorinal cortex slices were used. The recording electrode, a borosilicate 
glass microelectrode of 1–2mΩ resistance filled with ACSF was placed in 
stratum radiatum of CA1 region (Figure 2.3). 
A bipolar stimulating electrode was placed in the Schaffer 
collaterals/commissural fibre region (see Figure 2.3). Stimulation intensity of 
0.3-0.27 mA was used and single pulses [100µs width] with a 20 s intervals 
were delivered. After 20 min of recording, drug or vehicle was added to the 
perfusion solution and recorded for another 20 min. Recordings were filtered at 
4 kHz, obtained using a MultiClamp 700B amplifier (Molecular Devices) and 
digitized at 10 kHz. The LabView (National Instruments) software was used for 
data acquisition and off-line analysis. 
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Figure 2.3. Evoked extracellular field potential recording.  
B)  Electrode positioning: R - Recording electrode filled with normal aCSF solution and 
positioned in CA1 area S- bipolar stimulating electrode on Schaffer collaterals region. EC – 
entorhinal cortex A) An example trace of fEPSP in CA1 after stimulation of Schaffer collateral 
(single pulse stimulus of 100µs duration) during baseline recording.  
 B 
1
A 
2
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2.5 Data	  analyses	  and	  statistics	  	  
For in vitro seizure recordings with unstable baseline - amplitude gradually 
decreasing or increasing by 10% - were excluded from analyses both in control 
and drug-treated groups.  To check for Gaussian distribution Shapiro-Wilk and 
Anderson Darling tests were carried out. 
2.5.1 In	  vitro	  seizure	  experiments	  	  
All in vitro recordings obtained from WinEDR 3.1.9. (Strathclyde 
Electrophysiology Software) and were analysed using pCLAMP 10.3 software 
(see Figure 2.4). Each event was selected manually after applying a threshold 
detection tool. The data were transferred into an excel datasheet to perform 
further analysis. OriginPro 9.0 (OriginLab) software was used for creating 
figures. Recordings with both ictal-like and interictal-like activity were included 
in the analyses in the low Mg2+ in vitro model to test the effect of the TRPM7 
blocker. Ictal-like activities occurred every 3-4 minute lasting 0.5-1.5 minutes. 
Therefore, overall activity was assessed in 5 minute intervals. All data with both 
Low Mg2+ and PTZ induced seizure models are illustrated in mean 5 minute 
intervals; mean frequency and amplitude for each 5 minute activity were 
calculated and then the values were normalised to baseline mean values. 
Epileptiform bursts were defined as field potential activity with an amplitude 
more than three times that of baseline, containing more than 2 subsequent 
spikes that do not return to baseline, and with overall duration ≥ 40 ms. Single 
spikes and polyspikes not meeting this criteria were not included in analyses.  
Normalised frequency and normalised amplitude were compared in drug-
treated and control samples. Descriptive data expressed in mean±SEM. 
Statistical  
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Figure 2.4. PClamp Seizure like activity analysis window.  
Each blue rhomb-like shape represents counted seizure-like activity. 
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analyses were carried out using STATA V.11. Mean discharge frequency and 
mean discharge amplitude in drug-treated experiments was compared versus 
control recordings using Student t-test, P-values of ≤ 0.05 were considered as 
significant. 
2.5.2 Evoked	  fEPSP	  experiments	  	  
Data was analysed using Lab view (National Instruments) software. Average 
traces of last 10 min of baseline time and last 10 min after addition of carvacrol 
were used. fEPSP and fibre volley slopes were normalised to baseline; mean 
slope of last 10 min during baseline and drug-treated time were compared 
using paired t-test. 
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3. In	  vivo	  experiments	  
3.1 Perforant	  path	  stimulation/chronic	  epilepsy	  
model	  
Male Sprague-Dawley rats (280-310g) were used for all in vivo experiments. 
Animals were allowed to acclimatise to the animal house for at least 1 week 
after arrival.  
3.1.1 Electrode	  implantation	  	  
All electrodes were purchased from Plastics One Inc, Bilaney Consultants UK 
Ltd. To prepare a bipolar stimulating electrode two steel teflon-coated 
electrodes (diameter 0.15 mm) were twisted manually (to prevent coating being 
removed from the remainder of the wire) and conductive tips were exposed and 
left ~0.8mm apart. The tip of the recording electrode, a steel teflon- coated 
electrode (diameter 0.28mm) was also exposed for about 1 mm. The reference 
electrode was prepared by soldering about 4 cm silver wire (diameter 0.125 
mm) to a steel gold plated socket contact. 
The procedure was undertaken in a stereotaxic frame (David Kopf Instruments, 
USA) with the animal under isoflurane anaesthesia (2-3 % in 2 L/min O2). A 
small area on the head of the animal was shaved and cleaned with iodine 
(Videne, MidMeds Ltd., UK). Then Buprenorphine 0.2 mg/kg was administered 
subcutaneously (40 min onset, 12 hour analgesia). Once sufficient anaesthesia 
was confirmed with absence of response to ear and toe pinch, about 1cm2 area 
of skin on the top of the head was cut and subcutaneous tissue was cleared for 
better surface for glue/dental cement and to reduce infection.  
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Table 2.1. Electrode coordinates: distance from bregma 
 
Electrodes  A-P (cm) M-L (cm) 
 Stimulating electrode -0.81 -0.44 
 Recording electrode -0.4 -0.25 
 
              A-P –Anterio-posterior, M-L -medio-lateral 
 
 
 
 
 
 
A drill attached to the stereotaxic frame was used to drill holes through the 
skull; one for a stimulating, one for a recording electrode and additional three 
holes for screws to secure the head piece (see Figure 2.5). The positions for 
electrodes were calculated as follows (see Table 2.1): 1) for the stimulation 
electrode -8.1mm antero-posterior and -4.4mm medio-lateral from the bregma, 
2) for the recording electrode -4mm anteriolateral and -2.5mm medio-lateral 
from the bregma. The reference electrode was wound around the screws to 
secure it and the free end was placed subcutaneously (see Figure 2.5). The 
stimulation electrode was inserted into the angular bundle and recording were 
made from the dentate granule cells.  
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Figure 2.5. Electrode implantation sites in the rat skull in PPS. 
 After taking coordinates for bregma stimulation and recording electrode positions were 
calculated. 1 - 3 screws were inserted to stabilise head peace. Reference electrode is a silver 
wire bounded to screw in one end and the other end placed subcutaneously near the skull area 
 
 
 
 
Bregma 
Lambda 
Stimulating electrode  
Recording electrode  
Reference 
electrode  
Coronal suture 
Lamboid suture 
1 
1 1 
TRPM7 channels and epilepsy 
Chapter 2.  General methods 
 
 
 74	  
The optimal position for electrodes was identified by lowering slowly the 
recording and the stimulating electrodes into the brain until maximal population 
field excitatory postsynaptic potential (fEPSP) was achieved. A single pulse 
stimulus of 3.5 mA and 150μs width was delivered from a Neurolog system 
(Digitimer Ltd, Welwyn Garden City, UK) and a stimulus isolator (Digitimer, 
UK). Recordings were bandpass-filtered at 0.1-50 Hz. The presence of positive 
going field potentials with >2 mV population spike indicated that the electrodes 
were correctly positioned. At this point, isoflurane level was reduced to 1-1.5 %. 
Then the other end of electrodes was inserted into six-channel pedestal 
(Plastics One, UK) and this was fixed with dental cement. The anaesthesia was 
disconnected and 5 ml 0.9% w/v saline was administered subcutaneously and 
rats were monitored until recovery.  
Single pulse stimulus generated population spike after insertion of electrodes 
into the perforant path. This was done during electrode implantation to ensure 
the electrode in the right position. Population spikes recorded from the 
implanted electrodes represent activation of a system of axons that terminate 
on hilar neurons and the pyramidal cells of CA3 (Walker et al., 1999). 
 
3.1.2 Induction	  of	  Status	  Epilepticus	  
The perforant path was stimulated through implanted bipolar electrodes 7-10 
days postoperatively. Animals were randomly divided into 3 groups: naive 
controls (had surgery but not stimulated), epileptic stimulated (stimulated, not 
given the drug) and epileptic treated group (stimulated and given the drug). 
The 6-channel pedestral on the head of the animal was connected to a 
counterbalanced six-channel commutator via a cable. Stimulation was delivered 
from a Neurolog system with intensity selected at 50-75 % of the maximum 
population spike amplitude. 50 μs alternating monopolar pulses at 20 Hz were 
continuously delivered for 2 hours after initial 10 min baseline recording. 
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Impulses were bandpass-filtered (0.1-50 Hz), digitized at 100 Hz (CED micro 
1401; CED, Cambridge, UK) and recorded using Spike 2 software (CED, 
Cambridge, UK). 
During stimulation and subsequent self-sustaining status epilepticus (SSSE) 
period behaviour, seizure type and severity were monitored and recorded for 
every 15 min. Behavioural seizures were graded according to the Racine scale 
(Racine, 1972). After 2 hours the stimulation was stopped. The recording was 
continued and monitored for 10-20 min to ensure animal had developed SSSE. 
Then diazepam (10 mg/kg IP) was given and recording continued for 20-30 min 
to ensure SE was stopped.  
3.1.3 Racine	  scale	  
During induction of the SE seizure severity was assessed for each animal 
every 15 min based on the Racine scale (see Table 2.2) (Racine, 1972). 
 
              Table 2.2  Seizure severity scale (Racine) 
Stages Seizure characteristics 
Stage 1   mouth and facial movements 
Stage 2   Head nodding 
Stage 3   forelimb clonus 
Stage 4   seizures characterized by rearing 
Stage 5   full motor seizure with loss of postural controlling 
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3.2 Histology	  
3.2.1 Perfusion/fixation	  
Three to four weeks following induction of status epilepticus/epilepsy animals 
were culled using transcardial perfusion method. For this purpose, transcardial 
infusion of 0.01M phosphate-buffer saline (PBS) - regular PBS solution, to 
remove blood from the body was followed by the infusion of 4% 
paraformaldehyde (PFA) solution in 0.01M PBS [pH was adjusted to 7.2-7.4] to 
fixate the brain. Not stimlated control animals were also culled after the same 
time following surgery, 3-4 weeks.  
After sedating animal with isofurane, a sublethal dose of pentobarbital 
(140mg/kg) was administrated intraperitoneally (i.p.). Once unresponsive to toe 
pinch, the animal was fixed on a surgical table for the perfusion. The chest of 
the animal was opened to expose the thoracic cavity and a needle filled with 
heparinised PBS was inserted approximately 5mm into the left ventricle. 
Heparin was used to prevent the blood from coagulating and to enable 
complete removal of the blood from the brain as it can auto-fluoresce or 
contribute to non-specific antibody staining. The needle was attached to the 
tubing and the solution was pumped transcardially through the inserted needle. 
A cut was made at the top of the right atrium to allow free blood flow. When the 
liver and lungs lightened in colour and the solution run clear the perfusion 
solution was switched to 4% PFA/PBS to fixate the brain. Around 150 ml of 4% 
PFA/PBS was perfused. During perfusion with PFA muscles twitching was 
observed in the animal due to skeletal muscle fixation indicating efficient 
fixation. The brain was removed and placed in a tube containing 4%PFA/PBS 
solution and kept overnight at 4oC.The following day the fixed brain tissue was 
removed from 4 % PFA solution and washed several times with regular PBS 
solution. 
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3.2.2 Dissection	  and	  selecting	  slices	  for	  immunostaining	  	  
Slicing was performed in PBS solution. For immunohistochemistry 45 µm slice 
thickness were selected for optimal penetration of the antibody. Coronal brain 
sections were made using Leica vibratome (Leica mycrosystems, Nussloch, 
Germany). First, frontal part of the brain as well as cerebellum was cut and the 
hemispheres were separated with a scalpel. Then a hemisphere was glued 
onto the surface of the specimen holder with cyano-acrylic glue. 
To ensure that the same area of the hippocampus is analysed in all animals, 
slicing was performed in a systematic randomised fashion as follows:  for each 
animal brain when slicing was initiated and once the dentate gyrus was seen in 
the coronal section the first 5 slices were discarded. Then, all slices from the 
dorsal hippocampus (this part of the hippocampus appears first in coronal view) 
were collected until the junction between ventral and dorsal hippocampus 
appears. The slices were placed in wells in the same order as they appeared in 
the hippocampus and they were numbered   as 1, 2, 3 etc. Thereafter, 6 non-
adjacent slices were taken from each right medial dorsal hippocampus in the 
following order: every third slice starting from 12th slice in the order (this is 
where the whole hippocampus was visible). Then slices were placed in wells of 
a plate containing PBS. The right hemisphere was used in all animals for 
immunohistochemistry because this was the part of the brain that was 
stimulated for seizure induction and therefore was assumed to be the primary 
side of cell damage. Anti-NeuN (1:400) was used as a primary antibody due to 
specificity to neurons; it does not stain glia or other cells. However, anti-NeuN 
does not differentiate between different types of neurons. To stain TRPM7 
channels anit-TRPM7 (1:300) was used after initial testing for optimal 
concentrations.  
Initially to test the antibody the staining was done only with anti-NeuN. Then for 
the main staining DAPI (4',6-diamidino-2-phenylindole) was also added. DAPI 
is a fluorescent stain that specifically stains regions of DNA; this was used to 
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confirm the presence of nucleus and whether it was damaged or not.  DAPI is 
not specific to neurons, stains any nucleus, however can clearly define edges 
of a nucleus. 
3.3 Immunostaining	  	  
3.3.1 Immunostaining	  protocol	  optimisation	  
Firstly, to test the primary antibody and to optimise subsequent staining 
protocol the following combination of compounds were tested (see Table 2.3): 
1) with and without adding Triton X-100, a detergent that used to permeabilise 
cell membrane 2) with and without primary antibody added 3) different 
combination of blocking agents such as 5% Normal Goat Serum (NGS) alone, 
3% Bovine Serum Albumin (BSA) alone and combination of both - NGS (3%) / 
BSA(1%). Although the concentration of Anti-NeuN 1:400 was well established 
in the lab, other parameters still needed to be tested as well as optimal 
concentrations for anti-TRPM7 antibody had to be established before main 
staining. The most optimal protocol then was used for subsequent 
immunostaining.  
3.3.2 Main	  staining	  protocol	  
The hippocampal slices were washed 3-4 times for 15 min with PBS on a 
rocker to remove all free PFA as this can affect immunostaining (see Table 
2.4). Then slices were blocked for an hour with 5-10% normal goat serum/PBS 
on a rocker at room temperature after which they were incubated overnight at 
4oC on a rocker in mouse anti NeuN antibody (1:400) and goat anti TRPM7 
(1:300). 
The next day slices were washed with PBS at room temperature and then 
incubated with the secondary antibody. For secondary antibody a Goat Anti-
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mouse (Alexa Fluor) secondary was used (e.g. goat-anti-mouse Alexa 546). 
Normal Goat Serum was used as a blocking agent.  
 
Table 2.3. Immunostaining protocol developmentTable 2.3 
	  	  Wells	   Triton	  X-
100 
(0.2%)	  
Blocking	  
agent	  
	  	  	  	  Primary	  antibody	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Secondary	  antibody	  
 
 
   
Anti-NeuN 
 (1:400)       
 
   Anti- 
TRPM7  
 
Alexa 546 
 (1:500)
 
Alexa 488 
(1:500) 
       
1 + BSA + 1:600 + + 
2 + BSA/NG
S 
+ 1:300 + + 
3 + NGS + 1:600 + + 
4 + NGS -       - + + 
5 - BSA + 1:300 + + 
6     - BSA/NG
S 
    +     1:600    +    + 
7 - NGS  + 1:300 +  + 
8 - BSA -       - +  + 
9 + BSA + 1:300    +     +  
10 + BSA/NG
S 
+ 1:600 + + 
11 + NGS + 1:50  +  + 
12 + BSA/NG
S 
-       -  +  + 
13 - BSA + 1:50 + + 
14 - BSA/NG
S 
 + 1:50  + + 
15 - NGS  + 1:50 + + 
16 - BSA/NG
S 
-       -  + + 
	   	   	   	   	   	   	  
BSA -bovine serum albumin, NGS –normal goat serum, Alexa - goat anti 
mouse, +   substance added, - not added  
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Table 2.4. Immunostaining main protocol  
Steps                        Procedure 
	  
Step	  1	  
	  
Wash	  slices	  (10-­‐15	  min	  3x)	  with	  regular	  PBS	  
Step	  2	   Block	  for	  60	  minutes	  with	  5-­‐10%	  normal	  goat	  serum/PBS	  on	  a	  rocker	  at	  
room	  temperature	  
Step	  3	   Wash	  slices	  with	  PBS	  (10-­‐15	  min	  3x)	  
Step	  4	   Incubate	  overnight	  at	  4oC	  on	  a	  rocker	  in	  the	  primary	  antibody-­‐	  mouse	  
anti-­‐NeuN	  (1:400),	  anti-­‐TRPM7	  (1:300)/	  0.5%	  normal	  goat	  serum	  /PBS	  
Step	  5	   Wash	  with	  PBS	  at	  room	  temperature	  (10-­‐15	  min	  3x)	  
Step	  6	   Incubate	  with	  the	  secondary	  antibody	  (i.e.	  goat-­‐anti-­‐mouse	  Alexa	  546	  
1:500,	  Alexa	  488	  1:500)	  2	  h	  at	  room	  temperature	  on	  a	  rocker	  
Step	  7	   Wash	  slices	  (10-­‐15	  min	  3x)	  with	  PBS	  
Step	  8	   Wash	  slices	  (10-­‐15	  min	  3x)	  with	  deionised	  water	  
Step	  9	   Add	  DAPI	  (1:1000)	  
Step	  10	   Wash	  slices	  (10-­‐15	  min	  3x)	  with	  deionised	  water	  
Step	  11	   Mount	  the	  slices	  onto	  a	  coverslip	  
 
TRPM7 channels and epilepsy 
Chapter 2.  General methods 
 
 
 81	  
Slices were also stained with DAPI. Then slices were mounted onto a coverslip 
with Vectashield mounting medium. About 30 min after mounting edges of 
cover slips were sealed with nail varnish to prevent drying.  
3.4 Confocal	  imaging	  and	  cell	  counting	  	  
Zeiss LSM 710 Confocal Microscope was used for imaging. The following 
confocal settings were used: x20 optical magnification, range indicator, Pinhole 
of 8 μm, laser intensity was adjusted for each image to maximise visibility of 
cells. The tile scan configuration was used that enables a large area of interest 
whilst taking continuous multiple images. Imaging and subsequent cell counting 
was done in a blinded fashion for all three groups: epileptic, epileptic-treated 
and controls. 
First, the whole hippocampus was scanned using tiles (mazoik method) with 
optical magnification of x10 (see Figure 2.6) to capture the whole 
hippocampus. Then regions of interest were selected in three zones of 
hippocampus (CA1, CA3, hilus). Following this, magnification of x20 was used 
to scan images in three selected regions of the hippocampus. Single plane 
images were obtained; this avoided the possible confounder of counting 
neurons multiple times.  
The number of cells in the following three areas of the hippocampus was 
calculated - CA3, CA1 and hilus- in all three groups of animals. In the software 
Image J the plugin Cell Counter was used to count the number of neurons. 
Only bright, clearly visible anti-NeuN stained cells that were also confirmed with 
DAPI staining were counted. Brightness and contrast were adjusted to reveal 
the maximum number of cells. 75% zoom in imageJ was selected for all images 
during counting.  
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Figure 2.6. A Confocal image (x10 magnification) of the hippocampus showing cell 
counting areas three hippocampal regions.  
Cells were counted in the marked areas of the CA1 and hilus and in CA3b area of CA3. 3 
areas of 300 µm in CA1, 3 areas of 300 µm in CA3 were selected for cell counting, that 
represented the whole CA1/CA3 regions. In the hilus cells between DG and CA3c were 
counted. 
 
 
 
 
 
Hilus 
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Hilus cell counting: CA3 area has three parts: CA3a, CA3b and CA3c (see 
Figure 2.6). CA3c (sometimes referred as CA4) is between two dentage gyrus 
blades. The hilar cells are between dentate gyrus and CA3c area. In order to 
differentiate hilus from CA3c area, cells within a distance of 20 µm or less from 
CA3c were not included. The rest of the region between DG and CA3c were 
selected and the area was measured.  Cells in this area were counted followed 
by cell density calculation. The region highlighted ‘hilus’ in the figure 2.6. was 
selected and its area was measured. Thereafter number of cells was counted in 
this selected region, followed by calculation of density (Cell 
count/area=density). Shrinkage of the tissue due to fixation can occur, which 
will affect the density calculation, however, the same procedure was applied to 
tissues from all three groups of animals and the shrinkage level would be 
expected to be the same. Moreover, no significant difference in area was seen 
between epileptic and control groups.  
CA1 cell counting: Cells in this region were counted as number of cells per 
length of CA1. For this purpose three areas of 300 µm length each were 
selected. First, a 300 µm-long area was selected in the centre of the CA1, and 
then other two areas of the same length on either side with about 50-100 µm 
distance between them depending on the size of CA1 area. Cells that were 
apart from main CA1 cell cluster were included if they were within 45 µm of cell 
area.  
CA3 cell counting: Cells were counted in the middle part of CA3 area i.e. 
CA3b. As in CA1 area the number of cells per length of CA3 was counted in 
three areas of 300 µm length each, and about 20-50 µm apart from each other 
depending on the length of the CA3 area. Cells that were apart from the main 
CA3 area were only counted if they were within 45 µm of this area.  
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3.4.1 Data	  analysis	  and	  statistics	  	  
In hilar region cell density was measured for each slice i.e. number of cells per 
area in a slice. Mean hilar cell density per animal was calculated by averaging 
cell density from six slices for each animal. Number of cells per length of the 
CA3 and CA1 was measured in three areas then this was summed for each 
slice followed by calculation of the average (six slices from each animal) cell 
number in each animal. To check for Gaussian distribution Shapiro-Wilk and 
Anderson Darling tests were carried out. One way ANOVA test was used to 
compare cell number between the groups. This was carried out using OriginPro 
9.0 (OriginLab) software. 
 
 
 
 
 
 
 
 
 
TRPM7 channels and epilepsy 
Chapter 2.  General methods 
 
 
 85	  
3.5 PPS	  model	  with	  implanted	  wireless	  
subcutaneous	  EEG	  transmitters	  
The stimulation electrode used for these surgeries consisted of a two-channel 
threaded plastic pedestal with two stainless twisted leads attached to it 
[Plastics One Inc], each with a diameter of 0.125 mm; the tips of the electrode 
were exposed about 1-2 mm (see 0). 
3.5.1 Wireless	  Subcutaneous	  EEG	  Transmitter	  implantation	  
A Wireless Subcutaneous Transmitter (A3019D, Open Source Instruments) is a 
small, battery-powered sensor with an antenna, which is a loop of stainless 
steel wire, and two electrode leads (stainless steel springs), all enclosed in 
silicone ( see Figure 2.7).  
A transmitter was implanted subcutaneously in the dorsal part of the rat body. 
The reference and the recording electrodes were inserted down into the scalp 
through the drilled holes (see Figure 2.8). The recording electrode was 
positioned 2 mm further down intracranially to enable recordings from the 
cortex, with the coordinates as described above. The reference electrode with a 
screw attached to its end was implanted in the contralateral side of the brain. 7-
10 days following surgery the same protocol as described above was used for 
inducing status epilepticus and subsequent drug administration. Animals were 
then transferred to the telemetry unit with Subcutaneous Transmitter System 
(Open Source Instruments) for continuous 24 hour electroencephalogram 
(EEG) recording. 
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Figure 2.7. A - Subcutaneous transmitter. 
 A) Recording electrode b) Reference electrode c) antenna d) battery-powered sensor. B - 
Stimulating electrode a) plastic pedestal b) stainless twisted leads  
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Figure 2.8. Electrode implantation sites in the rat skull in PPS.  
After taking coordinates for bregma stimulation and recording electrode position was calculated. 
1 - 2 screws were inserted to stabilise head peace. Reference electrode with screw attached to t 
was inserted in the contralateral side to stimulation side. Recording electrode was inserted 
intracranially and then secured with a screw. 2, 3 – wires were tunnelled under the skin 
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3.5.2 Wireless	  Subcutaneous	  Transmitter	  System	  
The system (circuit) includes a subcutaneous transmitter with a loop antenna, 
external antenna, antenna combiner, data receiver and Long-wire-data 
acquisition (LWDAQ) driver (see Figure 2.9).  
The transmitter conveys signals to the external antenna that acts as a signal 
receiver, via radio transmission over a distance of between 50-300cm. External 
interference was isolated by use of Faraday cages; up to two animal cages in 
each. Each Faraday cage had an independent antenna, outside the animal 
cage. Antenna conducts signal to the Data Receiver via the antenna combiner 
(Chang et al., 2011). 
The Data Receiver connects to the LWDAQ driver with Ethernet interface, 
which provides an interface between the Internet and the Data Receiver. The 
LWDAQ driver transmits the signal to the computer that records and stores the 
signal. In the software a Recorder instrument enables to download data from 
the Data Receiver and a Neuroarchiver Tool used to record and analyse 
transmitter signals (Chang et al., 2011). Sampling rate was 512 Hz for all 
recordings. 
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Figure 2.9. Schematic illustration of the of the wireless transmitter circuit.   
Each Faraday cages contains two rat cages. Two faraday cages are connected via Antenna 
Combiner and then transmit signals to the Data Receiver. The latter connected to the computer 
via LWDAQ driver and internet. 
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3.5.3 Automatic	  Seizure	  detection	  tool	  
The Event Classifier program in Neuroarchiver was used to detect seizures. It 
detects events automatically based on comparison of pre-selected events in an 
Event library (Figure 2.10). The Classifier operates based on the baseline 
power and the interval metrics (Open source instruments).  
1.1  Event detection library  
In order to create an Event detection library different types of events were 
selected and added to the library from each animal’s EEG. 1 s epochs of 
events were included in the library; this time period was validated for better 
detection of seizures. EEG Recordings of a week or more from each animal 
that were selected at random times from stimulation date were visually 
processed to identify seizures and detected seizures were recoded. Various 
seizure types from each animal were included in the library; fragments from 
different parts of seizures as well as afterdischarges were included. Then other 
seizure-related activities such as high frequency, interictal events, short spikes 
etc. were also included. Thereafter, various EEG events due to noise, muscle 
artefacts from eating or moving were added to the library. Events were 
classified in the library as seizure, eating artefact, high frequency etc. and all 
non-specific artefacts were categorised as non-event. 
Then the Event library was tested and modified multiple times with addition or 
exclusion of some events until desirable balance of seizures and non-seizure 
events are present in the library i.e. it has high sensitivity and detects all 
various types of seizures. To confirm this all previously identified seizures had 
to be correctly detected. However, a perfect library was not possible to create. 
Moreover, because the library identifies only 1 s long events interictal activity 
was also detected as a seizure. Therefore, this automatic analysis was followed 
by visual detection of to further classify detected activity (i.e. this was a semi-
automated approach). 
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Figure 2.10. Event Classifier.  
A - Event Classifier opens in a new window. Different type of seizures from all animals (n=13) 
were included in the library, 1007 events in total. Left-hand side of the window shows event map 
and the right side event list. B – Batch classification window. The text files uploaded and channel 
and event of interest is selected (i.e. seizure) for batch analysis. 
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Seizure counting: Seizure counting was done on blinded fashion, for 
treatment and epileptic groups. Only events of 20 s duration or more were 
included, with spiking frequency more than 3 Hz and evolution of spiking 
activity. These are conservative criteria but were selected in order to identify 
definite seizures rather than runs of spikes or polyspike activity. 
Seizure duration measuring: Duration of seizure was counted from the start 
of seizure till the end when the frequency of spiking was less than 3 Hz. The 
start of the seizure was defined when there was an abrupt change in baseline 
power and continuous activity with a frequency of  3Hz occurred. 
Afterdischarges following a seizure were not included. 
3.5.4 Coastline	  analyses	  
A coastline length of the EEG is the sum of absolute difference in voltage 
between consecutive data points. Neuroarchiver tool determined EEG power 
for different frequency bands; 6-8 hour EEG periods were processed in 
Neuroarchiver. Then exported text files were uploaded into Labview (National 
Instruments) for coastline analysis. “Glitches were excluded if they exceeded 5 
× root mean square, and the signal was high pass–filtered at 10 Hz before 
calculating the coastline” (Wykes et al., 2012).  
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3.6 Behavioural	  study:	  alternating	  T	  maze	  
Perforant path stimulated rats were tested 3-4 month following SE induction.  
The alternating T maze is widely used to assess cognitive function in rodents, 
in particular memory and spatial learning. Rats and mice have natural tendency 
to alternate between branches: this reflects the animal’s desire to explore the 
surrounding environment and locate the presence of resources such as food. 
Alternation test (Both spontaneous and rewarded) is very reliable in detecting 
hippocampal dysfunction and is superior to other behavioural tests. Rewarded 
t-maze is more reliable and precise (Deacon and Rawlins, 2006). Although 
radial maze and water maze are also used to test spatial memory function, the 
alternating t-maze was chosen in the current study for the following reasons. 
Radial maze has certain disadvantages: animals may solve the maze without 
relying on spatial memory function, such as chaining or a serial strategy. 
Animals may enter each arm successively in a systematic order, either always 
turning to the right or left and entering adjacent arm and this may not measure 
working memory efficiently. Although experimenter observes animal for such 
chaining behaviour irregular chaining patterns can be difficult to distinguish 
from working memory (Vorhees and Williams, 2014). Although the water-maze 
is a very robust test, the task is dependent on recognising visual cues; since 
SD rats that I used in this study have poor vision this test would not be the best 
option.  
3.6.1 Apparatus	  	  
The t-maze apparatus [Med Associates, Inc. , USA; UK distributor: Sandown 
Scientific, UK; Standard T-Maze Package for Rat] consisted of Rat T-Maze 
Hub, 2 Rat Modular Maze Runways, Rat Modular Maze Runway, Start/Goal 
Box and 3 Manual Guillotine Doors. The walls made of transparent plastic 
material (see Figure 2.11). 
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Figure 2.11. T maze apparatus.  
1) Rat T-Maze Hub, 2)  Rat Modular Maze Runways (46 cm), 3) Rat Modular Maze Runway (31 
cm), 4) Start/Goal Box (25.4 cm) and 5) Manual Guillotine Door.  
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3.6.2 Procedure	  
The protocol described by Deacon and Rawlins (Deacon and Rawlins, 2006) 
was used with little variations. Reward t-maze test consisted of the following 
parts: habituation, training, main experiments. Animal were weighed 2 
subsequent days before starting restricted diet to obtain baseline weight. 
Then on daily basis to ensure that animals maintain 90-95% of their free-
feeding body weight. Animals were brought in to study room 5-10 min before 
starting trial: if left longer they may fall asleep and not perform well whereas 
starting trial immediately may result in the rats being over-excited with poor 
concentration.  
3.6.3 Habituation	  
Animals were handled for couple of days several times a day until they are 
thoroughly tamed. Only if well habituated and relaxed an animal will learn well 
(Deacon and Rawlins, 2006). Animals were familiarised with reward pellets 
(45mg dustless precision pellets) in their home cages for a couple of days. 
Then the night before starting habituation all regular diet was removed from the 
cages and animal were given only restricted amount (4-5g/100 g rat) of reward 
pellets. The following day animals were weighed. An individual animal was 
placed in the t-maze with all arms open to freely explore the maze. Both arms 
were full of reward pellets. Animals were allowed no more than 3 min to freely 
explore the maze: this is adequate time to explore the maze and eat pellets 
however longer exposure may induce aversion to unknown environment and 
following exposure can cause anxiety. Then animals immediately returned to 
the home cages. This procedure was repeated 3-4 times per rat every day until 
they each eat several pellets on both sides of the maze. Once animal fully 
habituated then following the training started.  
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2.1  Initial training 
Initial training procedure aimed to allow animal to explore the maze and to 
reduce anxiety to the novel environment. Moreover, to train animals to eat 
reward pellets in the goal arms. This training had six steps (see Table 2.5).  
3.1  Main training 
Access to the correct choice arm was restricted. Animal were placed in the start 
arm. The sample arm was baited with one pellet and the choice arm with 2 
pellets. Once animal reaches the end of sample arm and consumed the pellet it 
was placed back to the start arm not facing T junction. Then the door to choice 
arm was open animal was allowed to make a choice. If the correct arm was 
chosen, the rat was given time to eat both pellets and then returned back to the 
cage. If an incorrect arm was chosen then rat still remained in the arm for the 
duration of time necessary to consume the pellet and thereafter was removed 
from the maze. Left/Right (R/L) arm sequence during training and main 
experiments were randomised so that all rats receive the same number of both 
left and right arm; the sequence to one side was no more than three times, for 
example, RRRLLL, LRRL, but not RRRRL.  
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Table 2.5. T maze initial training steps 
Training 
steps 
 Procedure 
Step	  1	   Access	   to	   start	   arm	  was	   closed	   and	   goal	   arms	  were	   filled	  with	  
reward	  pellets.	  Animals	  were	  placed	  from	  one	  arm	  to	  the	  maze.	  
Once	   each	   rat	   eats	   several	   pellets	   they	  were	   returned	   back	   to	  
the	  cage.	  
Step	  2	   Rats	  are	  placed	  on	  a	  goal	  arm	  and	  access	  to	  the	  rest	  of	  the	  maze	  
was	   restricted.	   The	   aim	   is	   to	   ensure	   each	   rats	   eats	   about	   6	  
pellets.	  
Step	  3	   Access	   to	   the	   start	   arm	   was	   blocked;	   both	   goal	   arms	   were	  
available	  and	  full	  of	  food	  
Step	  4	   Starts	  as	  step	  3	  then	  the	  block	  was	  removed	  
Step	  5	   Similar	  to	  step	  3	  without	  block.	  
Step	  6	   Animal	  was	   placed	   on	   the	   distal	   end	   of	   the	   start	   arm	  with	   no	  
block	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During the main test animal was given 5 second retention interval (the time 
period between expose to sample and choice phase) before making choice of 
arm, and then 60 seconds. Increasing retention interval can help to reveal 
dysfunction better. Time from when animal started going towards T junction to 
make a choice until it entered a goal arm with 4 feet was noted as delay time.  
3.6.4 Data	  analysis:	  T-­‐maze	  	  
The average correct choice (%) for all trails was calculated per animal group. 
Shapiro-Wilk and Anderson Darling tests were carried out to check for 
Gaussian distribution.  One way ANOVA test, followed by Tukey’s post hoc test 
was carried out to compare correct arm choice between the groups. 
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1. Introduction	  
The association between low Mg2+ and epilepsy is well known. Seizures 
commonly occur in genetic Mg2+ deficiency syndromes and in acquired 
hypomagnesaemia, due to malabsorption, alcoholism and certain medications 
(Baaij et al., 2015). In addition, magnesium sulphate is the first line treatment in 
eclampsia - pregnancy induced seizures. The exact mechanism of this is not 
well known, and it has been suggested that the magnesium may be having 
effects by vasodilation and lowering the blood pressure. There have also been 
reports of the successful treatment of SE with intravenous magnesium, but 
other studies have not found such an effect, possibly because increasing 
peripheral magnesium levels has a minimal effect on central nervous system 
(CNS) levels (Baaij et al., 2015). Furthermore, lowering extracellular Mg2+ is a 
very well established method to induce in vitro seizure-like activity. Initially, it 
was thought that low Mg2+ model induced epileptiform activity through releasing 
the magnesium block of NMDA receptors. Although blocking NMDA receptors 
in the early stages can prevent the induction of epileptiform activity, NMDA 
antagonists fail to block epileptiform activity in the later stages. This raises the 
possibility that other mechanisms contribute to late sustained seizure-like 
activity in this model. Opening of TRPM7 channels is one possibility, as TRPM7 
channels are also activated by low intracellular Mg2+. Once open, TRPM7 
channels can depolarise neurons, as the channels are also permeable to 
sodium and calcium, and such depolarisation could exacerbate epileptic 
activity.  
What about the possible role of TRPM7 channels in seizure activity that is not 
the result of lowering magnesium concentrations? Since low extracellular Ca2+ 
concentrations, oxidative stress and decreased pH also open TRPM7 channels 
and these processes occur during seizure activity, then TRPM7 channels could 
play a role in seizure-like activity generated in conditions when magnesium 
concentrations are not reduced.  
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Therefore the current study, for the first time, aimed to test the involvement of 
TRPM7 channels in seizure generation in low magnesium and normal 
magnesium conditions.  
I used two different blockers of TRPM7 channels to test my hypotheses. The 
drugs used were carvacrol and a novel, possibly more specific antagonist, 
Waxienicin A. As explained previously carvacrol was the most appropriate of 
other antagonists to extend to in vivo studies (see chapter 1). It is a naturally 
occurring compound with a simple structure that is unlikely to have many 
adverse effects on animals. Moreover, carvacrol has already been used in in 
vivo studies and was well tolerated without known toxic effects. However, 
carvacrol later has been reported to have an effect on sodium channels (Joca 
et al., 2012), then I wished also to investigate further the specificity of carvacrol. 
1.1 Aims	  and	  hypotheses	  	  
Hypothesis 1. TRPM7 current will increase during low Mg2+ induced seizure 
activity. We hypothesized that blocking TRPM7 channel by antagonists added 
to the extracellular medium would decrease or abolish in vitro epileptiform 
activity by reducing influx of cations, such as Na+ and Ca2+ to cells and thus 
decrease cell depolarisation.  
Hypothesis 2. TRPM7 channels will also be activated during seizure activity 
induced in physiological Mg2+ concentrations, under the influence of other 
mechanism that open the channel and take place during seizure activity, such 
as decreased low extracellular Ca2+, low pH and reactive oxygen species 
(ROS) formation.  
Aim 1: To investigate the effect of TRPM7 channel inhibition on in vitro 
epileptiform activity in two different models – one with reduced extracellular 
magnesium and the other with physiological magnesium. 
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Aim 2: To determine whether carvacrol has relevant effects on sodium 
channels that would reduce it’s potential to be used as a specific inhibitor of 
TRPM7 channels. 
 
2. Methods	  	  
To test the above hypotheses two different TRPM7 channel blockers were 
used. Carvacrol, a non-specific blockers. Waxiencin A is a newly identified 
specific blocker of the channel, which was obtained recently from Hawaii 
Pacific University.  
2.1 Carvacrol	  experiments	  	  
For the drug-treated experiment after initial 20 minute baseline recording 1 mM 
carvacrol (Sigma Aldrich, UK) was added to the perfusion solution and the 
effects were recorded for 20 minute (see Figure 3.1). Then the drug was 
washed out from the slice for an hour. In 7 out of 14 experiments carvacrol was 
dissolved in DMSO (0.26%) prior to adding to the perfusion solution and in 
other seven experiments carvacrol was added without DMSO.  
For the control recordings the same procedure was applied and recorded for 
the same total amount of time (100 minute). In 6 out of total 13 control 
experiments DMSO was added as a vehicle to the perfusion solution (0.26%) 
after 20 minute of the baseline recording. This was recorded for next 20 minute. 
Then, DMSO was washed out during one hour. In 7 control recordings vehicle 
was not added. This was done in order to have 2 types of control recordings 
that matched drug treated experiments.  
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Half of experiments with carvacrol in drug and control groups were conducted 
with DMSO and half without. There was no significant difference between these 
two sets of experiments, therefore they were combined for analyses. 
 
 
 
 Figure 3.1. Timeline of in vitro experiment protocols treated with: 
  A –Carvacrol, B and C - Waxiencin A 
 
 
2.2 Waxienicin	  A	  experiments	  
Waxiencin A is a potentially selective TRPM7 channel blocker (Zierler et al., 
2011). It was isolated from Hawaiian soft coral in Hawaii Pacific University. I 
used the minimal effective dose (10 µM) for PTZ and 10-20 µM for low Mg2+  
experiments. 
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Dissolving Waxiencin A:  The specific protocol provided by DH from Hawaii 
Pacific University was used to dissolve Waxiencin A. In brief, 50 μl of 99% 
methanol was added to the vial containing 50 μg Waxiencin A, then once half 
of methanol volume evaporated 1035 μl of a buffer (PTZ or low Mg2+ containing 
ACSF) was added to dissolve the compound completely. Then this solution 
was added to the perfusion solution to make required concentration. Final 
concentration of methanol in the perfusion solution was 0.23% in PTZ and 
0.46% in Low Mg2+ experiments. 
Low Mg2+ induced activity. After 20 minute of baseline activity, 10-20 μM of 
Waxiencin A dissolved in methanol was added to the perfusion solution. After 
20 minute Waxiencin A was washed out from the slice by low Mg2+ containing 
ACSF and recorded for another 30 minute (see Figure 3.1). Similar to 
carvacrol Waxiencin A also inhibited both ictal and interictal like activity induced 
by low Mg2+.  
PTZ induced activity. After 20 minute of baseline activity, 10 μM of Waxiencin A 
dissolved in methanol was added to the perfusion solution. After 20 minute 
Waxiencin A was washed out from the slice by PTZ containing ACSF and 
recorded for another 30 minute. 
Control recordings. In control recordings 0.23 % methanol was added to the 
perfusion solution in PTZ experiments and 0.46 % methanol in low Mg2+ 
experiments after 20 minute of baseline recording and after 20 minute was 
washed out from the slice for 30 minute.  
The frequency and amplitude of epileptiform activity in all in vitro experiments 
were averaged per 5 minute. The data (frequency and amplitude of epileptiform 
activity in each group) was normally distributed (p > .05, Shapiro Wilk test –
cannot reject normality)	  in all set of in vitro experiments. Therefore, appropriate 
parametric tests were employed:  unpaired t-test to compare unmatched 
groups and paired t-test for comparing matched data. To compare the effect of 
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the compounds mean last 10 minute of drug versus vehicle administration 
interval were compared.	  
 
3. Results	  
3.1 Carvacrol	  inhibited	  in	  vitro	  seizure-­‐like	  activity	  	  
3.1.1 Low	  Mg2+	  experiments	  
Types of activity: In low Mg2+ seizure model both ictal-like and interictal-like 
epileptiform activities are generated in combined hippocampo-cortical slices 
(see Figure 3.2 and Figure 3.3). Ictal-like activity occurred every 3-4 minutes 
and lasted about 0.5-1.5 minute. Ictal-like activity is purportedly generated in 
entorhinal cortex and spreads to CA3 and CA1 areas, whereas interictal activity 
is generated in CA3 and then spreads to CA1 area (Jefferys et al., 2012). 
Spikes and polyspike events occurred throughout some recordings, more 
frequently in PTZ induced activities. These were not included in the analysis. 
An epileptiform burst was defined as field potential activity with an amplitude 
more than three times that of baseline, containing more than 2 subsequent 
spikes that do not return to baseline, and with overall duration ≥ 40 ms. Single 
spikes and polyspikes not meeting this criteria were not included in analyses. 
Epileptiform discharges initiated in combined hippocampal-entorhinal cortex 
slices 20-30 minutes after transferring the slices into low Mg2+ containing ACSF 
solution. Both ictal and interictal-like activity were used to assess the effect of 
the TRPM7 channel blocker.  
Carvacrol significantly inhibited the frequency and amplitude of low Mg2+ 
induced epileptiform activity (p <0.001, two sample t-test, for both frequency 
and amplitude) (see Figure 3.4). In carvacrol treated slices after 5 minute of 
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the drug administration epileptiform activity started to decrease. The activity 
was completely abolished after about 10 minute following carvacrol 
administration. Carvacrol had the same inhibitory effect on both ictal and 
interictal-like activity. During washout of the drug with low Mg2+ ACSF only very 
little restoration of the activity was observed towards the end of washout period. 
Random short single spikes or polyspikes were observed in all experiments 
that were distinct from baseline epileptiform activity, and were not included in 
the count of burst activity (see Figure 3.3 C). Frequency and amplitude of 
epileptiform activity in control recordings were constant over the first 80 minute 
with a small decrease in some recordings thereafter.  
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Figure 3.2. An example trace of ictal like activity induced by low Mg2+ 
Ictal like activity occurred every 3-4 minutes and lasted about 0.5-1.5 minute. 
Frequency of epileptoform discharges initially is high, then this gradually 
decreases  
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Figure 3.3. Example traces of inter-ictal like activity induced by: 
 Low Mg2+ (A) and PTZ (B); and spike-like activities (C) 
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Figure 3.4. Carvacrol inhibited low Mg2+ induced seizure-like activity in    
hippocampal-entorhinal cortex slices:  
A - scatter plot shows frequency of epileptiform discharges (mean±SEM) (normalised to 
baseline) of carvacrol–treated (1 mM) (n=7) and control experiments (n=6), averaged to 5 
minute. B - bar charts represent mean±SEM frequency of baseline, vehicle/carvacrol-
treated and washout periods, ***P .001 (two sample t-test). C - scatter plot shows amplitude 
of epileptiform discharges (mean±SEM) (normalised to baseline) of carvacrol –treated and 
control experiments, averaged to 5 minute. D - bar charts represent mean±SEM amplitude 
of baseline, vehicle/carvacrol-treated and washout periods, ***P .001(two sample t-test). E – 
Low Mg2+ induced ictal-like epileptiform activity recorded from CA1 region of the 
hippocampus during; 1) baseline activity 2)-carvacrol-treated and 3)- washout periods 
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3.1.2 PTZ	  experiments	  
One possible confounder in the above experiments could be that low Mg2+may 
preferentially open TRPM7 channels. I, therefore, used an alternative in vitro 
seizure model where epileptiform activity is induced in normal extracellular 
magnesium concentrations, using the GABAA receptor antagonist PTZ. PTZ (2 
mM) induced epileptiform events in combined hippocampo-entorhinal cortex 
slices after ~30-40 minute of exposure. PTZ generates almost exclusively 
interictal-like epileptiform activity. However, this activity tends to cluster 
sometimes. 
In carvacrol treated slices epileptiform activity started to diminish about 5 
minute after drug administration and completely stopped within 10 minute. 
Carvacrol significantly reduced the frequency and amplitude of PTZ induced 
epileptiform discharges [two sample t- test P <0.001 for both] (see Figure 3.5). 
During washout period there is a partial restoration of the activity towards the 
end of the washout period. However, in some recordings inhibition of 
epileptiform activity was not reversible. Control recordings had stable frequency 
and amplitude over  
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Figure 3.5. Carvacrol inhibites low PTZ induced epileptiform discharges in 
hippocampal-entorhinal cortex slices:  
A - scatter plot shows frequency of epileptiform discharges (mean± SEM) (normalised to 
baseline) of carvacrol–treated (1 mM) (n=7) and control experiments (n=7), averaged to 5 
minute. B - bar charts represent mean± SEM frequency of baseline, vehicle/carvacrol-
treated and washout periods, ***p<.001 (two sample t-test). C - scatter plot shows amplitude 
of epileptiform discharges (mean± SEM) (normalised to baseline) of carvacrol –treated and 
control experiments, averaged to 5 minute. D - bar charts represent mean± SEM amplitude 
of baseline, vehicle/carvacrol-treated and washout periods, ***p <.001(two sample t-test).  
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the recording time. As with Low Mg2+ induced activity, the PTZ induced activity 
also decreased in both frequency and amplitude after about 80 minute of 
recording in some control recordings. 
 
3.2 Effect	  of	  Carvacrol	  on	  fEPSP	  	  
Since carvacrol is the most convenient of the two inhibitors to be used for in 
vivo experiments, (more easily obtainable than waxiencin A), but has been 
reported to have effects on peripheral sodium channels, I wished to test its 
action on central neurotransmission. After 20 minute of baseline recording of 
fEPSP, carvacrol (1mM) was added to the perfusion solution for 20 minutes. 
Carvacrol increased the amplitude and slope of fEPSPs; the slope and 
amplitude started to increase 3-4 minute after adding carvacrol to the perfusion 
solution (see Figure 3.6). The normalised mean slope during carvacrol 
treatment period was significantly greater than the baseline (p< .05 paired t-
test). There was no significant change in fibre volley slope after carvacrol 
addition suggesting that carvacrol does not affect sodium channels in acute 
brain slices.  
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Figure 3.6. Effect of carvacrol (1mM) on single pulse induced fEPSP. 
 A - Scatter plot of normalised (mean ±  SEM) fibre volley slope over 40 min, averaged for 1 
min (n=7).  Carvacrol was added after 20 minute of baseline recording. B – Average trace of 
fEPSP and bar charts represents mean ±  SEM fibre volley slope of baseline period and 
carvacrol-treated time, ns P>0.05 (paired t-test).  C - Scatter plot of normalised fEPSP slope 
(mean ±  SEM) over 40 min, averaged for 1 min (n=7).  D – bar chart represents mean 
(SEM) slope of fEPSP, Carvacrol significantly increased the slope of fEPSP, * P<0.05 
(paired t-test).   
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3.3 Waxiencin	  A	  inhibited	  in	  vitro	  epileptiform	  
activity	  	  
3.3.1 Low	  Mg2+	  experiments	  	  
In Waxiencin A added slices low Mg2+ induced epileptiform activity started to 
diminish immediately after the drug administration: the activity substantially 
decreased within 5 minute and completely stopped by 20 minute from the drug 
addition time. Blocking TRPM7 channel by Waxiencin A significantly reduced 
frequency of epileptiform discharges [p <.001, two sample t- test] (see Figure 
3.7). During washout of the drug the epileptiform activity was partially restored. 
Control recordings had stable frequency and amplitude over the recording time.  
3.3.2 PTZ	  experiments	  	  
In Waxiencin A treated slices epileptiform activity induced by PTZ started to 
decline immediately after the drug administration and completely stopped by 15 
minute. Waxiencin A significantly reduced frequency of PTZ induced 
epileptiform discharges [two sample t- test p<.001] (see Figure 3.8). During 
washout period the activity although partially restored but did not reach 
baseline level. Control recordings had stable frequency and amplitude over the 
recording time.  
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Figure 3.7. Waxiencin A inhibits low Mg2+ induced epileptiform discharges in 
hippocampal-entorhinal cortex slices:  
A - scatter plot shows frequency of epileptiform discharges (mean± SEM) (normalised to 
baseline) of Waixenicin A –treated (10-20 µM) (n=5) and control experiments (n=5), 
averaged to 5 minute. B - bar charts represent mean± SEM frequency of baseline, 
vehicle/carvacrol-treated and washout periods, ***P< .001 (two sample t-test).  
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Figure 3.8. Waxiencin A inhibits PTZ induced epileptiform discharges in hippocampal-
entorhinal cortex slices: 
 A - scatter plot shows frequency of epileptiform discharges (mean± SEM) (normalised to 
baseline) of Waixenicin A –treated (10 µM) (n=5) and control experiments (n=5), averaged 
to 5 minute. B - bar charts represent mean± SEM frequency of baseline, vehicle/carvacrol-
treated and washout periods, ***P< .001 (two sample t-test).  
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4. Discussion	  
The present study for the first time assessed the effect of TRPM7 channel 
antagonists on in vitro seizure-like activity; here we provide evidence of TRPM7 
channel involvement in seizure generation in two in vitro seizure models. The 
inhibitory effect of TRPM7 channel blocking on seizure-like activity is shown 
with two different TRPM7 channel antagonists.  
Carvacrol, a non-selective TRPM7 channel antagonist completely abolished 
epileptiform activity in both low Mg2+ and PTZ in vitro seizure models. This 
study used carvacrol for the first time to assess its effect on epileptiform activity 
in vitro through blocking TRPM7 channel currents.  
Carvacrol completely blocks epileptiform discharges within 10 minute of 
addition to the perfusion solution. During washout period in both low Mg2+ and 
PTZ experiments only a small reversible activity was seen. Insufficient washout 
may be caused by high affinity of carvacrol to the binding sites of TRPM7 
channel. This can also be due to slow restoration of the TRPM7 channel 
currents. An alternative, and perhaps more likely, explanation is that there is 
significant non-specific binding of carvacrol in the slice preparation.. Control 
recordings had constant frequency and amplitude over about 80 minute with 
only a slight decrease of both amplitude and frequency thereafter. 
However, it is not clear if such remarkable effect of carvacrol is exclusively due 
to TRPM7 channel inhibition or alternative pathways are also involved. 
Carvacrol has numerous therapeutic effects: antimicrobial, antifungal, antitumor 
and antidepressant-like effects.  Of the TRP family carvacrol has stimulatory 
effect on thermo TRP channels, TRPV3 and TRPA1 and inhibits drosophila 
TRPL channel which is a mammalian TPRC analogue (Parnas et al., 2009). 
Nevertheless, none of these channels have known effects on neuronal 
excitation. Only one study suggested inhibition of sodium channels by 
carvacrol. The study showed a block of the compound action potentials (CAP) 
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with carvacrol. In our experiments carvacrol not only did not inhibit but 
potentiated fEPSPs in hippocampal-entorhinal cortex slices and also had no 
effect on the fibre volley, suggesting that a significant inhibitory effect on 
sodium channels did not occur in this preparation. This could possibly be 
explained by different variants of sodium channels in peripheral nerves and 
CNS, and different duration of application. In the above mentioned study 
inhibition of CAP was observed after 180 minute of carvacrol administration, 
which is much longer than the administration used in the current study. 
Waxiencin A, a potentially specific antagonist of TRPM7 channel, had 
significant inhibitory effect on epileptiform activity in small concentrations in 
both low Mg2+ and PTZ induced activity. Waxiencin A initiates an effect almost 
immediately as it reaches the slice. The minimal effective concentration of 
Waxiencin A (10μm) was sufficient to inhibit epileptiform activity induced in the 
presence of normal Mg2+ concentrations and in low Mg2+ conditions.  Zierler et 
al. reported that that higher dose of Waxienicin A needed to block TRPM7 
current in low Mg2+ concentrations (Zierler et al., 2011). 10 µM Waxiencin A 
blocks the channel current completely in physiological intracellular Mg2+ (700 
µM) concentrations but the same concentration blocks the current by 50% in 
zero Mg2+ conditions. However, when in addition extracellular Mg2+ was also 
removed Waxiencin A supressed the channel’s activity only by 30% (Zierler et 
al., 2011). Waixenicin A was initially tested in low magnesium model with 20μm 
because of concerns that in low magnesium conditions channels activate and 
large dose maybe needed to block it. However, when later I tried smaller doses 
(10 μm) this concentration also decreased the epileptiform activity. When I 
analysed the results I saw no difference between i.e. in both concentrations (10 
μm and 20 μm) Waxiencin A significantly inhibited epileptiform activity. This 
suggests that TRPM7 channel play a role in seizure activity whether under low 
Mg2+ or physiological Mg2+ concentrations. 
Both non-specific and a potentially specific TRPM7 channels antagonists block 
in vitro epileptiform activity generated by both PTZ and low Mg2+. This two 
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seizure models induce epileptiform activity via different mechanisms; increasing 
excitability (low Mg2) and decreasing inhibition (PTZ) in the network. The low 
Mg2+ ASCF solution would activate TRPM7 channels due to decreased 
extracellular Mg2+ concentrations whereas PTZ induces seizure through a 
mechanism that does not change Mg2+ levels. This shows that activation of 
TRPM7 channels in epilepsy may occur not only due to reduced low 
magnesium concentrations but also through other mechanisms such as 
oxidative stress and low pH. 
In vitro seizure models can be used to study as defined electrographic 
excessive neuronal discharge in an isolated brain tissue. This is a useful tool 
for initial investigation of the effect of certain compounds on isolated abnormal 
activity to identify a possible targets involved in seizure generation. Benefit of 
such in vitro experiments is that they can be employed to detect subtle changes 
in isolated tissue, and the blood brain barrier and other pharmacokinetic issues 
are avoided. However, the in vitro seizure-like activity may differ 
mechanistically from in vivo seizure activity, and together with the 
pharmacokinetic considerations, in vitro data should be used cautiously to 
extrapolate to the in vivo situation.  
5. Summary	  of	  the	  chapter	  
The effect of blocking TRPM7 channel on epileptiform activity was assessed in 
two in vitro seizure models: low Mg2+ and PTZ with two different TRPM7 
channel antagonists. Carvacrol, a non-selective blocker of the TRPM7 channel, 
completely abolished epileptiform activity induced by both low Mg2+ and PTZ 
after 10 minute of administration. Waxiencin A, a potentially selective blocker of 
TRPM7 channel substantially decreased epileptiform activity induced by both 
low Mg2+ and PTZ after 5 minute of administration, completely abolishing the 
activity after ~15 minute.  
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1. Introduction	  
Status epilepticus causes cell damage in the hippocampus and related 
structures. In perforant path stimulation animal model of status epilepticus, cell 
loss is most prevalent the first day following induced SE, reaching the peak 
during first 24 hours and some damage continues to occur during the first 
week. Cell loss in TLE is more prominent in the hilus followed by CA1 and to a 
lesser extend in CA3 area. In animal models (PPS) with shorter duration of 
stimulation, less than 60 minute, damage is confined to the hilus, whereas 
longer stimulation period causes damage to other parts of hippocampus and 
related structures (Norwood et al., 2011). Post SE cell damage was related to 
excessive neuronal firing and Ca2+ influx to the cell triggering excitotoxicity 
related cell death pathways. One of the goals in disease modification in 
epilepsy is to prevent neurodegeneration/cell death and thus, related functional 
deficits and possibly prevent epileptogenesis. 
Although NMDA receptors are thought to play an essential role in excitotoxic 
cell death in conditions such as stroke, anoxia, brain trauma and epilepsy the 
role of TRPM7 channels in this process is now becoming widely recognised. 
Blocking NMDA and L-type channels alone did not prevent anoxia induced cell 
damage in clinical trials (Nicotera and Bano, 2003). Therefore, involvement of 
other pathways in excitotoxicity was suggested, such as TRPM7 channels. 
Oxidative stress and ROS production induced by excessive NMDA activation 
leads to TRPM7 channel activation, allowing further CA2+ influx, and this in turn 
triggers further ROS production, which contributes to positive feedback loop, 
opening more TRPM7 channels. Moreover, the TRPM7 channel was suggested 
to predominate in this pathway and play essential role even in the absence of 
NMDA receptor block (Nicotera and Bano, 2003). Therefore, even though 
NMDA receptors play a role initially in excitotoxicity later TRPM7 channel 
activation in such stress conditions leads to continuous cell firing and damage.  
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Blocking TRPM7 channels had neuroprotective effect in an in vivo stroke model 
(Sun et al., 2009) in CA1 region of the hippocampus. Moreover, other studies 
have also shown neuroprotective effects following ischemia –hypoxia induced 
cell damage by blocking TRPM7 channel with carvacrol (Yu et al., 2012; Chen 
et al., 2015). However, the involvement of TRPM7 channels in epilepsy related 
cell death has not been investigated yet.  
Given that TRPM7 antagonists also have antiseizure effects in vitro, I also 
wished to test whether carvacrol could stop status epilepticus, unfortunately 
due to toxicity this experiment was not possible (see below). 
Aim: To test the effect of TRPM7 channel inhibition on cell survival after SE 
induced hippocampal damage  
Hypothesis: TRPM7 channel activation during excessive neuronal firing will 
contribute to cell depolarisation, and Ca2+ entry via the channel can trigger a 
cascade of processes contributing to cell toxicity and death. Moreover, Zn2+ as 
well as other trace metals entering the cells in stress conditions via TRPM7 
channel can play a role in cell death. Therefore, blocking TRPM7 channel 
would prevent or reduce cell damage in vulnerable areas of the hippocampus. 
2. Methods	  
In order to assess neuronal cell loss in the hippocampus cells were counted in 
six non-adjacent slices per hippocampus representing dorsal part of the 
hippocampus. Cell counting described in details previously (see chapter 2). Cell 
death was quantified in CA1, CA3 and hilar regions of the hippocampus in 
epileptic, epileptic treated and control animals three to four weeks following 
induction of SE. Because maximum cell death in PPS model is observed in the 
first week following induced SE, this time window would be sufficient to detect 
hippocampal damage. Initially, carvacrol was given to animals in doses of 200 
mg/kg to tes
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poorly tolerated by the animals. Therefore, these experiments were 
discontinued. Lower doses of carvacrol (75 mg/kg) instead were used to test its 
effect on preventing cell death following SE.  
Although some authors reported that similar damage occur ipsi- and 
contralateral to the stimulation side in PPS model, other studies have shown 
that contralateral sparing does occur. Therefore, I assessed cell death 
ipsilateral to the stimulation, i.e. right hemisphere. 
2.1 Carvacrol	  protocol	  development	  	  
In order to choose the appropriate dose of the carvacrol for the in vivo use i.e. 
that could be tolerated well by animals several different protocols were tried.  
Protocol I. After stopping stimulation and ensuring the SSSE had developed 
200 mg/kg of carvacrol in DMSO was administered i.p. to animals in the 
treatment group. Then recording of SSSE was continued for 3 hours. To 
terminate SE after 3 hour 10 mg/kg diazepam was given i.p. and 5 ml saline 
was administrated s.c. to hydrate the animal. Carvacrol did not stop SE, and 
the animals died after diazepam administration. This could possibly be due to 
combined inhibitory effect of carvacrol and diazepam on respiration. Two drug 
treated animals died after injecting diazepam. Although minor respiratory 
depression was observed in control-stimulated animals after diazepam 
administration this improved later. In one of two drug treated PPS experiments 
inhibition of both motor and electrographic seizures for 30-40 minutes was 
observed with later reverse of seizure discharges on EEG but not behavioural 
seizures. 
Protocol II. The same procedure as above was applied with reduced dose of 
carvacrol - 100 mg/kg. The following day a small proportion of animals 
displayed features of distress and following vet advice were culled and 
therefore not included in this study. 
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Final protocol. After stopping stimulation and ensuring the SSSE had 
developed, diazepam (10 mg/kg IP) was given and EEG was observed for 20-
30 minutes to ensure SE had stopped. 5 ml saline was administrated S.C. to 
hydrate the animal. Following this, drug treatment group (n=6) received 
75mg/kg i.p. of carvacrol without DMSO (see Figure 4.1). Stimulated control 
group (n=6) received the same amount of IP saline injection. Then next two 
doses of carvacrol and saline were administrated (i.p.) about every 8 hour so 
that animals received 3 doses of carvacrol during the first 24 hour after SE 
induction. Control animals (n=6) that were not stimulated did not receive any 
treatment. All animals that developed SSSE after perforant path stimulation 
were included in study. Animals that were unwell after stimulation and those 
that lost headpiece were culled early and excluded from the analysis (two in 
epileptic, two in drug treated group).  
 
 
 
Figure 4.1. Time line of carvacrol treatment protocol.  
Carvacrol was given 3   times during first 24 hour after induction of status epilepticus (SE): 
first dose after 30 min of diazepam injection then next 2 doses with about 8-10 hour intervals 
between injections.   
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SSSE
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Perfusion/fixation and immunostaining protocol as well as cell counting is 
reported in the general methods chapter (see chapter 2.). Due to difficulty in 
differentiating between cells in hilar and CA3c area I used the criteria described 
in the general methods section (see chapter 2.). When counting NeuN stained 
cells if uncertain i.e. staining is not very bright, checking DAPI on the same cell 
by switching between channels enabled to confirm presence of a neuron.    
3. Results	  	  
3.1 PPS	  reliably	  induced	  SE	  
Perforant pathway stimulation following a week of electrode implantation 
reliably induces self-sustaining status epilepticus after 2 hours of stimulation 
(see Figure 4.2) in about 95% of animals. Seizure severity during stimulation 
varied between stage 3 (forelimb clonus) and stage 5 (full motor seizure with 
loss of postural controlling) based on Racine scale. Most animal develop stage 
1 and stage 2 seizures initially, immediately or within the first 10-15 minutes. 
Afterwards seizure severity was between  stage 3 to stage 5 for the rest of the 
stimilation duration. After stopping stimluation during SSSE seirure severity 
varied between  stage 1 and 5. 
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Figure 4.2. Perforant path stimulation.  
A  sample traces of electrophysiology recordings during: baseline activity (A), electrically 
induced status epilepticus (SE) (B) and self sustained status epilepticus (SSSE)(C). 
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3.2 Carvacrol	  had	  neuroprotective	  effect	  in	  the	  
hilus	  
The summary of cell count statistics is shown in Table 4.1. The difference in 
cell density in the hilar region across the three groups was statistically 
significant [F (2,14) = 7.14, p = .007, one way ANOVA]. The average cell 
density in the hilar region (see Table 4.1, Figure 4.3) in epileptic animals 
reduced significantly compared to control animals [p=0.007, One-way ANOVA, 
Turkey post hoc].  
Epileptic animals had ~43 % neuronal cell reduction compared to control 
animals whereas in epileptic animals treated with TRPM7 channel blocker, only 
~13 % cell reduction was observed. Likewise the cell density in epileptic treated 
animals was also higher compared to epileptic animals [p = .04, post hoc 
Tukey’s test]. However, there was no significant difference in hilar cell density 
between treated epileptic and control groups. This shows that inhibiting TRPM7 
channel by carvacrol significantly rescued cell death in the hilus.  
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Table 4.1. Summary statistics of cell count in three area of the 
hippocampus 
Groups	  	   	  Mean*	  ±	  SD	   	  	  	  	  SEM	   95%	  Confidence	  
Interval	  
	   	  	  	  	  	  	  Hlius	   	    
Epileptic	  	   0.22±0.02 0.01	   0.20	  -­‐0.23 
Control	   0.38±0.04 0.02	   0.32	  -­‐0.43 
Epileptic	  +	  Carv	   0.33±0.12 0.05	   0.21	  -­‐0.45 
	   	  	  	  	  	  	  CA1	   	    
Epileptic	  
125.15±7.88	   	  	  	  	  3.52	   	  	  	  	  	  115.37	  -­‐134.93 
Control	   156.95±11.53 5.16	   142.64	  -­‐171.27 
Epileptic	  +	  Carv	   160.31±4.14	  
	  
 
1.85	   155.17	  -­‐165.45 
	   	  	  	  	  	  CA3	   	    
Epileptic	   107.90±9.43 4.22	   96.20-­‐	  119.60 
Control	   125.47±18.72 	  	  8.37	  
	  
102.22	  -­‐148.72 
Epileptic	  +	  Carv	   120.59±11.42 5.11	   106.42	  -­‐134.76 
SD – standard deviation, SEM – standard error of the mean, Carv- carvacrol, * mean cell 
density in hilar region and mean cell count in CA1 and CA3 regions. 
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Figure 4.3. Cell count in hilar region of the hippocampus.  
A - Confocal images (x20 magnification) showing coronal sections of anti-NeuN stained hilar 
region in control (left), epileptic (middle) and carvacrol treated (right) animals. B – A 
Confocal image (x10 magnification) of the hilar area showing the region of cell counting. C- 
Bar charts show mean±  SEM cell count in three groups of animals. *** p < 0.007,  ** p 
=0.04, One-way ANOVA, Tukey’s test. 
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3.1 Carvacrol	  had	  neuroprotective	  effect	  in	  CA1	  	  
In CA1 area neurons were counted as a number of cells per length of the CA1 
region as describe in general methods section due to difficulty in defining 
borders of CA1. Therefore, cell count per length would give more accurate 
estimate of cell number per region compared to calculating cell density. Only 
very few cells were located further apart from CA1 region, whereas most of 
them within 45 μm distance. Therefore, cells within the distance of 45 μm were 
also were included.  
 One way ANOVA showed that cell number in CA1 differed significantly across 
the three groups [F (2,12) = 26.6, p  .0.001]. Mean neuronal cell count in CA1 
region was significantly reduced in epileptic animals compared to control 
animals [p <.001, post hoc Tukey’s test]. A lesser degree of cell loss was 
observed in CA1 region (by ~ 20 %) compared to hilar region in epileptic rats. 
This cell loss was completely rescued by blocking TRPM7 channel. There was 
almost no difference in CA1 cell count between carvacrol treated epileptic and 
control animals (see Figure 4.4) [p >0.05, post hoc Tukey’s test] whereas cell 
count between epileptic and treated epileptic groups was statistically significant 
[p< .001, post hoc Tukey’s test]. In some slices in certain areas of CA1 
complete loss was also seen.  
3.1 No	  significant	  cell	  death	  was	  observed	  in	  CA3	  
No significant cell loss was observed in CA3 area [F (2,12) = 2.16, p = .16, 
One way ANOVA]. There was not significant difference in cell number across 
the three groups. Although epileptic animals had slightly reduced cell number 
this was not statistically significant. 
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Figure 4.4. Cell count in CA1 region of the hippocampus. 
  A. - Confocal images (x20 magnification) showing coronal sections of NeuN stained CA1 
area from slices in control (left), epileptic (middle) and epileptic  animas treated with 
carvacrol (right). B – A confocal image (x10 magnification) of CA1 region showing the region 
of cell counting. C – bar chart represent mean± SEM cell number per length of CA1 in three 
groups of animals. ***p <.001, ns – p>0.05, One-way ANOVA, post hoc Tukey ‘s test  
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Figure 4.5. Cell count in CA3 region of the hippocampus.   
A. - Confocal images (x20 magnification) of CA3 area from slices in control, epileptic and 
epileptic animas treated with carvacrol. B – A confocal image (x10 magnification) of CA3 
area showing the region of cell counting. C – bar charts represent mean± SEM cell number 
per length of CA3 in three groups of animals. There is no significant difference in cell count 
between control, epileptic and treated animals. ns – p > .05, One-way ANOVA. 
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3.2 Expression	  of	  TRPM7	  channel	  in	  the	  
hippocampus	  
I then was interested to see qualitatively the pattern of expression of TRPM7 
channel in the three areas of the hippocampus: CA1, CA3 and the hilus. The 
example images taken from a heathy control animal in order to assess if the 
areas where I quantified cell damage TRPM7 channel is present. To exclude 
non-specific binding of TRPM7 channel, a negative control was performed 
without adding primary anti-TRPM7 antibody (see chapter 2) and this did not 
show any staining. Immunostaining pattern shows that TRPM7 channels are 
expressed widely in the hippocampus. They are expressed in the neuronal cell 
bodies as well as in dendrites and axons (see Figure 4.6). Although I did not 
quantify the intensity, it seems that greater TRPM7 channel immunoreactivity is 
present in the CA1, followed by hilus and to a lesser degree in CA3 region.  
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Figure 4.6 Confocal images (20x) showing expression pattern of TRM7 channel in the 
hippocampus in healthy control animal  (A) –hilus, (B) – CA3, (C) – CA1.  
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4. Discussion	  
The pattern of cell damage following SE seen here was consistent with what 
has been observed in PPS model in previous studies, except the absence of 
damage in CA3 area. The most severe damage was seen in hilar region with 
almost half of the neurons lost. To a lesser degree damage was observed in 
CA1 area, about 20% of CA1 neurons were lost in epileptic animals. Blocking 
TRPM7 channel prevented cell loss in both hilar and CA1 regions; almost no 
cell loss was observed in CA1 region of epileptic animals treated with carvacrol.  
Contrary to previous studies I did not detect cell loss in CA3 region in epileptic 
rats compared to control animals. Although there was a trend for the cell 
number in CA3 area in epileptic animals to be lower compared to that in the 
control group, this did not reach significance. While cell damage in CA3 area 
was reported in PPS epilepsy model, the cell loss was minimal in this area 
compared to CA1 and hilus (Pauli et al., 2006). A possible explanation for not 
detecting cell damage in CA3 area in the current study could be that cell 
damage was subtle in CA3 area and was not detected with conservative cell 
counting methods.  
Moreover, CA3 region is generally less sensitive to excitotoxic cell damage 
compared to CA1 area (Gee et al., 2006; Ohmori et al., 1996). CA1 region is 
more vulnerable to variety of damage such as oxidative stress, ischemia/stroke 
as well as in neurodegenerative disorders (Butler et al., 2010).This has been 
explained by lower expression of AMPA and NMDA receptors in CA3 
compared to CA1 area (Baltan et al., 2013). AMPA receptors are activated first 
then depolarised cells trigger NMDA activation. Therefore, in CA3 fewer AMPA 
and NMDA receptors are activated, hence the region is less vulnerable to 
excitotoxic damage. As discussed above NMDA receptors are important to 
induce excitotoxic cell damage. This then could trigger activation of TRPM7 
channels. 
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Blocking TRPM7 channel by carvacrol provided better protection of neuronal 
cell death in CA1 area compared to hilar region: cell death in CA1 was 
completely prevented by carvacrol. First, this could be explained by less severe 
damage to CA1 area (~ 20 % cell loss) compared to hilar region (~ 50 % cell 
loss) after SE. In addition, cell damage in hilar region is initiated earlier than in 
CA1 during perforant path stimulation (Norwood et al., 2011). It was shown that 
40 minute stimulation already causes damage to hilar region whereas 
stimulation over 60 min led to damage to other areas of the hippocampus.  
Blocking TRPM7 channel with carvacrol prevented initial cascade of processes 
triggered by excessive neuronal firing that leads to cell damage. Although 
treatment was given only during the first 24 hour following induced SE this was 
sufficient to prevent neuronal cell death in the hippocampus. It was shown in 
previous studies that cell death in PPS model is at peak level during first 24 
hour. Carvacrol has short half-life and rapidly excreted by kidneys (Tisserand 
and Young, 2013; Michiels et al., 2008). Therefore, we proposed administration 
of carvacrol 3 times during first 24 hour after SE, every 8-10 hour, could provide 
better neuroprotection than a single injection post SE. 
TRPM7 channel inhibition prevented cell death in ischemia/anoxia induced 
brain damage. Carvacrol has been reported to reduce infarct volume and 
improve neurological defect after ischemia/reperfusion injury in mice (Yu et al., 
2012). Yu et al. showed that carvacrol substantially decreased infarct volume 
and improved neurological deficits after 75 min of ischemia and 24 h of 
reperfusion(Yu et al., 2012). This neuroprotection was dose-dependent. This 
result is consistent with previous studies that have reported a neuroprotective 
role of blocking TRPM7 in ischemia induced damage in CA1 (Sun et al., 2009).  
Intrahippocampal injections of viral vectors bearing shRNA against TRPM7 
channel made neuronal cells resistant to ischemic death after brain ischemia 
and prevented ischemia-induced deficits in LTP and preserved memory 
function (Sun et al., 2009). Here I showed that TRPM7 inhibition also prevented 
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cell death induced by SE. In both ischemia and SE induced cell death 
excitotoxicity and Ca2+ overload of the cells play an essential role.  
However, NMDA blockers alone did not prevent cell death in anoxia induced 
cell damage. Blocking TRPM7 by sRNAi had significant effect in preventing 
Ca2+ overload and cell death in the absence of NMDA block suggesting its 
essential role in this pathway for both excitotoxic and non-excitotoxic neuronal 
damage. TRPM7 is more important in prolonged anoxia induced excitotoxicity 
because NMDA receptors become desensitised quickly under anoxia 
conditions. Blocking NMDA receptors did not have protective effects in clinical 
trials. Further, NMDA antagonists would only block excitotoxicity and unmask 
the predominant pathway for Ca2+ entry -TRPM7 pathway (Nicotera and Bano, 
2003). 
Possibly in the future concurrent use of NMDA and TRPM7 blockers in vivo and 
in clinical trials could provide better protection against cell death following brain 
insult that leads to cell damage. Because carvacrol is a food additive and 
hence a safe compound it can also be transferred easily into clinical research. 
5. Summary	  of	  the	  chapter	  	  
Perforant path stimulation in 8-9 week old rats produced chronic epilepsy in 
~95% of animals. Hippocampal coronal sections 3-4 week following induced SE 
was immunostained with anti-NeuN followed by counting neurons in three 
areas of the hippocampus; CA1, CA3 and hilar region. Epileptic rats had 40-
50% loss of neurons in hilar region and ~20% loss in CA1 region. No significant 
difference was observed in cell number in CA3 area between control and 
epileptic groups. The cell loss was prevented by blocking TRPM7 channels with 
carvacrol in both CA1 and hilar region, with complete preservation of neuron in 
CA1 area. This finding suggests an essential role of TRPM7 channels in SE 
induced hippocampal damage. 
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1. Introduction	  	  
The development of chronic acquired epilepsy has been linked to an initial 
brain insult. However, it is not clear whether loss of neurons itself is the main 
contributing factor or downstream pathways that are triggered after an insult or 
compensatory synaptic modification are important for the development of 
epilepsy. In previous experiments in the current study TRPM7 channel 
inhibition with carvacrol prevented cell loss in the hippocampus after SE. 
Therefore, the next objective was to test whether protecting neuronal cell death 
will prevent against the development of epilepsy. 
Early pharmacological treatment after initial insult can prevent or modify the 
development of epilepsy. The goal is to prevent or reverse the epileptogenic 
process in those at risk (Löscher and Brandt, 2010). Three different strategies 
have been suggested; 1) early treatment after an insult to modify onset of the 
disease – insult modification, 2) treatment during the latent period, 3) 
administration of the treatment once the symptoms of disease are manifest. 
The latter is most likely to be applicable to human epilepsy, however, much 
longer period of treatment will be needed to assess its effectiveness. The 
disease modification in epilepsy also aims to decrease seizure severity, if they 
occur, as well as modify sensitivity to current AEDs and comorbidity onset 
(Barker-Haliski et al., 2015).  
The approach was used in the current study is similar to the first strategy 
mentioned above - early post-insult treatment to modify the disease i.e. insult 
modification.  
Aim: To test the effect of TRPM7 channel inhibition on epileptogenesis 
following PPS induced SE. 
Hypothesis: Blocking TRPM7 channel after initial insult, i.e. SE prevents 
neuronal cell loss. Cell death by itself or by triggering downstream mechanisms 
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can contribute to the development of epilepsy. Therefore, rescuing 
hippocampal damage would prevent epileptogenesis. 
2. Methods	  
A wireless EEG transmitter and a stimulating electrode were implanted in 
animals and then SE was induced after one week (see chapter 2). 24 hour EEG 
recordings for 2 month was analysed in epileptic control (n=6) vs. epileptic 
treated (carvacrol 75 mg/kg i.p.) animals (n=7). The same carvacrol treatment 
protocol was used as mentioned in the previous chapter (see chapter 4). 
Coastline length analysis was used initially to analyse seizure frequency. An 
event detection library was then created for comprehensive seizure analysis.  
In general, definitions of a seizure are not completely satisfactory from both a 
research and clinical perspective and amendments are needed. Moreover, as 
suggested separate definitions rather than one unique would be more realistic 
(Walker and Kovac, 2015). In the current study, I used a conservative approach 
to define a seizure. Short duration, possible seizures (<15 s), that had low 
frequency and low amplitude (see Figure 5.2B) were challenging sometimes to 
distinguish from some non-seizure events, such as runs of spikes or certain 
artefacts. In order to avoid a bias and enable accurate comparison such short 
and unclear seizures were not included. Therefore the following criteria were 
used to count seizures: events that show clear evolution over time of frequency 
and amplitude and that lasted over 20 s (see Figure 5.2A).  
Shapiro-Wilk and Anderson Darling tests were carried out to check for 
Gaussian distribution. 
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3. Results	  
3.1 Coastline	  analysis	  results	  	  
I initially examined coastline length, which is a measure of absolute difference 
in voltage between consecutive data points, and which is increased during 
seizure activity. However, along with seizures, a high amount of muscle activity 
such as eating artefacts as well as high frequency events and noise also 
increased coastline length. Eating artefact was a major problem in many 
recordings as this was present throughout some recordings and occurred in 
clusters and if a seizure occurs amongst these events it was impossible to 
distinguish them using this measure. High frequency oscillations and noise 
occurred as discrete events. In all these non-seizure events, the coastline 
increased and the pattern was indistinguishable from seizure activity. This 
suggested coastline length analysis as a non-specific and unreliable tool to 
analyse seizure frequency.Therefore, for accurate and comprehensive analysis 
of seizures, an event detection library was developed.  
3.2 Event	  detection	  library	  	  
An Event Classifier uses an Event detection library to detect events of interest. 
I created an Event detection library to identify seizures in PPS model.  The 
classifier detected 1 sec epochs of a seizure. Sometimes throughout one 
seizure multiple epochs were identified (see Figure 5.1) or in some occasions 
only one point in a seizure was detected. The main problem arose when 
animals exhibited interictal events throughout; these are short events that 
resembled a fragment of a seizure.  
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Figure 5.1.Neuroarchiver outputs of seizure fragments identified by the Event 
detection library.  
(A) A baseline trace recorded before start of the seizure (1 second) (B) a seizure detected by the 
library in multiple locations (32 second), several examples of which are shown a, b, c and d 
areas (C) expanded 1 second epochs of the seizure (B) detected at various points  
a b 
c d 
a b c d 
A B 
C 
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Figure 5.2. EEG seizure examples 
 (A) Examples of ‘long’ definite seizures that were used as criteria for determining seizure 
frequency. (B) – examples of ‘short’ probable seizure activities, that were not included in analysis 
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Because the library detected only 1 sec epochs it could not distinguish between 
an interictal event and a seizure fragment. False positives occasionally would 
also occur, such as non-specific activities, for example runs of spikes, or high 
amplitude baseline, but these were rare.  
In contrast to coastline length analysis, event detection library perfectly 
distinguished between non seizure events such as eating artifact, high 
frequency oscillation and noise from seizures; these were not detected as a 
seizure. All seizures were checked visually; hence this was a semi-automatic 
tool. In total 1440 hours EEG recording in each animal (n=13) was analysed 
using Event detection library followed by visual analysis. 
3.3 TRPM7	  channel	  inhibition	  by	  carvacrol	  
prevents	  the	  development	  of	  recurrent	  status	  
epilepticus	  	  
The next day following induction of SE some animals developed prolonged 
seizures, recurrent SE (see Figure 5.3). Therefore, I first analysed if blocking 
TRPM7 channel by carvacrol affected SE rate, i.e. if recurrent SE rate was 
different in epileptic compared to epileptic treated animals. In addition to 13 
animals’ with long-term EEG recordings, two animals that had only one week 
recordings (due to problems with the transmitter battery) were also included in 
the analysis. SE was defined as prolonged seizures lasting over 30 minute, 
with a spike frequency of 3 Hz or higher, or recurrent seizures occurring with an 
interval of less than two minutes between them. Some animals exhibited 
cyclical pattern of SE (see Figure 5.3B). Six out of seven epileptic animals 
(~85%) had recurrent SE following initial induced SE whereas only 2 in 8 
epileptic animals treated with carvacrol (25%) developed recurrent SE (see 
Figure 5.4). This difference was statistically significant (p=0.04, Fisher exact 
test) suggesting that blocking TRPM7 channel protected against recurrent SE. 
Analyzing the duration of SE, i.e. to determine when exactly SE stops is  
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Figure 5.3 Examples traces of status epilepticus. 
  (A) top trace show a ~30 min interval of status epilepticus, middle and bottom traces are 
zoomed fragments of the top trace showing three consecutive seizures and a single seizure 
trace respectively. (B) a ~22 min fragment of SE that has cyclical pattern.  
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Figure 5.4. Recurrent SE. 
 (A) – Bar charts show frequency of recurrent SE in each animal group, SPSS output for 
contingency table. Six out of seven epileptic animals developed recurrent SE and only one 
animal did not have recurrent SE, whereas in epileptic animals treated with carvacrol only two 
out of eight animals developed recurrent SE and six animals did not, p=0.04 (Fisher exact test). 
(B) - pie chart illustrates proportion of recurrent SE in epileptic (85.71%) versus (C) epileptic 
animals treated with carvacrol (25%). 
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challenging although an approximate estimate of SE duration was possible to 
determine: some animals had continued SE lasting up to 10-12 hours. 
3.4 Inhibiting	  TRPM7	  channel	  by	  carvacrol	  
prevents	  early	  seizures	  
Seizure frequency was quantified per week for each animal group after one 
week following induced SE. I did not quantify the first week because some 
animals continued to have SE in the first week. Some animals had SE, whereas 
others only single seizures following induced SE, yet others had both SE and 
then recurrent seizures. Therefore, it would be difficult to compare SE against 
short single seizures. Also after prolonged SE, some of which continued up to 
10 hours, animals would have a period of recovery.  
Animals developed spontaneous seizures almost immediately after initial SE.  
In the following day after induced SE, animals had single seizures and 
recurrent SE. Analysis of seizure per day revealed that epileptic animals had 1-
2 seizure per day occasionally clustering up to 4-6 seizures per day (see 
Figure 5.5). The maximum number of seizures animals had per day was 7. 
The number of seizures was highest in the second week in epileptic animals 
(see Figure 5.5 and Figure 5.6). Following this peak seizure frequency 
abruptly declined in the third week. Epileptic treated animals in contrast had the 
lowest seizure frequency in the second week following SE induction. Similarly, 
treated animals had 1-2 seizure per day, with highest seizure count reaching 7 
seizures a day in one animal.  
To compare seizure frequency per week during seven weeks in the two groups 
a generalized linear model (with a poisson probability distribution, week as a 
within-subject effect and treatment as the between-subject factor) was applied 
(this test was performed with help from my supervisor, Professor Matthew 
Walker). 
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Figure 5.5. Seizure counts in each animal per day.  
Number of seizures in epileptic (A) and treated (B) animals shown separately. Each symbol 
represents number of seizure in an individual animal in a given day. X axis shows days from the 
induction of SE: seizure counts starts from day 7 (week 2). Red and grey dashed rectangles 
indicate the areas with significant difference in seizure number in epileptic control and epileptic 
treated animals respectively  
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Figure 5.6. Box plots show seizure count per week in two groups of animals, epileptic 
and treated.  
Median, 25th and 75th interquartile ranges (IQR), minimum and maximum data values are 
shown. There was significant difference in seizure count between epileptic control (n=6) and 
epileptic treated (n=7) groups in the second week following status epilepticus. * p=0.015 
(generalized linear model, post-hoc Mann-Whitney test). One outlier in the week two in epileptic 
animals not shown in the graph, at point 21.  
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The test result revealed that overall there were no significant difference 
between epileptic and epileptic treated groups [Wald-Chi Square 1.77, DF (1), p 
= 0.18). However, the interaction of treatment with week was significant [Wald-
Chi Square 37.8, DF (6), p < 0.001]. This indicates that there is a different 
effect of treatment depending on week. With a post-hoc Mann-Whitney test, 
only the second week treatment effect was significantly different p = 0.015 
between epileptic (median=5) and treated groups (median=0) (see Figure 
5.6).This effect was not sustained in the subsequent weeks i.e. no significant 
difference between the groups in seizure frequency was seen afterwards.  
3.5 Seizure	  duration	  	  
Duration of a seizure was counted from the start of an abrupt change in 
baseline power and until the end when the frequency of spiking was less than 3 
Hz. Afterdischarges following seizures were not included. Mean seizure 
duration was 61±5.2 seconds in epileptic animals versus 51±3.1 seconds in 
epileptic treated animals. Seizure duration varied from ~30 second to ~100 
second across all animals analysed. Seizure duration was measured starting 
from week two, due to recurrent SE that occurred in animals in the first week. 
As mentioned above, duration of SE is difficult to determine precisely and also 
difficult to compare with single short seizures.   
To compare difference in seizure duration per week between epileptic-control 
and epileptic-treated animals two-way ANOVA test was used. There were no 
significant change in seizure duration over time (between weeks) [F(6,41)=1.5, 
p=0.2) and no significant difference in seizure duration between epileptic-
control and epileptic-treated animals [F(1,41)=3.4, p=0.07), and interaction of 
week and treatment group was not significant [F(6,41)=0.5, p=0.8) (see  Figure 
5.7). 
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Figure 5.7. Seizure duration.  
Seizure duration per week (mean ±SEM) in epileptic and epileptic treated group over during 7 
weeks is illustrated as bar charts. Seizure duration was measure started form second week after 
SE induction. There was no difference in seizure duration over time, as well as between epileptic 
and treated animal groups, and interaction of time and treatment (p0.05, two-way ANOVA).  
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4. Discussion	  	  
Coastline analysis proved to be a non-specific method for seizure analysis. It 
detected any event that causes increase in coastline length such as various 
artifacts from muscle movements, high frequency events, as well as noise. 
Event detection library could differentiate between those non-seizure events 
and seizures and reliably detected all seizures. The library had relatively low 
specificity and interictal events were detected as a seizure in 1 second epochs. 
However, such automatic detection of seizures by the Event detection library 
followed by visual checking of each identified epoch provided a robust means 
of seizure analysis. 
The development of spontaneous seizures in PPS model was observed within 
few days following SE induction (Bumanglag and Sloviter, 2008). The 
conventional view suggests that from initial insult until development of clinical 
epilepsy there is a ‘latent’ period during which a number of structural, molecular 
and functional changes occur. However, recent animal and human studies 
suggest that processes leading to epilepsy-epileptogenesis start immediately 
after an insult. Moreover, subclinical epilepsy can also occur immediately 
following brain injury suggesting there is no notable ‘latent’ phase (Löscher et 
al., 2015). I here observed the development of spontaneous seizures 
immediately after SE, i.e. the following day after SE induction, which is 
consistent with the lack of a clear latent period in some epilepsy models.  
Recurrent early SE occurred in animals during the first 24 hour following SE 
induction. Inhibiting TRPM7 channels by carvacrol prevented the development 
of recurrent status epilepticus and early spontaneous seizures in the second 
week following SE induction. Thus, seizure severity was prevented by blocking 
TRPM7 channel during the first two weeks following the initial damage; 
recurrent SE in the first week and frequency of spontaneous seizures in the 
second week were prevented. Moreover, blocking TRPM7 channels prevented 
both generation of seizures (in the second week) and maintenance of sustained 
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neuronal discharges. Although animals in both epileptic-control and epileptic-
treated groups developed seizures in the following day after SE, only a small 
proportion of animals in treated group (25%) developed recurrent SE as 
compared to ~85 % in epileptic untreated group. This suggests that blocking 
TRPM7 channel by carvacrol during the first 24 hour time interval following 
induced SE reduced or prevented depolarization of neurons and hence 
excessive neuronal firing which prevented the occurrence of early recurrent SE. 
However, it is unclear what mechanisms are involved in the prevention of 
seizures after one week following initial suppression of TRPM7 channels in 
treated animals.  
Nevertheless, inhibiting TRPM7 channels post insult did not have an effect on 
later - chronic seizures; there was no significant difference in seizure numbers 
after two weeks between treated and control groups. Thus, preventing recurrent 
SE and early seizures was sufficient to prevent cell damage but not to prevent 
development of epilepsy. This supports some early studies suggesting 
neuroprotection does not always stop the disease development in epilepsy. 
The relationship between cell loss and development of epilepsy is complex and 
not well understood yet. Studies reported selective loss of GABA-ergic 
interneurons and formation of excitatory circuits after death of principal neurons 
enhance excitability, contributing to epileptogenesis (Ben-Ari and Dudek, 
2010). However, neuroprotective treatment did not prevent development of 
epilepsy in previous studies. In a kainic acid model it was shown that 
preventing cell death in rats by blocking NMDA receptors did not stop 
development of epilepsy (Brandt et al., 2003). In a study of a COX2 knock out 
mouse, status epilepticus resulted in less severe cell damage but no change in 
behavioural and EEG seizures (Serrano et al., 2011). Similarly, some of the 
AEDs have shown neuroprotection in epilepsy but they did not have disease 
modifying effects (Acharya et al., 2008). Maybe markers other than cell death 
can be used in the future to predict the development of epilepsy or the extent of 
brain damage and receptor/synaptic modification.   
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The current research indicates that different mechanisms are involved in the 
generation of early and late seizures following status epilepticus. Mechanisms 
that trigger early seizures are linked to neuronal depolarization and excessive 
neuronal discharge, whereas later seizures are the consequence of synaptic 
modification in the brain. Possibly processes that can trigger epileptogenesis 
begin to occur during two hour of perforant path stimulation and involves 
mechanisms other than neuronal loss. Since blocking TRPM7 channel prevents 
cell damage and loss, then other factors such as synaptic modification are 
driving the development of epilepsy. Moreover, some damage in the hilus still 
occurred in treated animals that can potentially lead to reduction of inhibitory 
neurons. Furthermore, in 2 hour perforant path stimulation model with high 
frequency stimulation (20 Hz) in awake animals, that was used in the current 
study, extrahippocampal brain structures can also be damaged that could 
potentially be also involved in the development of epilepsy (Sloviter, 1983). 
However, the role of damage to these structures in the development of TLE is 
not clear. 
I defined a criteria and cut-off to count only long and definite seizures, and not 
to include short seizures (< 15 s) that also do not show clear evolution of 
amplitude and frequency.  One of the problems with setting such a cut-off for 
the seizure count could be that seizures may become shorter in the treatment 
group. However, in such case overall duration of counted seizures would have 
been shorter in the treated animals but there was no significant difference 
between groups in seizure duration.   
In the current study only short term treatment during first 24 hour following 
induced SE was employed. This approach assesses the effect of intervention 
just after an insult, i.e. insult modification. Chronic treatment during latent 
phase for longer duration, for instance for a week, when cell damage and as a 
result synaptic reorganisation still continues to occur, could possibly have had a 
better antiepileptogenic effect. However, from clinical perspective long term 
treatment during the latent phase could be challenging, because patients not 
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experiencing any problem after an insult would not always agree to be treated 
and would not want to be exposed to potentially harmful side effects of a 
treatment. Moreover, in the PPS model the disease developed almost 
immediately after the insult without a latent phase. Therefore, in PPS continuing 
the treatment in the initial phase of the disease could aid to reverse the disease 
that has already developed. The current study demonstrates that TRPM7 
channel can further be investigated as a potential target to be tested for 
treatment during chronic disease, and may have effect later into disease.  
The disease prevention could also be dependent on seizure severity and 
frequency during perforant path stimulation and afterwards, depending which 
parts of the hippocampus and other brain regions are recruited and this can 
vary substantially. Bigger variety from animal to animal may require a much 
larger sample size to assess the true effect. In addition, we only monitored 
seizures for 2 month therefore it is difficult to say whether in those animals with 
rescued cell damage seizures would discontinue or seizure frequency would 
substantially decrease later or not. On the other hand, it is not clear for how 
long after treatment individuals need to be evaluated, to conclude that there is 
or is not a disease modifying effect. Evaluation of true antiepileptogenic effect 
can require much longer time and a more thorough analysis. It is difficult to say 
when is the appropriate time to stop observation. Moreover, another issue in 
disease modification is that treatment needs to be administered as a 
prophylaxis; not all patients will go on to develop disease after insult, this figure 
is less than 50%. Instead, biomarkers such as cognitive decline and 
neurodegeneration have been proposed as a good alternative (Barker-Haliski 
et al., 2015). 
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5. Summary	  of	  the	  chapter	  	  
8-9 week old SD rats were implanted wireless EEG transmitter followed by 
were perforant path stimulation after one week to induced SE. EEG was 
recorded for 2 month. Based on EEG, animals developed spontaneous 
seizures almost immediately following initial SE. Some animals developed 
recurrent early SE and this was prevented by blocking TRPM7 channel with 
carvacrol. Moreover, early seizures, in the second week after initial damage 
were prevented by inhibiting TRPM7 channels. However, later seizures, i.e. 
development of epilepsy was not prevented by carvacrol. There was no 
difference in seizure frequency after 2 weeks and in seizure duration overall 
between epileptic-control and epileptic-treated animals.  
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Chapter 6. Cognitive decline 
in epilepsy: the role of 
TRPM7 channels 
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1. Introduction	  
Cognitive decline is one of the major comorbidities affecting patients’ quality of 
life in TLE, in particular in MTLE, where hippocampal sclerosis is the hallmark 
of the disease. Hippocampus has a central role in variety types of memory 
function. Hippocampus and medial temporal lobes are the principal locations 
responsible for spatial memory (Burgess et al., 2002). Loss of visual spatial 
memory has been described in MTLE (Lv et al., 2014; Pereira et al., 2010). 
Moreover, patients with TLE who underwent selective 
amygdalohippocampectomy showed impaired spatial memory in virtual Morris 
water maze task (Astur et al., 2002; Barkas et al., 2010). Spatial memory 
impairment has also been shown in pilocarpine and PPS animal models 
(Kalemenev et al., 2015; Chauvière et al., 2009; Kelsey et al., 2000). Cell loss 
in hippocampus is associated with cognitive dysfunction in various neurological 
disorders including epilepsy. Correlation of memory dysfunction with cell loss in 
CA1, CA3 and CA4, DG has been shown in specimens obtained from patients 
who underwent TLE surgery (Pauli et al., 2006). Cell death in CA1 in particular 
was linked to cognitive and memory impairment (Sun et al., 2009). 
In previous chapters I showed that Inhibiting TRPM7 channels by carvacrol 
prevented recurrent status epilepticus and early seizures following initial 
damage (SE). As a consequence carvacrol prevented cell loss in the hilar and 
CA1 region of the hippocampus. One of the goals in disease modification in 
epilepsy is to identify drugs that can prevent or improve comorbidities 
associated with epilepsy, amongst which cognitive decline is one of the most 
important. Therefore, the final question was whether rescuing neuronal cell 
death, preventing recurrent SE and early seizures by blocking TRPM7 channels 
will improve cognitive function in animals treated with carvacrol after SE. 
Blocking TRPM7 channel and as a result prevention of cell damage in CA1 
region in a stroke model prevented spatial-navigational memory deficit in rats 
(Sun et al., 2009).  
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Aim: To assess effect of blocking TRPM7 channel on memory dysfunction in 
animals following SE induced chronic epilepsy 
Hypothesis: Cell death in the hippocampus is linked to memory impairment. 
Blocking TRPM7 channel with carvacrol prevents cell damage in hilar and CA1 
region of the hippocampus. Therefore, rescuing cell death would prevent 
memory impairment in animals treated with TRPM7 antagonist, carvacrol. 
2. Methods	  
Cognitive function was assessed in epileptic (n=5), epileptic-treated (75 mg/kg 
carvacrol) (n=6) and in control animals (n=6). The same PPS and carvacrol 
treatment protocol as for previous experiments (see chapter 2 and 4) was used, 
except EEG was not recorded. In addition, animals kept for longer time before 
assessing for a cognitive dysfunction (3-4 month) following SE induction. The 
longer time was speculated to allow for the damage to influence the cognitive 
function. I was blinded to the treatment groups. Alternating reward T-maze test 
was used. T-maze training steps are described in the general methods section 
(see chapter 2). The diagram below (see Figure 6.1) shows steps of the main 
test. During the main test animals initially were given 5 sec delay and then 60 s 
delay before making choice after the first run in the T-maze. One animal in the 
epileptic group that was not possible to train, was very aggressive and not 
moving in the T-maze was excluded.  
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Figure 6.1. Delayed alteration reward T-maze steps in (A) right and (B) left correct 
choice arm. 
 In step ‘forced choice’ the choice arm is blocked and both arms baited with reward pellets, 
one in sample arm and 2 pellets in the correct choice arm. After entering the sample arm 
animal eats a pellet, then animals returned back to start arm (not facing T junction) which 
will be blocked to introduce 5/60 s ‘delay’, and the block to enter choice arm will be 
removed. Then in step ‘free choice’ animal choose which arm to enter. Rats typically 
alternate location – correct arm. If they enter the same side this is incorrect choice. 
Left/Right (R/L) arm sequences during experiments were randomised so that all rats receive 
the same number of both left and right arm. 
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3. Results	  
3.1 Habituation	  and	  training	  
Epileptic animals tend to exhibit aggressive behavior (‘jumpy’) frequently during 
the training and the main test: they were difficult to handle initially and would 
frequently jump out of the cage and sometimes t-maze. However, such 
behavior was observed very rarely in the control and treated groups. However, 
all groups of animals spent similar time to reach goal arm and the time required 
to fully habituate animals was similar in all groups. Habitation, i.e. to train 
animals to run freely run in the t-maze and eat several reward pellets in both 
goal arms was achieved in one week. Animals were anxious initially and 
reluctant to eat pellets in the t-maze in the first 4-5 days. Once they consumed 
at least 1 pellet they could continue each time consume more and were less 
hesitant with each trial. This was important step to initiate stepwise training. 
Initial stepwise training and the main training required 7-8 days. After a 
successful training, i.e. each animal eat 5-6 pellets in both arms and move 
towards the goal arm quickly and without hesitation the main training was 
initiated. During trainings after several trials animals would fall asleep and be 
lazy, and thus they would not move in the T-maze. Therefore, after 3-4 trials 
animals were taken back to their room, either to continue later in the day or the 
following day. Occasionally rats would not move in the t-maze, and stayed 
motionless during the trial. If this happened after 2-3 minute animal was 
returned back to the cage to try later.  
3.2 	  The	  main	  test	  	  
During the main test when all four limbs of the animal were on a goal arm this 
was considered a choice arm. Sometimes animals turn head to both sides 
before making a choice. Occasionally animals had seizures during the training 
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as well as the main test. If a seizure occurred in the start arm or at the T-
junction before making a choice, the animal was returned back to the home 
cage and left for about 20-30 minutes to recover before starting the next trial. 
This would allow sufficient time to recover from post ictal confusion and 
lethargy. Animals are more aggressive (‘jumpy’) postictally for a while. If a 
seizure occurred after animal entered a choice arm that trial would be counted 
however animal again would rest 20-30 min before the next trial.  
Animals were initially tested with 5 second delay then with 60 second delay, no 
significant difference was observed between these trials. Total percentages of 
correct choice for all trials per animals were calculated (18 trials for each 
animal). To compare difference of correct arm choice between the three groups 
of animals one way ANOVA was used. There was significant difference 
between the three groups in the percentage of correct arm choice [F (2,14) = 
9.7; p=0.002] (see Figure 6.2).  
 
Table 6.1. Summary of correct arm choice (%) in reward alternation T- maze   
test  
Groups  Mean ± SD     
(%) 
    SEM 95% 
Confidence   
Interval 
Control 95.3±3.9 1.6	   91.2	  -­‐99.5 
Epileptic  63.4±14.5 6.5	   45.4	  -­‐81.4 
Epileptic + Carv 86.5±15.3 6.2	   70.4	  -­‐100 
             SD- standard deviation, SEM- standard error of mean, Carv - carvacrol 
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Figure 6.2. Bar charts illustrate correct arm choice percentage 
 in control (n=6), epileptic (n=5), and epileptic animals treated with carvacrol (n=6). The 
correct arm choice in epileptic animals significantly lower compared to  control (healthy) 
animals and epileptic –treated animals, **p=0.002 and *p=0.02 respectively. No significant 
difference between control and epeileptic-treated animas in the percent of correct arm 
choice, p=0.44. 
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The mean percentage of correct arm choice in the T-maze was 95.3±3.9% in 
control animals versus 63.4±14.5 % in epileptic animals (see Table 6.1). This 
difference was statistically significant (post hoc Tukey’s test, p=0.002) 
suggesting that spatial memory was impaired in epileptic animals. Whereas 
animals treated by carvacrol performed 86.5±15.3 % correct which was 
significantly higher compared to epileptic animals (post hoc Tukey’s test 
p=0.02) and not significantly different from control animals (post hoc Tukey’s 
test p=0.44) suggesting that carvacrol was able to prevent status epilepticus 
and seizure induced memory dysfunction.   
4. Discussion	  	  
Alternating T-maze test is a measure of working spatial memory function. The 
terms working and short-term memory have been used interchangeably and 
are not very distinct. Short-term memory has been defined as a limited amount 
of information that can be stored temporarily in an assessable way. In contrast 
to long-term memory this type of memory has limited capacity and decays in 
time. Whereas working memory is referred to the short-term memory that in 
addition includes other mechanisms that are necessary to plan and conduct 
certain tasks. Tests measuring working memory have been shown better 
associated with intellectual capacity than tests for a short-term memory 
(Cowan, 2008). Rats have remarkable ability to alternate spatial location, this 
can be spontaneous or by using reinforcement. For alternation rats use short-
term memory, so that they remember which part of the maze they entered first 
(Dudchenko, 2004).  
Here I observed substantial impairment of spatial working memory in epileptic 
rats in delayed T-maze alternating test. Following 3-4 months from the 
development of chronic epilepsy animals had substantial impairment of spatial 
memory.  However, it is not clear how this time interval in animals can be 
compared with cognitive impairment in human epilepsy. Memory impairment in 
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PPS model of TLE is substantial. Epileptic animals made ~63 % correct arm 
choice (almost down to chance) compared to ~95% in control animals. This is 
consistent with the observation that in rats hippocampal damage leads to 
selective spatial memory deficit (O’Keefe and Burgess, 1996). ‘Place cells’ 
located in CA1/CA3 regions of the hippocampus encode the rat's location within 
an open environment and have an important role in spatial memory; in freely 
moving rats place cells respond whenever a rats enter a specific portion of its 
environment independent of rats orientation (Burgess et al., 2002).  Damage to 
place cells in CA1 region could be responsible for the impairment of spatial 
memory in the current study. Inhibiting TRPM7 channel by carvacrol 
significantly improved memory function. This suggests that preventing cell 
damage in CA1 and hilus had robust effect to prevent memory impairment in 
PPS model. In previous chapters I showed that cell loss in CA1 region was 
completely rescued by blocking TRPM7 channel after SE. The CA1 region is 
particularly important in spatial memory function. Prevention of this region from 
damage in treated animals could explain preserved memory function. 
Involvement of CA1/CA3 regions in memory is well known. Selective 
impairment of spatial memory was observed in CA1 NMDA receptor 
knockdown mice (Tsien et al., 1996). In addition, the role of hilar GABAergic 
interneurons in spatial memory and learning have been demonstrated in Morris 
water maze test (Andrews-Zwilling et al., 2012). These findings highlight the 
importance of hippocampal pyramidal and as well as inhibitory neurons in the 
spatial memory.  
Along with disease modification e.g. preventing development of epilepsy, a 
comorbidity modification is another important goal in epilepsy. In fact, often 
patients describe comorbidities being more troublesome and affecting quality of 
life more than seizures themselves (Barker-Haliski et al., 2015). Therefore, this 
highlights the important role of TRPM7 channels as a target for cognitive 
comorbidity modification in epilepsy. This is worthy of further studied for 
consideration of translation into clinical trials.  
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5. Summary	  of	  the	  chapter	  	  
Three to four month following PPS induced chronic epilepsy animals were 
assessed for memory impairment using delayed reward alternation T-maze 
test. Performance on T-maze was compared in three groups of animals: 
healthy controls, epileptic and epileptic animals treated with TRPM7 channel 
blocker, carvacrol. Epileptic animals had significant spatial memory impairment 
compared to control animals suggesting substantial memory deficit in PPS 
model. Whereas animal treated with carvacrol had significantly improved short 
term memory function compared to epileptic animals suggesting protective role 
of blocking TRPM7 channel against cognitive impairment in chronic epilepsy. 
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Chapter 7. General discussion 
 
1. Summary	  of	  in	  vitro	  findings	  
The current study provides evidence that stress activated TRPM7 channels are 
involved in seizure generation in epilepsy and blocking these channels stops 
seizure activity in vitro. Activation of TRPM7 channels can be the consequence 
of molecular alterations that occur during seizure activity such as electrolyte 
disturbance (low intracellular Mg2+ and extracellular Ca2+, decreased pH) or 
increased ROS production (Kozak and Cahalan, 2003; Monteilh-Zoller et al., 
2003; Jiang et al. 2005; Lipski et al. 2006). These conditions promote TRPM7 
channel activation, and Na+ and Ca2+ entering cells through the channel can 
exacerbate seizure activity. It has been shown that in acidic conditions the 
inward rectification in TRPM7 channels is much greater than under 
physiological conditions (Jiang et al., 2005). Prominent intracellular acidification 
occurs with seizure activity (Xiong et al., 2000), suggesting that there may be a 
positive feedback whereby acidification due to seizure activity contributes to 
TRPM7 channel opening which in turn further promotes seizure activity.  
The following hypotheses were tested in in vitro studies: Hypothesis 1. TRPM7 
current will increase during low Mg2+ induced seizure activity and blocking 
TRPM7 channel by antagonists added to the extracellular medium would 
decrease or abolish in vitro epileptiform activity by reducing influx of cations, 
such as Na+ and Ca2+ to cells and thus decrease cell depolarisation; 
Hypothesis 2. TRPM7 channels will also be activated during seizure activity 
induced in physiological Mg2+ concentrations, under the influence of other 
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mechanism that open the channel and occur during seizure activity, such as 
decreased low extracellular Ca2+, low pH and ROS formation. The two models 
of seizure that were used in the current study relied on different mechanisms to 
induce seizure activity; increasing excitability of cells by decreasing Mg2+ 
concentrations in the perfusion solution and via blocking inhibitory pathways by 
a GABAA receptor antagonist. Here, I showed that TRPM7 channels are 
involved in seizure generation in both conditions. Carvacrol, a non-selective 
blocker of TRPM7 channel completely abolished in vitro seizure activity within 
10 min of administration in both seizure models. Similarly, Waxiencin A, a 
potentially selective TRPM7 blocker significantly decreased seizure-like activity 
within 5 min of addition to the perfusion solution and completely blocked the 
activity by 20 min in both seizure models. PTZ and low Mg2+ generated distinct 
type of seizure-like activity, low Mg2+ mainly ictal-like whereas PTZ principally 
interictal-like seizure activity. This enabled me to test the effect of TRPM7 
blockers on both types of epileptiform discharges; inhibiting TRPM7 channel 
abolished both ictal-like and interictal-like activity.  Hyothesis 3. A study 
published by Joca et al. suggested that carvacrol inhibited peripheral sodium 
channels (Joca et al., 2012). Therefore, to determine whether carvacrol has 
relevant effects on sodium channels that would reduce it’s potential to be used 
as a specific inhibitor of TRPM7 channels I tested the effect of carvacrol on 
fEPSP. In contrast to the previous study, carvacrol did not affect slope of fibre 
volley and interestingly increased the slope of fEPSP, suggesting no inhibition 
of sodium channels in the hippocampus occurred. This could possibly be 
explained by different variants of sodium channels in peripheral nerves and 
CNS.	  
2. Summary	  of	  in	  vivo	  findings	  
The following hypotheses were tested in in vivo studies: Hypothesis 1. TRPM7 
channel activation during excessive neuronal firing will contribute to cell 
depolarisation, and Ca2+ entry via the channel can trigger a cascade of 
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processes contributing to cell toxicity and death. Moreover, Zn2+ as well as 
other trace metals entering the cells in stress conditions via TRPM7 channel 
can play a role in cell death (Montell, 2005; Nadler et al., 2001). Influx of Ca2+ 
via TRPM7 channel can further increase ROS production and then trigger 
downstream mechanisms that may also contribute to cell death. Activation of 
TRPM7 may therefore contribute to neuronal death after a brain insult. 
Therefore, blocking TRPM7 channel would prevent or reduce excitotoxicity 
induced cell damage in vulnerable areas of the hippocampus. TRPM7 inhibition 
in hippocampal CA1 area has been shown to prevent cell death after ischemia 
in animal studies (Chen et al., 2015; Yu et al., 2012; Sun et al., 2009). Here I 
showed that blocking TRPM7 channel completely prevented cell damage in 
CA1 area and significantly reduced cell loss in hilar region. This effect was 
achieved only by short time treatment with carvacrol after SE (24 hours). This 
suggests a strong potential of TRPM7 channel inhibition in preventing 
excitotoxicity induced neuronal cell death. Possibly synergy between opening 
of NMDA receptors and TRPM7 channels are responsible for cell damage 
mechanisms post SE initially. However, TRPM7 channels are principally 
responsible for sustaining the processes leading to neuronal cell loss (Nicotera 
and Bano, 2003).   
CA1 and hilus are the most commonly affected areas in hippocampal sclerosis 
in animal models as well as in humans: both principal neuron and interneuron 
degeneration have been described. In the current study I did not investigate for 
cell type specific cell loss, this was out of scope of the study. However, loss of 
various type of neurons were suggested by others, and pattern of cell loss 
varies among species and epilepsy models (Houser, 2014). Although certain 
patterns of cell loss has been described it is not clear if those cell types are 
particularly vulnerable or corresponding to overall cell loss (Matthew et al., 
2006). Loss of excitatory mossy cells and various interneurons types in hilar 
region was reported (Schwarcz and Witter, 2002). Although both parvalbumin 
and somatostatin cell loss has been described in hippocampal sclerosis the 
loss of somatisation expressing interneurons in hilar and CA1 region is more 
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prominent and has been most common finding in animal models and human 
epilepsy. Somatostatin neurons in these regions provide inhibitory innervation of 
granule cell and pyramidal cell dendrites; they control excitability of the principal 
cells directly at the sites of their main excitatory inputs and are therefore implicated 
in epileptogenesis (Houser, 2014).  
Hypothesis 2. Cell death by itself or by triggering downstream mechanisms 
can contribute to the development of epilepsy. Therefore, rescuing 
hippocampal damage may prevent epileptogenesis. Here I showed that 
blocking TRPM7 channel by carvacrol reduced the disease severity in the first 
two weeks following initial damage. Blocking TRPM7 channels inhibited early 
recurrent SE in the first week and early seizures in the second week. However, 
blocking TRPM7 channel in the first 24 hour post insult did not prevent the 
development of late seizures, i.e. chronic epilepsy. I did not analyse short 
seizures; it could be speculated that with carvacrol treatment seizures could 
become shorter and those were not included in analysis. However, in such 
case overall duration of counted seizures would have been shorter in treated 
animals compared to control group but no significant difference was observed 
in seizure duration between treated and control groups. This highlights the 
importance of understanding the relationship between initial neuronal cell 
damage and epileptogenesis. Many studies that reported neuroprotection in 
epilepsy failed to show antiepileptogenic effects (Serrano et al., 2011; Acharya 
et al., 2008; Brandt et al., 2003). Possibly markers other than cell death can be 
used in the future to reliably predict development of epilepsy after an insult.  
Blocking TRPM7 channel in the first 24 hour following SE was sufficient to 
prevent recurrent status epilepticus and related neuronal cell death. It was 
reported that cell death in PPS model mainly occurs in the first 1-2 days after 
initial damage (Gorter et al., 2003). Here I observed recurrent SE the next day 
following perforant path stimulation that would lead to more extensive cell 
damage. This could explain the peak of cell death during this time interval in 
PPS model. The correlation between duration of SE and extent of cell damage 
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has been shown previously (Norwood et al., 2011). This highlights the 
importance of stopping SE early to prevent cell damage and related cognitive 
deficit.  
Hypothesis 3. Cell death in the hippocampus is linked to memory impairment 
in humans as well as in animals (Kalemenev et al., 2015; Lv et al., 2014; 
Pereira et al., 2010; Chauvière et al., 2009; Pauli et al., 2006; Kelsey et al., 
2000). Therefore, I tested if rescuing cell death would prevent memory 
impairment in animals treated with TRPM7 antagonist, carvacrol. The 
association between cell damage and memory deficit is well established, in 
particular spatial memory impairment was linked to cell loss in CA1 area (Sun 
et al., 2009;Tsien et al., 1996). Here I showed significant preservation of 
memory function in animals treated with a TRPM7 channel antagonist. This 
suggests that prevention of cell death in CA1 and hilus rescued memory 
impairment in these animals. 
Although blocking TRPM7 channels did not modify the disease development, 
i.e. development of recurrent spontaneous seizures, this prevented the 
development of cognitive comorbidity associated with epilepsy which is a 
remarkable effect. Cognitive comorbidity is a major challenge in epilepsy that 
hugely affects patients’ quality of life and is not possible to reverse or treat 
(Fisher et al., 2000; Thompson and Corcoran, 1992). Therefore, development 
of therapies that can prevent cognitive impairment is crucial. 
Activation of inflammatory processes in the brain following injury and 
excitotoxicity, and presence of inflammation in the brain during the period prior 
to the development of epilepsy and in chronic epilepsy led to suggestion that 
inflammation can play a role in the development of epilepsy. Although certain 
anti-inflammatory compounds demonstrated anti-seizure effect in animal 
models, the role of such immunosuppressive treatment in the prevention of 
epileptogenesis is unclear (Vezzani et al., 2013). While anti-inflammatory 
treatment can have anti-seizure effect in chronic epilepsy, there is a concern 
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about harmful effect of long term immunosuppression use. TRPM channel 
subfamily, including TRPM7 channels have been suggested to play a role in 
inflammatory processes, in innate and adaptive immunity. TRPM7 channels 
modulate the entry of Ca2+ during receptor stimulation and other Ca2+-
dependent cellular functions and being one of the main routes for the entry of 
divalent cations into immune cells can act as immunomodulator (Massullo et 
al., 2006). Blocking TRPM7 channel could therefore be potent alternative anti-
inflammatory target in the treatment of epilepsy.  
The main limitation of this study is that carvacrol, a non-specific blocker of 
TRPM7 channel was used for in vivo experiments. Carvacrol was chosen as 
relatively more specific antagonist of TRPM7 channel that has a simple 
structure and is a safe compound to use in vivo. Waixenicin A which we only 
could obtain recently and only in small quantities could possibly be a good 
alternative. Waixenicin A has not been yet tested for in vivo use whereas 
carvacrol has been used extensively for in vivo research.  
3. Future	  perspectives	  
Cell death prevention by blocking TRPM7 channel as well as prevention of 
cognitive impairment in epilepsy can be transferred in the future into clinical 
trials. Concurrent use of TRPM7 channel and NMDA receptors blockers can 
also be tested for better neuroprotection and possibly prevention of the disease 
development after an insult. Agents to block TRPM7 channel can be tested in 
the future for use after clinical refractory SE to prevent potential cell damage. 
Possibly longer treatment period with TRPM7 channel blockers after an insult 
or even when the disease has developed can decrease the disease severity or 
provide better seizure control. Third of patients with epilepsy and even higher 
proportion in TLE do not respond to currently available AEDs, this can offer a 
new and possibly more effective symptomatic treatment. Blocking TRPM7 
channel can offer a novel target that acts through a different mechanism. Here 
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blocking the channel prevented prolonged seizures as well as neuronal cell 
loss and hence such target can reduce severity of epilepsy and associated 
neurodegeneration. Moreover, suggested anti-inflammatory effect of blocking 
TRPM7 channels could have additional beneficial effect and increase seizure 
threshold. By acting on multiple pathways such as prevention of inflammation, 
neuronal cell death and seizure generation targeting TRPM7 channel may offer 
not only antiseizure effects but also the possibility of disease modification which 
has not been seen with other AEDs. Moreover, a new target may overcome 
resistance to drugs that act on other targets (e.g. sodium channels). Perhaps 
the best approaches will be those that target multiple mechanisms and 
pathways.  
Carvacrol is a food additive and therefore is a safe compound to be tested in 
clinical research. However, In order to confirm that the effect I have seen here 
is exclusively due to TRPM7 channel inhibition an shRNA study has to be 
conducted in a larger animal cohort. On the other hand, whole cell patching can 
provide better understanding of mechanism of action of carvacrol. Possibly 
Waxiencin A can further be tested for in vivo safety or new compounds 
specifically targeting TRPM7 channel that can also be developed and tested for 
in vivo use.  
Analysing cell death in animals that underwent behavioural experiments could 
provide useful information in respect to correlation between cell death and 
cognitive impairment and seizure frequency. This could identify whether there 
is a correlation between degree of cognitive impairment and cell loss, as well 
as a correlation between cell death and seizure frequency. Moreover, 
investigating cell death in animals 3-4 month following induction of SE (i.e. in 
animals that underwent behavioural experiments) versus 3-4 weeks post SE 
that was analysed in the current study, could provide information on how cell 
degeneration changes over time, whether cell number remains the same, 
increases or decrease. Evidence suggests that in earlier stage cell death can 
be more prominent, thereafter neurogenesis can take place and lost cells can 
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be replaced. However, the process of neurogenesis is aberrant in chronic 
epilepsy and the new cells do not provide adequate function for memory and 
learning (Scharfman and Gray, 2007).   
4. Conclusion	  
The current study, for the first time, provides valuable information about the role 
of stress activated TRPM7 channels in epilepsy. Here I showed that inhibiting 
TRPM7 channel in vitro significantly reduced seizure-like activity in two different 
in vitro seizure models, both that relies on reduced Mg2+ concentration to 
activate TRPM7 channel and the model independent of Mg2+ concentrations. 
First, this indicates that TRPM7 channel are involved in seizure generation. 
Moreover, opening of TRPM7 channel during seizure activity occurs also 
independent of reduced Mg2+ levels suggesting other mechanisms that occur 
during seizure activity can also open TRPM7 channels. In vivo results suggest 
that TRPM7 channel activation contributes to seizure induced cell death and 
cell loss can be prevented by blocking TRPM7 channels. Blocking TRPM7 
channel affected early post damage disease severity, recurrent SE and 
frequency of early seizures were prevented. However, blocking TRPM7 
channels in vivo did not prevent the development of epilepsy, at least in two 
month post initial damage monitoring. Nevertheless, preventing cell death and 
early disease severity was protective against cognitive comorbidity. These 
results indicate that TRPM7 is a good candidate to study further and be 
translated into clinical research. 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 176	  
Chapter 8. References 
 
Aarts, M., Iihara, K., Wei, W.-L., Xiong, Z.-G., Arundine, M., Cerwinski, W., 
MacDonald, J.F., Tymianski, M., 2003. A Key Role for TRPM7 
Channels in Anoxic Neuronal Death. Cell 115, 863–877. 
doi:10.1016/S0092-8674(03)01017-1 
Acharya, M.M., Hattiangady, B., Shetty, A.K., 2008. Progress in 
neuroprotective strategies for preventing epilepsy. Prog. Neurobiol. 84, 
363–404. doi:10.1016/j.pneurobio.2007.10.010 
Agrawal, N., Govender, S., 2011. Epilepsy and neuropsychiatric comorbidities. 
Adv. Psychiatr. Treat. 17, 44–53. doi:10.1192/apt.bp.108.006510 
Amaral, D.G., Scharfman, H.E., Lavenex, P., 2007. The dentate gyrus: 
fundamental neuroanatomical organization (dentate gyrus for 
dummies). Prog. Brain Res. 163, 3–22. doi:10.1016/S0079-
6123(07)63001-5 
Andersen, P., Bliss, T.V., Skrede, K.K., 1971. Lamellar organization of 
hippocampal pathways. Exp. Brain Res. 13, 222–238. 
Andersen, P., Holmqvist, B., Voorhoeve, P.E., 1966. Entorhinal Activation of 
Dentate Granule Cells. Acta Physiol. Scand. 66, 448–460. 
doi:10.1111/j.1748-1716.1966.tb03223.x 
Andrews-Zwilling, Y., Gillespie, A.K., Kravitz, A.V., Nelson, A.B., Devidze, N., 
Lo, I., Yoon, S.Y., Bien-Ly, N., Ring, K., Zwilling, D., Potter, G.B., 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 177	  
Rubenstein, J.L.R., Kreitzer, A.C., Huang, Y., 2012. Hilar GABAergic 
interneuron activity controls spatial learning and memory retrieval. PloS 
One 7, e40555. doi:10.1371/journal.pone.0040555 
Astur, R.S., Taylor, L.B., Mamelak, A.N., Philpott, L., Sutherland, R.J., 2002. 
Humans with hippocampus damage display severe spatial memory 
impairments in a virtual Morris water task. Behav. Brain Res. 132, 77–
84. 
Baaij, J.H.F. de, Hoenderop, J.G.J., Bindels, R.J.M., 2015. Magnesium in Man: 
Implications for Health and Disease. Physiol. Rev. 95, 1–46. 
doi:10.1152/physrev.00012.2014 
Baltan, S., Carmichael, S.T., Matute, C., Xi, G., Zhang, J.H., 2013. White 
Matter Injury in Stroke and CNS Disease. Springer Science & Business 
Media. 
Barkas, L.J., Henderson, J.L., Hamilton, D.A., Redhead, E.S., Gray, W.P., 
2010. Selective temporal resections and spatial memory impairment: 
cue dependent lateralization effects. Behav. Brain Res. 208, 535–544. 
doi:10.1016/j.bbr.2009.12.035 
Barker-Haliski, M.L., Friedman, D., French, J.A., White, H.S., 2015. Disease 
modification in epilepsy: from animal models to clinical applications. 
Drugs 75, 749–767. doi:10.1007/s40265-015-0395-9 
Baxendale, S.A., van Paesschen, W., Thompson, P.J., Connelly, A., Duncan, 
J.S., Harkness, W.F., Shorvon, S.D., 1998. The relationship between 
quantitative MRI and neuropsychological functioning in temporal lobe 
epilepsy. Epilepsia 39, 158–166. 
Ben-Ari, Y., Dudek, F.E., 2010. Primary and secondary mechanisms of 
epileptogenesis in the temporal lobe: there is a before and an after. 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 178	  
Epilepsy Curr. Am. Epilepsy Soc. 10, 118–125. doi:10.1111/j.1535-
7511.2010.01376.x 
Brandt, C., Potschka, H., Löscher, W., Ebert, U., 2003. N-methyl-D-aspartate 
receptor blockade after status epilepticus protects against limbic brain 
damage but not against epilepsy in the kainate model of temporal lobe 
epilepsy. Neuroscience 118, 727–740. 
Briellmann, R.S., Newton, M.R., Wellard, R.M., Jackson, G.D., 2001. 
Hippocampal sclerosis following brief generalized seizures in 
adulthood. Neurology 57, 315–317. doi:10.1212/WNL.57.2.315 
Brito, V.B., Folmer, V., Puntel, G.O., Fachinetto, R., Soares, J.C.M., Zeni, G., 
Nogueira, C.W., Rocha, J.B.T., 2006. Diphenyl diselenide and 2,3-
dimercaptopropanol increase the PTZ-induced chemical seizure and 
mortality in mice. Brain Res. Bull. 68, 414–418. 
doi:10.1016/j.brainresbull.2005.09.007 
Brophy, G.M., Bell, R., Claassen, J., Alldredge, B., Bleck, T.P., Glauser, T., 
LaRoche, S.M., Jr, J.J.R., Shutter, L., Sperling, M.R., Treiman, D.M., 
Vespa, P.M., Committee, N.C.S.S.E.G.W., 2012. Guidelines for the 
Evaluation and Management of Status Epilepticus. Neurocrit. Care 17, 
3–23. doi:10.1007/s12028-012-9695-z 
Bumanglag, A.V., Sloviter, R.S., 2008. Minimal latency to hippocampal 
epileptogenesis and clinical epilepsy after perforant pathway 
stimulation-induced status epilepticus in awake rats. J. Comp. Neurol. 
510, 561–580. doi:10.1002/cne.21801 
Burgess, N., Maguire, E.A., O’Keefe, J., 2002. The Human Hippocampus and 
Spatial and Episodic Memory. Neuron 35, 625–641. 
doi:10.1016/S0896-6273(02)00830-9 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 179	  
Butler, C.R., Zeman, A.Z., 2008. Recent insights into the impairment of memory 
in epilepsy: transient epileptic amnesia, accelerated long-term 
forgetting and remote memory impairment. Brain 131, 2243–2263. 
doi:10.1093/brain/awn127 
Butler, T.R., Self, R.L., Smith, K.J., Sharrett-Field, L.J., Berry, J.N., Littleton, 
J.M., Pauly, J.R., Mulholland, P.J., Prendergast, M.A., 2010. Selective 
vulnerability of hippocampal cornu ammonis 1 pyramidal cells to 
excitotoxic insult is associated with the expression of polyamine-
sensitive N-methyl-D-asparate-type glutamate receptors. Neuroscience 
165, 525–534. doi:10.1016/j.neuroscience.2009.10.018 
Carletti, F., Ferraro, G., Rizzo, V., Cannizzaro, C., Sardo, P., 2013. Antiepileptic 
effect of dimethyl sulfoxide in a rat model of temporal lobe epilepsy. 
Neurosci. Lett. doi:10.1016/j.neulet.2013.04.031 
Chang, P., Hashemi, K.S., Walker, M.C., 2011. A novel telemetry system for 
recording EEG in small animals. J. Neurosci. Methods 201, 106–115. 
doi:10.1016/j.jneumeth.2011.07.018 
Chauvière, L., Rafrafi, N., Thinus-Blanc, C., Bartolomei, F., Esclapez, M., 
Bernard, C., 2009. Early Deficits in Spatial Memory and Theta Rhythm 
in Experimental Temporal Lobe Epilepsy. J. Neurosci. 29, 5402–5410. 
doi:10.1523/JNEUROSCI.4699-08.2009 
Chen, W., Xu, B., Xiao, A., Liu, L., Fang, X., Liu, R., Turlova, E., Barszczyk, A., 
Zhong, X., Sun, C.L.F., Britto, L.R.G., Feng, Z.-P., Sun, H.-S., 2015. 
TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-
ischemic injury. Mol. Brain 8. doi:10.1186/s13041-015-0102-5 
Chen, X., Numata, T., Li, M., Mori, Y., Orser, B.A., Jackson, M.F., Xiong, Z.-G., 
MacDonald, J.F., 2010. The modulation of TRPM7 currents by 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 180	  
nafamostat mesilate depends directly upon extracellular concentrations 
of divalent cations. Mol. Brain 3, 38. doi:10.1186/1756-6606-3-38 
Chokshi, R., Fruasaha, P., Kozak, J.A., 2012. 2-Aminoethyl diphenyl borinate 
(2-APB) inhibits TRPM7 channels through an intracellular acidification 
mechanism. Channels 6. doi:10.4161/chan.21628 
Chubanov, V., Mederos y Schnitzler, M., Wäring, J., Plank, A., Gudermann, T., 
2005. Emerging roles of TRPM6/TRPM7 channel kinase signal 
transduction complexes. Naunyn. Schmiedebergs Arch. Pharmacol. 
371, 334–341. doi:10.1007/s00210-005-1056-4 
Clapham, D.E., Runnels, L.W., Strübing, C., 2001. The TRP ion channel family. 
Nat. Rev. Neurosci. 2, 387–396. doi:10.1038/35077544 
Cook, N.L., Van Den Heuvel, C., Vink, R., 2009. Are the transient receptor 
potential melastatin (TRPM) channels important in magnesium 
homeostasis following traumatic brain injury? Magnes. Res. Off. Organ 
Int. Soc. Dev. Res. Magnes. 22, 225–234. doi:10.1684/mrh.2009.0189 
Cowan, N., 2008. What are the differences between long-term, short-term, and 
working memory? Prog. Brain Res. 169, 323–338. doi:10.1016/S0079-
6123(07)00020-9 
Deacon, R.M.J., Rawlins, J.N.P., 2006. T-maze alternation in the rodent. Nat. 
Protoc. 1, 7–12. doi:10.1038/nprot.2006.2 
Demeuse, P., Penner, R., Fleig, A., 2006. TRPM7 channel is regulated by 
magnesium nucleotides via its kinase domain. J. Gen. Physiol. 127, 
421–434. doi:10.1085/jgp.200509410 
Devinsky, O., 2003. Psychiatric comorbidity in patients with epilepsy: 
implications for diagnosis and treatment. Epilepsy Behav., 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 181	  
Comorbidities of Epilepsy: Special Topics 4, Supplement 4, 2–10. 
doi:10.1016/j.yebeh.2003.10.002 
Dingledine, R., Varvel, N.H., Dudek, F.E., 2014. When and how do seizures kill 
neurons, and is cell death relevant to epileptogenesis? Adv. Exp. Med. 
Biol. 813, 109–122. doi:10.1007/978-94-017-8914-1_9 
Dreier, J.P., Heinemann, U., 1991. Regional and time dependent variations of 
low Mg2+ induced epileptiform activity in rat temporal cortex slices. 
Exp. Brain Res. Exp. Hirnforsch. Expérimentation Cérébrale 87, 581–
596. 
Dreier, J.P., Zhang, C.L., Heinemann, U., 1998. Phenytoin, phenobarbital, and 
midazolam fail to stop status epilepticus-like activity induced by low 
magnesium in rat entorhinal slices, but can prevent its development. 
Acta Neurol. Scand. 98, 154–160. 
Dudchenko, P.A., 2004. An overview of the tasks used to test working memory 
in rodents. Neurosci. Biobehav. Rev. 28, 699–709. 
doi:10.1016/j.neubiorev.2004.09.002 
Elizondo, M.R., Arduini, B.L., Paulsen, J., MacDonald, E.L., Sabel, J.L., Henion, 
P.D., Cornell, R.A., Parichy, D.M., 2005. Defective skeletogenesis with 
kidney stone formation in dwarf zebrafish mutant for trpm7. Curr. Biol. 
CB 15, 667–671. doi:10.1016/j.cub.2005.02.050 
Elliott, B., Joyce, E., Shorvon, S., 2009. Delusions, illusions and hallucinations 
in epilepsy: 2. Complex phenomena and psychosis. Epilepsy Res. 85, 
172–186. doi:10.1016/j.eplepsyres.2009.03.017 
Fisher, R.S., Vickrey, B.G., Gibson, P., Hermann, B., Penovich, P., Scherer, A., 
Walker, S., 2000. The impact of epilepsy from the patient’s perspective 
I. Descriptions and subjective perceptions. Epilepsy Res. 41, 39–51. 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 182	  
Fleig, A., Penner, R., 2004. The TRPM ion channel subfamily: molecular, 
biophysical and functional features. Trends Pharmacol. Sci. 25, 633–
639. doi:10.1016/j.tips.2004.10.004 
Gee, C.E., Benquet, P., Raineteau, O., Rietschin, L., Kirbach, S.W., Gerber, U., 
2006. NMDA receptors and the differential ischemic vulnerability of 
hippocampal neurons. Eur. J. Neurosci. 23, 2595–2603. 
doi:10.1111/j.1460-9568.2006.04786.x 
Gleissner, U., Helmstaedter, C., Elger, C., 1998. Right hippocampal 
contribution to visual memory: a presurgical and postsurgical study in 
patients with temporal lobe epilepsy. J. Neurol. Neurosurg. Psychiatry 
65, 665–669. 
Gorter, J.A., Gonçalves Pereira, P.M., van Vliet, E.A., Aronica, E., Lopes da 
Silva, F.H., Lucassen, P.J., 2003. Neuronal cell death in a rat model for 
mesial temporal lobe epilepsy is induced by the initial status epilepticus 
and not by later repeated spontaneous seizures. Epilepsia 44, 647–
658. 
Guidelines for Epidemiologic Studies on Epilepsy, 1993. . Epilepsia 34, 592–
596. doi:10.1111/j.1528-1157.1993.tb00433.x 
Harteneck, C., 2005. Function and pharmacology of TRPM cation channels. 
Naunyn. Schmiedebergs Arch. Pharmacol. 371, 307–314. 
doi:10.1007/s00210-005-1034-x 
Hermann, B.P., Seidenberg, M., Schoenfeld, J., Davies, K., 1997. 
Neuropsychological characteristics of the syndrome of mesial temporal 
lobe epilepsy. Arch. Neurol. 54, 369–376. 
Houser, C.R., 2014. Do Structural Changes in GABA Neurons Give Rise to the 
Epileptic State?, in: Scharfman, H.E., Buckmaster, P.S. (Eds.), Issues 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 183	  
in Clinical Epileptology: A View from the Bench, Advances in 
Experimental Medicine and Biology. Springer Netherlands, pp. 151–
160. 
Hu, H.-Z., Gu, Q., Wang, C., Colton, C.K., Tang, J., Kinoshita-Kawada, M., Lee, 
L.-Y., Wood, J.D., Zhu, M.X., 2004. 2-Aminoethoxydiphenyl Borate Is a 
Common Activator of TRPV1, TRPV2, and TRPV3. J. Biol. Chem. 279, 
35741–35748. doi:10.1074/jbc.M404164200 
Inoue, K., Branigan, D., Xiong, Z.-G., 2010. Zinc-induced neurotoxicity 
mediated by transient receptor potential melastatin 7 channels. J. Biol. 
Chem. 285, 7430–7439. doi:10.1074/jbc.M109.040485 
Jefferys, J.G.R., Jiruska, P., de Curtis, M., Avoli, M., 2012. Limbic Network 
Synchronization and Temporal Lobe Epilepsy, in: Noebels, J.L., Avoli, 
M., Rogawski, M.A., Olsen, R.W., Delgado-Escueta, A.V. (Eds.), 
Jasper’s Basic Mechanisms of the Epilepsies. National Center for 
Biotechnology Information (US), Bethesda (MD). 
Jiang, J., Li, M., Yue, L., 2005. Potentiation of TRPM7 inward currents by 
protons. J. Gen. Physiol. 126, 137–150. doi:10.1085/jgp.200409185 
Jiang, X., Newell, E.W., Schlichter, L.C., 2003. Regulation of a TRPM7-like 
current in rat brain microglia. J. Biol. Chem. 278, 42867–42876. 
doi:10.1074/jbc.M304487200 
Jin, J., Desai, B.N., Navarro, B., Donovan, A., Andrews, N.C., Clapham, D.E., 
2008. Deletion of Trpm7 Disrupts Embryonic Development and 
Thymopoiesis Without Altering Mg2+ Homeostasis. Science 322, 756–
760. doi:10.1126/science.1163493 
Joca, H.C., Cruz-Mendes, Y., Oliveira-Abreu, K., Maia-Joca, R.P.M., Barbosa, 
R., Lemos, T.L., Lacerda Beirão, P.S., Leal-Cardoso, J.H., 2012. 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 184	  
Carvacrol decreases neuronal excitability by inhibition of voltage-gated 
sodium channels. J. Nat. Prod. 75, 1511–1517. doi:10.1021/np300050g 
JOHNSON, M., JOHNSON, M., SANDER, J., SANDER, J., 2001. The clinical 
impact of epilepsy genetics. J. Neurol. Neurosurg. Psychiatry 70, 428–
430. doi:10.1136/jnnp.70.4.428 
Kaitsuka, T., Katagiri, C., Beesetty, P., Nakamura, K., Hourani, S., Tomizawa, 
K., Kozak, J.A., Matsushita, M., 2014. Inactivation of TRPM7 kinase 
activity does not impair its channel function in mice. Sci. Rep. 4. 
doi:10.1038/srep05718 
Kalemenev, S.V., Zubareva, O.E., Frolova, E.V., Sizov, V.V., Lavrentyeva, 
V.V., Lukomskaya, N.Y., Kim, K.K., Zaitsev, A.V., Magazanik, L.G., 
2015. Impairment of exploratory behavior and spatial memory in 
adolescent rats in lithium-pilocarpine model of temporal lobe epilepsy. 
Dokl. Biol. Sci. 463, 175–177. doi:10.1134/S0012496615040055 
Kelsey, J.E., Sanderson, K.L., Frye, C.A., 2000. Perforant path stimulation in 
rats produces seizures, loss of hippocampal neurons, and a deficit in 
spatial mapping which are reduced by prior MK-801. Behav. Brain Res. 
107, 59–69. 
Kienzler, F., Jedlicka, P., Vuksic, M., Deller, T., Schwarzacher, S.W., 2006. 
Excitotoxic hippocampal neuron loss following sustained electrical 
stimulation of the perforant pathway in the mouse. Brain Res. 1085, 
195–198. doi:10.1016/j.brainres.2006.02.055 
Kovac, S., Domijan, A.-M., Walker, M.C., Abramov, A.Y., 2012. Prolonged 
seizure activity impairs mitochondrial bioenergetics and induces cell 
death. J. Cell Sci. 125, 1796–1806. doi:10.1242/jcs.099176 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 185	  
Kow, R.L., Jiang, K., Naydenov, A.V., Le, J.H., Stella, N., Nathanson, N.M., 
2014. Modulation of Pilocarpine-Induced Seizures by Cannabinoid 
Receptor 1. PLoS ONE 9, e95922. doi:10.1371/journal.pone.0095922 
Kozak, J.A., Cahalan, M.D., 2003. MIC channels are inhibited by internal 
divalent cations but not ATP. Biophys. J. 84, 922–927. 
doi:10.1016/S0006-3495(03)74909-1 
Kucherenko, Y.V., Lang, F., 2010. Inhibition of cation channels in human 
erythrocytes by spermine. J. Membr. Biol. 237, 93–106. 
doi:10.1007/s00232-010-9310-1 
Lencz, T., McCarthy, G., Bronen, R.A., Scott, T.M., Inserni, J.A., Sass, K.J., 
Novelly, R.A., Kim, J.H., Spencer, D.D., 1992. Quantitative magnetic 
resonance imaging in temporal lobe epilepsy: relationship to 
neuropathology and neuropsychological function. Ann. Neurol. 31, 629–
637. doi:10.1002/ana.410310610 
Lévesque, M., Avoli, M., 2013. The kainic acid model of temporal lobe epilepsy. 
Neurosci. Biobehav. Rev. 37, 2887–2899. 
doi:10.1016/j.neubiorev.2013.10.011 
Li, M., Jiang, J., Yue, L., 2006. Functional characterization of homo- and 
heteromeric channel kinases TRPM6 and TRPM7. J. Gen. Physiol. 127, 
525–537. doi:10.1085/jgp.200609502 
Lipski, J., Park, T.I.H., Li, D., Lee, S.C.W., Trevarton, A.J., Chung, K.K.H., 
Freestone, P.S., Bai, J.-Z., 2006. Involvement of TRP-like channels in 
the acute ischemic response of hippocampal CA1 neurons in brain 
slices. Brain Res. 1077, 187–199. doi:10.1016/j.brainres.2006.01.016 
Löscher, W., 2012. Strategies for antiepileptogenesis: Antiepileptic drugs 
versus novel approaches evaluated in post-status epilepticus models of 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 186	  
temporal lobe epilepsy [WWW Document]. URL 
http://www.ncbi.nlm.nih.gov/books/NBK98148/ (accessed 1.9.13). 
Löscher, W., 2011. Critical review of current animal models of seizures and 
epilepsy used in the discovery and development of new antiepileptic 
drugs. Seizure J. Br. Epilepsy Assoc. 20, 359–368. 
doi:10.1016/j.seizure.2011.01.003 
Löscher, W., Brandt, C., 2010. Prevention or Modification of Epileptogenesis 
after Brain Insults: Experimental Approaches and Translational 
Research. Pharmacol. Rev. 62, 668–700. doi:10.1124/pr.110.003046 
Löscher, W., Hirsch, L.J., Schmidt, D., 2015. The enigma of the latent period in 
the development of symptomatic acquired epilepsy - Traditional view 
versus new concepts. Epilepsy Behav. EB 52, 78–92. 
doi:10.1016/j.yebeh.2015.08.037 
Löscher, W., Klitgaard, H., Twyman, R.E., Schmidt, D., 2013. New avenues for 
anti-epileptic drug discovery and development. Nat. Rev. Drug Discov. 
12, 757–776. doi:10.1038/nrd4126 
Lv, Z., Huang, D., Ye, W., Chen, Z., Huang, W., Zheng, J., 2014. Alteration of 
functional connectivity within visuospatial working memory-related brain 
network in patients with right temporal lobe epilepsy: A resting-state 
fMRI study. Epilepsy Behav. 35, 64–71. 
doi:10.1016/j.yebeh.2014.04.001 
Manford, M., Hart, Y.M., Sander, J.W., Shorvon, S.D., 1992. The National 
General Practice Study of Epilepsy. The syndromic classification of the 
International League Against Epilepsy applied to epilepsy in a general 
population. Arch. Neurol. 49, 801–808. 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 187	  
Massullo, P., Sumoza-Toledo, A., Bhagat, H., Partida-Sánchez, S., 2006. 
TRPM channels, calcium and redox sensors during innate immune 
responses. Semin. Cell Dev. Biol. 17, 654–666. 
doi:10.1016/j.semcdb.2006.11.006 
Matthew, W., Dennis, C., Maria, T., 2006. Hippocampus and Human Disease, 
in: Andersen, P., Morris, R., Amaral, D., Bliss, T., O’Keefe, J. (Eds.), 
The Hippocampus Book. Oxford University Press, pp. 769–812. 
McNulty, S., Fonfria, E., 2005. The role of TRPM channels in cell death. Pflüg. 
Arch. Eur. J. Physiol. 451, 235–242. doi:10.1007/s00424-005-1440-4 
Menon, B., Ramalingam, K., Kumar, R.V., 2012. Oxidative stress in patients 
with epilepsy is independent of antiepileptic drugs. Seizure J. Br. 
Epilepsy Assoc. 21, 780–784. doi:10.1016/j.seizure.2012.09.003 
Michiels, J., Missotten, J., Dierick, N., Fremaut, D., Maene, P., De Smet, S., 
2008. In vitro degradation and in vivo passage kinetics of carvacrol, 
thymol, eugenol and trans-cinnamaldehyde along the gastrointestinal 
tract of piglets. J. Sci. Food Agric. 88, 2371–2381. 
doi:10.1002/jsfa.3358 
Monteilh-Zoller, M.K., Hermosura, M.C., Nadler, M.J.S., Scharenberg, A.M., 
Penner, R., Fleig, A., 2003. TRPM7 provides an ion channel 
mechanism for cellular entry of trace metal ions. J. Gen. Physiol. 121, 
49–60. 
Montell, C., 2005. The TRP superfamily of cation channels. Sci. STKE Signal 
Transduct. Knowl. Environ. 2005, re3. doi:10.1126/stke.2722005re3 
Moser, E.I., Roudi, Y., Witter, M.P., Kentros, C., Bonhoeffer, T., Moser, M.-B., 
2014. Grid cells and cortical representation. Nat. Rev. Neurosci. 15, 
466–481. doi:10.1038/nrn3766 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 188	  
Mosfeldt Laursen, A., 1984. The contribution of in vitro studies to the 
understanding of epilepsy. Acta Neurol. Scand. 69, 367–375. 
Nadkarni, S., Arnedo, V., Devinsky, O., 2007. Psychosis in epilepsy patients. 
Epilepsia 48, 17–19. doi:10.1111/j.1528-1167.2007.01394.x 
Nadler, M.J., Hermosura, M.C., Inabe, K., Perraud, A.L., Zhu, Q., Stokes, A.J., 
Kurosaki, T., Kinet, J.P., Penner, R., Scharenberg, A.M., Fleig, A., 
2001. LTRPC7 is a Mg.ATP-regulated divalent cation channel required 
for cell viability. Nature 411, 590–595. doi:10.1038/35079092 
Neligan, A., Hauser, W.A., Sander, J.W., 2012. The epidemiology of the 
epilepsies. Handb. Clin. Neurol. 107, 113–133. doi:10.1016/B978-0-
444-52898-8.00006-9 
Nicotera, P., Bano, D., 2003. The Enemy at the Gates: Ca2+ Entry through 
TRPM7 Channels and Anoxic Neuronal Death. Cell 115, 768–770. 
doi:10.1016/S0092-8674(03)01019-5 
Nilius, B., Voets, T., 2005. TRP channels: a TR(I)P through a world of 
multifunctional cation channels. Pflüg. Arch. Eur. J. Physiol. 451, 1–10. 
doi:10.1007/s00424-005-1462-y 
Norwood, B.A., Bauer, S., Wegner, S., Hamer, H.M., Oertel, W.H., Sloviter, 
R.S., Rosenow, F., 2011. Electrical stimulation-induced seizures in rats: 
a “dose-response” study on resultant neurodegeneration. Epilepsia 52, 
e109–112. doi:10.1111/j.1528-1167.2011.03159.x 
Numata, T., Shimizu, T., Okada, Y., 2007. TRPM7 is a stretch- and swelling-
activated cation channel involved in volume regulation in human 
epithelial cells. Am. J. Physiol. Cell Physiol. 292, C460–467. 
doi:10.1152/ajpcell.00367.2006 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 189	  
Ohmori, T., Hirashima, Y., Kurimoto, M., Endo, S., Takaku, A., 1996. In vitro 
hypoxia of cortical and hippocampal CA1 neurons: glutamate, nitric 
oxide, and platelet activating factor participate in the mechanism of 
selective neural death in CA1 neurons. Brain Res. 743, 109–115. 
doi:10.1016/S0006-8993(96)01034-7 
Ojo, B., Davies, H., Rezaie, P., Gabbott, P., Colyer, F., Kraev, I., Stewart, M.G., 
2013. Age-Induced Loss of Mossy Fibre Synapses on CA3 Thorns in 
the CA3 Stratum Lucidum. Neurosci. J. 2013, 839535. 
doi:10.1155/2013/839535 
O’Keefe, J., Burgess, N., 1996. Geometric determinants of the place fields of 
hippocampal neurons. Nature 381, 425–428. doi:10.1038/381425a0 
Olney, J.W., deGubareff, T., Sloviter, R.S., 1983. “Epileptic” brain damage in 
rats induced by sustained electrical stimulation of the perforant path. II. 
Ultrastructural analysis of acute hippocampal pathology. Brain Res. 
Bull. 10, 699–712. 
Ottman, R., Annegers, J.F., Risch, N., Hauser, W.A., Susser, M., 1996. 
Relations of Genetic and Environmental Factors in the Etiology of 
Epilepsy. Ann. Neurol. 39, 442–449. doi:10.1002/ana.410390406 
Paravicini, T.M., Chubanov, V., Gudermann, T., 2012. TRPM7: A unique 
channel involved in magnesium homeostasis. Int. J. Biochem. Cell Biol. 
44, 1381–1384. doi:10.1016/j.biocel.2012.05.010 
Parnas, M., Peters, M., Dadon, D., Lev, S., Vertkin, I., Slutsky, I., Minke, B., 
2009. Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian 
TRPM7 channels. Cell Calcium 45, 300–309. 
doi:10.1016/j.ceca.2008.11.009 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 190	  
Pauli, E., Hildebrandt, M., Romstöck, J., Stefan, H., Blümcke, I., 2006. Deficient 
memory acquisition in temporal lobe epilepsy is predicted by 
hippocampal granule cell loss. Neurology 67, 1383–1389. 
doi:10.1212/01.wnl.0000239828.36651.73 
Pedersen, S.F., Owsianik, G., Nilius, B., 2005. TRP channels: an overview. Cell 
Calcium 38, 233–252. doi:10.1016/j.ceca.2005.06.028 
Peinelt, C., Lis, A., Beck, A., Fleig, A., Penner, R., 2008. 2-
Aminoethoxydiphenyl borate directly facilitates and indirectly inhibits 
STIM1-dependent gating of CRAC channels. J. Physiol. 586, 3061–
3073. doi:10.1113/jphysiol.2008.151365 
Pereira, F.R.S., Alessio, A., Sercheli, M.S., Pedro, T., Bilevicius, E., Rondina, 
J.M., Ozelo, H.F.B., Castellano, G., Covolan, R.J.M., Damasceno, B.P., 
Cendes, F., 2010. Asymmetrical hippocampal connectivity in mesial 
temporal lobe epilepsy: evidence from resting state fMRI. BMC 
Neurosci. 11, 66. doi:10.1186/1471-2202-11-66 
Pitkänen, A., Lukasiuk, K., 2009. Molecular and cellular basis of 
epileptogenesis in symptomatic epilepsy. Epilepsy Behav. EB 14 Suppl 
1, 16–25. doi:10.1016/j.yebeh.2008.09.023 
Pitkänen, A., Nissinen, J., Nairismägi, J., Lukasiuk, K., Gröhn, O.H.J., 
Miettinen, R., Kauppinen, R., 2002. Progression of neuronal damage 
after status epilepticus and during spontaneous seizures in a rat model 
of temporal lobe epilepsy. Prog. Brain Res. 135, 67–83. 
doi:10.1016/S0079-6123(02)35008-8 
Pitkänen, A., Schwartzkroin, P.A., Moshé, S.L., 2005. Models of Seizures and 
Epilepsy. Academic Press. 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 191	  
Porter, R.J., Dhir, A., Macdonald, R.L., Rogawski, M.A., 2012. Chapter 39 - 
Mechanisms of action of antiseizure drugs, in: Theodore, H.S. and W.H. 
(Ed.), Handbook of Clinical Neurology, Epilepsy. Elsevier, pp. 663–681. 
Pun, R.Y.K., Rolle, I.J., Lasarge, C.L., Hosford, B.E., Rosen, J.M., Uhl, J.D., 
Schmeltzer, S.N., Faulkner, C., Bronson, S.L., Murphy, B.L., Richards, 
D.A., Holland, K.D., Danzer, S.C., 2012. Excessive activation of mTOR 
in postnatally generated granule cells is sufficient to cause epilepsy. 
Neuron 75, 1022–1034. doi:10.1016/j.neuron.2012.08.002 
Racine, R.J., 1972. Modification of seizure activity by electrical stimulation. II. 
Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281–294. 
Ramaswamy, S., 2015. Exciting times for inhibition: GABAergic synaptic 
transmission in dentate gyrus interneuron networks. Front. Neural 
Circuits 9, 13. doi:10.3389/fncir.2015.00013 
Ramsey, I.S., Delling, M., Clapham, D.E., 2006. An introduction to TRP 
channels. Annu. Rev. Physiol. 68, 619–647. 
doi:10.1146/annurev.physiol.68.040204.100431 
Rausch, R., Babb, T.L., 1993. Hippocampal neuron loss and memory scores 
before and after temporal lobe surgery for epilepsy. Arch. Neurol. 50, 
812–817. 
Reddy, D.S., Kuruba, R., 2013. Experimental models of status epilepticus and 
neuronal injury for evaluation of therapeutic interventions. Int. J. Mol. 
Sci. 14, 18284–18318. doi:10.3390/ijms140918284 
Rogawski, M.A., Löscher, W., 2004. The neurobiology of antiepileptic drugs. 
Nat. Rev. Neurosci. 5, 553–564. doi:10.1038/nrn1430 
Rozsa, E., Robotka, H., Nagy, D., Farkas, T., Sas, K., Vecsei, L., Toldi, J., 
2008. The pentylenetetrazole-induced activity in the hippocampus can 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 192	  
be inhibited by the conversion of l-kynurenine to kynurenic acid: An in 
vitro study. Brain Res. Bull. 76, 474–479. 
doi:10.1016/j.brainresbull.2007.12.001 
Rubio, C., Rubio-Osornio, M., Retana-Márquez, S., Verónica Custodio, M.L., 
Paz, C., 2010. In vivo experimental models of epilepsy. Cent. Nerv. 
Syst. Agents Med. Chem. 10, 298–309. 
Rugg-Gunn, F., Smalls, J. (Eds.), 2013. Epilepsy 2013 from Membranes to 
Mankind: A Practical Guide to Epilepsy, 14th edition edition. ed. 
Epilepsy Society. 
Runnels, L.W., Yue, L., Clapham, D.E., 2002. The TRPM7 channel is 
inactivated by PIP(2) hydrolysis. Nat. Cell Biol. 4, 329–336. 
doi:10.1038/ncb781 
Runnels, L.W., Yue, L., Clapham, D.E., 2001. TRP-PLIK, a Bifunctional Protein 
with Kinase and Ion Channel Activities. Science 291, 1043–1047. 
doi:10.1126/science.1058519 
Savanthrapadian, S., Meyer, T., Elgueta, C., Booker, S.A., Vida, I., Bartos, M., 
2014. Synaptic Properties of SOM- and CCK-Expressing Cells in 
Dentate Gyrus Interneuron Networks. J. Neurosci. 34, 8197–8209. 
doi:10.1523/JNEUROSCI.5433-13.2014 
Scharfman, H.E., Gray, W.P., 2007. Relevance of seizure-induced 
neurogenesis in animal models of epilepsy to the etiology of temporal 
lobe epilepsy. Epilepsia 48 Suppl 2, 33–41. 
Schmidt, D., Schachter, S.C., 2014. Drug treatment of epilepsy in adults. BMJ 
348. doi:10.1136/bmj.g254 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 193	  
Schmitz, C., Deason, F., Perraud, A.-L., 2007. Molecular components of 
vertebrate Mg2+-homeostasis regulation. Magnes. Res. Off. Organ Int. 
Soc. Dev. Res. Magnes. 20, 6–18. 
Schmitz, C., Perraud, A.-L., Johnson, C.O., Inabe, K., Smith, M.K., Penner, R., 
Kurosaki, T., Fleig, A., Scharenberg, A.M., 2003. Regulation of 
Vertebrate Cellular Mg2+ Homeostasis by TRPM7. Cell 114, 191–200. 
doi:10.1016/S0092-8674(03)00556-7 
Schwarcz, R., Witter, M.P., 2002. Memory impairment in temporal lobe 
epilepsy: the role of entorhinal lesions. Epilepsy Res. 50, 161–177. 
doi:10.1016/S0920-1211(02)00077-3 
Scimemi, A., Schorge, S., Kullmann, D.M., Walker, M.C., 2006. Epileptogenesis 
is associated with enhanced glutamatergic transmission in the perforant 
path. J. Neurophysiol. 95, 1213–1220. doi:10.1152/jn.00680.2005 
Semah, F., Picot, M.C., Adam, C., Broglin, D., Arzimanoglou, A., Bazin, B., 
Cavalcanti, D., Baulac, M., 1998. Is the underlying cause of epilepsy a 
major prognostic factor for recurrence? Neurology 51, 1256–1262. 
Serrano, G.E., Lelutiu, N., Rojas, A., Cochi, S., Shaw, R., Makinson, C.D., 
Wang, D., FitzGerald, G.A., Dingledine, R., 2011. Ablation of 
cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens 
brain inflammation after status epilepticus. J. Neurosci. Off. J. Soc. 
Neurosci. 31, 14850–14860. doi:10.1523/JNEUROSCI.3922-11.2011 
Seyfried, T.N., Glaser, G.H., 1985. A Review of Mouse Mutants as Genetic 
Models of Epilepsy. Epilepsia 26, 143–150. doi:10.1111/j.1528-
1157.1985.tb05398.x 
Shepherd, G.M. (Ed.), 2004. The Synaptic Organization of the Brain, 5th 
Edition, 5 edition. ed. Oxford University Press, Oxford ; New York. 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 194	  
Sloviter, R.S., 1983. “Epileptic” brain damage in rats induced by sustained 
electrical stimulation of the perforant path. I. Acute electrophysiological 
and light microscopic studies. Brain Res. Bull. 10, 675–697. 
Sloviter, R.S., Damiano, B.P., 1981. Sustained electrical stimulation of the 
perforant path duplicates kainate-induced electrophysiological effects 
and hippocampal damage in rats. Neurosci. Lett. 24, 279–284. 
Sloviter, R.S., Lømo, T., 2012. Updating the lamellar hypothesis of 
hippocampal organization. Front. Neural Circuits 6, 102. 
doi:10.3389/fncir.2012.00102 
Spiers, H.J., 2012. Hippocampal Formation, in: Ramachandran, V.S. (Ed.), 
Encyclopedia of Human Behavior (Second Edition). Academic Press, 
San Diego, pp. 297–304. 
Sun, H.-S., Jackson, M.F., Martin, L.J., Jansen, K., Teves, L., Cui, H., 
Kiyonaka, S., Mori, Y., Jones, M., Forder, J.P., Golde, T.E., Orser, B.A., 
Macdonald, J.F., Tymianski, M., 2009. Suppression of hippocampal 
TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat. 
Neurosci. 12, 1300–1307. doi:10.1038/nn.2395 
Swinkels, W.A.M., Kuyk, J., Dyck, R. van, Spinhoven, P., 2005. Psychiatric 
comorbidity in epilepsy. Epilepsy Behav. 7, 37–50. 
doi:10.1016/j.yebeh.2005.04.012 
Tassi, L., Meroni, A., Deleo, F., Villani, F., Mai, R., Russo, G.L., Colombo, N., 
Avanzini, G., Falcone, C., Bramerio, M., Citterio, A., Garbelli, R., 
Spreafico, R., 2009. Temporal lobe epilepsy: neuropathological and 
clinical correlations in 243 surgically treated patients. Epileptic Disord. 
Int. Epilepsy J. Videotape 11, 281–292. doi:10.1684/epd.2009.0279 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 195	  
Téllez-Zenteno, J.F., Hernández-Ronquillo, L., Téllez-Zenteno, J.F., 
Hernández-Ronquillo, L., 2011. A Review of the Epidemiology of 
Temporal Lobe Epilepsy, A Review of the Epidemiology of Temporal 
Lobe Epilepsy. Epilepsy Res. Treat. Epilepsy Res. Treat. 2012, 2012, 
e630853. doi:10.1155/2012/630853, 10.1155/2012/630853 
Theodore, W.H., Porter, R.J., 1995. Epilepsy: 100 elementary principles. 
Saunders. 
Thom, M., 2014. Review: Hippocampal sclerosis in epilepsy: a neuropathology 
review. Neuropathol. Appl. Neurobiol. 40, 520–543. 
doi:10.1111/nan.12150 
Thompson, P.J., Corcoran, R., 1992. Everyday memory failures in people with 
epilepsy. Epilepsia 33 Suppl 6, S18–20. 
Tian, S.-L., Jiang, H., Zeng, Y., Li, L.-L., Shi, J., 2007. NGF-induced reduction 
of an outward-rectifying TRPM7-like current in rat CA1 hippocampal 
neurons. Neurosci. Lett. 419, 93–98. doi:10.1016/j.neulet.2007.04.020 
Tisserand, R., Young, R., 2013. Essential Oil Safety: A Guide for Health Care 
Professionals. Elsevier Health Sciences. 
Trinka, E., Höfler, J., Zerbs, A., 2012. Causes of status epilepticus. Epilepsia 
53, 127–138. doi:10.1111/j.1528-1167.2012.03622.x 
Tsien, J.Z., Huerta, P.T., Tonegawa, S., 1996. The Essential Role of 
Hippocampal CA1 NMDA Receptor–Dependent Synaptic Plasticity in 
Spatial Memory. Cell 87, 1327–1338. doi:10.1016/S0092-
8674(00)81827-9 
Ugawa, S., Ishida, Y., Ueda, T., Inoue, K., Nagao, M., Shimada, S., 2007. 
Nafamostat mesilate reversibly blocks acid-sensing ion channel 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 196	  
currents. Biochem. Biophys. Res. Commun. 363, 203–208. 
doi:10.1016/j.bbrc.2007.08.133 
Vezzani, A., Friedman, A., Dingledine, R.J., 2013. The role of inflammation in 
epileptogenesis. Neuropharmacology 69, 16–24. 
doi:10.1016/j.neuropharm.2012.04.004 
Vicedomini, J.P., Nadler, J.V., 1987. A model of status epilepticus based on 
electrical stimulation of hippocampal afferent pathways. Exp. Neurol. 
96, 681–691. 
Vorhees, C.V., Williams, M.T., 2014. Assessing Spatial Learning and Memory 
in Rodents. ILAR J. 55, 310–332. doi:10.1093/ilar/ilu013 
Walker, M., 2007. Neuroprotection in epilepsy. Epilepsia 48 Suppl 8, 66–68. 
Walker, M.C., 2009. Basic physiology of limbic status epilepticus. Epilepsia 50 
Suppl 12, 5–6. doi:10.1111/j.1528-1167.2009.02373.x 
Walker, M.C., Kovac, S., 2015. Seize the moment that is thine: how should we 
define seizures? Brain J. Neurol. 138, 1127–1128. 
doi:10.1093/brain/awv091 
Walker, M.C., Perry, H., Scaravilli, F., Patsalos, P.N., Shorvon, S.D., Jefferys, 
J.G., 1999. Halothane as a neuroprotectant during constant stimulation 
of the perforant path. Epilepsia 40, 359–364. 
Walker, M.C., White, H.S., Sander, J.W.A.S., 2002. Disease modification in 
partial epilepsy. Brain J. Neurol. 125, 1937–1950. 
Worrell, G.A., Sencakova, D., Jack, C.R., Flemming, K.D., Fulgham, J.R., So, 
E.L., 2002. Rapidly progressive hippocampal atrophy: evidence for a 
seizure-induced mechanism. Neurology 58, 1553–1556. 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 197	  
Wykes, R.C., Heeroma, J.H., Mantoan, L., Zheng, K., MacDonald, D.C., 
Deisseroth, K., Hashemi, K.S., Walker, M.C., Schorge, S., Kullmann, 
D.M., 2012. Optogenetic and potassium channel gene therapy in a 
rodent model of focal neocortical epilepsy. Sci. Transl. Med. 4, 
161ra152. doi:10.1126/scitranslmed.3004190 
Wyllie, E., Cascino, G.D., Gidal, B.E., Goodkin, H.P., 2012. Wyllie’s Treatment 
of Epilepsy: Principles and Practice. Lippincott Williams & Wilkins. 
Wyllie’s Treatment of Epilepsy: Principles and Practice by Elaine Wyllie | eBook 
on, n.d. 
Xiong, Z.Q., Saggau, P., Stringer, J.L., 2000. Activity-dependent intracellular 
acidification correlates with the duration of seizure activity. J. Neurosci. 
Off. J. Soc. Neurosci. 20, 1290–1296. 
Yamaguchi, S., Rogawski, M.A., 1992. Effects of anticonvulsant drugs on 4-
aminopyridine-induced seizures in mice. Epilepsy Res. 11, 9–16. 
Yin, J., Kuebler, W.M., 2010. Mechanotransduction by TRP channels: general 
concepts and specific role in the vasculature. Cell Biochem. Biophys. 
56, 1–18. doi:10.1007/s12013-009-9067-2 
Yu, H., Zhang, Z.-L., Chen, J., Pei, A., Hua, F., Qian, X., He, J., Liu, C.-F., Xu, 
X., 2012. Carvacrol, a food-additive, provides neuroprotection on focal 
cerebral ischemia/reperfusion injury in mice. PloS One 7, e33584. 
doi:10.1371/journal.pone.0033584 
Zierler, S., Yao, G., Zhang, Z., Kuo, W.C., Pörzgen, P., Penner, R., Horgen, 
F.D., Fleig, A., 2011. Waixenicin A inhibits cell proliferation through 
magnesium-dependent block of transient receptor potential melastatin 7 
(TRPM7) channels. J. Biol. Chem. 286, 39328–39335. 
doi:10.1074/jbc.M111.264341 
TRPM7 channels and epilepsy 
Chapter 8.  References 
 
 
 198	  
 
